title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
Why Illumina  ( ILMN )  Shares Are Plunging Today - Illumina  ( NASDAQ:ILMN ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30358573/illumina-shares-tank-after-annual-guidance-fall-short-of-expectations,2023-01-10 20:02:09,"During JP Morgan Conference, Illumina Inc ILMN announced interim Q4 FY22 sales of $1.075 billion, lower than $1.10 billion in Q3 FY22. Grail sales reached $30 million. It recorded NextSeq 1k/2k shipments and orders and 750 total sequencing instruments shipped.",AMGN,0.223866,0.070809,Neutral
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/01/30360272/100-invested-in-amgen-15-years-ago-would-be-worth-this-much-today,2023-01-10 19:33:13,"Amgen AMGN has outperformed the market over the past 15 years by 5.15% on an annualized basis producing an average annual return of 12.37%. Currently, Amgen has a market capitalization of $145.75 billion.",AMGN,0.983605,0.387251,Bullish
Amgen  ( AMGN )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2036997/amgen-amgn-dips-more-than-broader-markets-what-you-should-know,2023-01-09 22:50:22,"Amgen (AMGN) closed the most recent trading day at $270.12, moving -1.85% from the previous trading session.",AMGN,0.664882,0.136771,Neutral
Why Amgen  ( AMGN )  is Poised to Beat Earnings Estimates Again,https://www.zacks.com/stock/news/2036911/why-amgen-amgn-is-poised-to-beat-earnings-estimates-again,2023-01-09 17:10:13,Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,AMGN,0.427184,0.46888,Bullish
"The Dogs of the Dow Worked Last Year, But This Strategy Could Make You More Money in 2023",https://www.fool.com/investing/2023/01/08/dogs-of-the-dow-strategy-make-more-money-2023/,2023-01-08 10:52:00,Meet the Dogs of the S&P.,AMGN,0.060848,0.11501,Neutral
Amgen  ( NASDAQ:AMGN )  Upgraded to Strong-Buy at StockNews.com,https://reporter.am/2023/01/07/amgen-nasdaqamgn-upgraded-to-strong-buy-at-stocknews-com.html,2023-01-07 09:52:45,StockNews.com upgraded shares of Amgen ( NASDAQ:AMGN - Get Rating ) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. Several other equities research analysts also recently weighed in on the stock.,AMGN,0.778291,0.325089,Somewhat-Bullish
"Amgen  ( NASDAQ:AMGN )  Raised to ""Strong-Buy"" at StockNews.com",https://www.etfdailynews.com/2023/01/07/amgen-nasdaqamgn-raised-to-strong-buy-at-stocknews-com/,2023-01-07 09:52:44,StockNews.com upgraded shares of Amgen ( NASDAQ:AMGN - Get Rating ) from a buy rating to a strong-buy rating in a research report released on Friday morning. AMGN has been the topic of several other reports.,AMGN,0.739709,0.363553,Bullish
"Blueprint Medicines Appoints John Tsai, M.D. to its Board of Directors",https://www.prnewswire.com/news-releases/blueprint-medicines-appoints-john-tsai-md-to-its-board-of-directors-301715456.html,2023-01-06 14:00:00,"CAMBRIDGE, Mass., Jan. 6, 2023 /PRNewswire/ -- Blueprint Medicines Corporation ( NASDAQ: BPMC ) today announced the appointment of John Tsai, M.D., to its board of directors.",AMGN,0.029399,0.038889,Neutral
3 Top U.S. Stocks to Watch in January,https://www.fool.com/investing/2023/01/06/3-top-us-stocks-to-watch-in-january/,2023-01-06 13:30:00,"Considering their potential, all three stocks look like good opportunities today.",AMGN,0.101582,0.078752,Neutral
"CRISPR, Genetics And AI - Why 2023 Could Be Biotech's Year",https://www.investors.com/news/technology/biotech-stocks-how-crispr-genetics-and-ai-could-drive-a-2023-inflection/,2023-01-06 13:00:00,"Biotech Stocks: How CRISPR, Genetics And AI Could Drive A 2023 ... Investor's Business Daily ...",AMGN,0.07031,-0.066329,Neutral
Healthcare Stocks Had a Strong 2022. It Isn't Too Late to Buy.,https://www.barrons.com/articles/healthcare-stocks-defensive-buy-51672951649,2023-01-05 20:49:00,"Healthcare stocks held their ground in 2022 when the rest of the market was getting crushed. Some still look cheap enough to considering buying. The Health Care Select Sector SPDR ETF ( XLV ) dropped only 3.5% in 2022. That isn't bad at all, considering the S&P 500 's 19% drop.",AMGN,0.406197,0.011316,Neutral
'Dogs Of The Dow' Stocks Just Paid Off; Here The Top 10 For 2023,https://www.investors.com:443/etfs-and-funds/sectors/sp500-dogs-of-the-dow-stocks-just-paid-off-here-are-the-top-10-for-2023/,2023-01-05 13:00:00,'Dogs Of The Dow' Stocks Just Paid Off. Here The Top 10 For 2023 Investor's Business Daily ...,AMGN,0.239698,0.116685,Neutral
'Dogs Of The Dow' Stocks Just Paid Off; Here The Top 10 For 2023,https://www.investors.com/etfs-and-funds/sectors/sp500-dogs-of-the-dow-stocks-just-paid-off-here-are-the-top-10-for-2023/,2023-01-05 13:00:00,'Dogs Of The Dow' Stocks Just Paid Off. Here The Top 10 For 2023 Investor's Business Daily ...,AMGN,0.239698,0.116685,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, MLVF, TCFC - Apollo Endosurgery  ( NASDAQ:APEN ) , Horizon Therapeutics  ( NASDAQ:HZNP ) ",https://www.benzinga.com/pressreleases/23/01/g30290362/shareholder-investigation-halper-sadeh-llc-investigates-apen-hznp-mlvf-tcfc,2023-01-05 11:39:50,"NEW YORK, Jan. 05, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Apollo Endosurgery, Inc.",AMGN,0.132368,0.092288,Neutral
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2035383/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-01-04 23:00:23,"Amgen (AMGN) closed at $264.39 in the latest trading session, marking a +1.05% move from the prior day.",AMGN,0.640349,0.251001,Somewhat-Bullish
AMGN: 2 Biotech Stocks to Buy Amid a Blazing Hot Run,https://stocknews.com/news/amgn-gild-2-biotech-stocks-to-buy-amid-a-blazing-hot-run/,2023-01-04 15:20:50,"After being thrust into the limelight during the pandemic, biotech stocks fell out of investors' radars as people got vaccinated and resumed their regular activities. However, with a rapidly aging population and the rise of sedentary lifestyles, diseases are on the rise, driving the demand for ...",AMGN,0.457566,0.355837,Bullish
Could the Dow Jones Keep Outperforming the Nasdaq Composite in 2023?,https://www.fool.com/investing/2023/01/04/dow-jones-keep-outperforming-the-nasdaq-2023/,2023-01-04 13:20:00,"The Dow crushed the Nasdaq in 2022, but that's no guarantee of a lasting trend.",AMGN,0.045139,0.15403,Somewhat-Bullish
10 Best Stock Traders In Congress In 2022  ( Spoiler: Nancy Pelosi Isn't No. 1 )  - SPDR S&P 500  ( ARCA:SPY ) ,https://www.benzinga.com/government/23/01/30260466/10-best-stock-traders-in-congress-in-2022-spoiler-nancy-pelosi-isnt-no-1,2023-01-03 18:53:15,A new report was out about the performance of members of the U.S. Congress who bought and sold stocks and options in 2022. The report broke down unusual trading activity from members of Congress and also showed the members who beat the returns of the S&P 500.,AMGN,0.087985,0.234377,Somewhat-Bullish
"How Two Key Question In 2023 Could Spark, Or Slam, This Pharma",https://www.investors.com/research/ibd-stock-of-the-day/lly-stock-the-key-issues-in-2023-that-could-spark-or-topple-shares/,2023-01-03 17:45:00,"LLY Stock: The Key Issues In 2023 That Could Spark, Or Topple ... Investor's Business Daily ...",AMGN,0.226477,0.101762,Neutral
"Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development",https://www.globenewswire.com/news-release/2023/01/03/2582180/0/en/Zai-Lab-Announces-the-Appointment-of-Dr-Rafael-G-Amado-as-President-Head-of-Global-Oncology-Research-and-Development.html,2023-01-03 13:30:00,"SHANGHAI and CAMBRIDGE, Mass., Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- Zai Lab Limited ( NASDAQ: ZLAB. HKEX: 9688 ) a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced the appointment of Rafael G.",AMGN,0.040622,0.009716,Neutral
"Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development - Zai Lab  ( NASDAQ:ZLAB ) ",https://www.benzinga.com/pressreleases/23/01/g30256385/zai-lab-announces-the-appointment-of-dr-rafael-g-amado-as-president-head-of-global-oncology-resear,2023-01-03 13:30:00,"SHANGHAI and CAMBRIDGE, Mass., Jan. 03, 2023 ( GLOBE NEWSWIRE ) -- Zai Lab Limited ZLAB HKEX: 9688 ) ) ) a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced the appointment of Rafael G.",AMGN,0.039548,0.008712,Neutral
Futures Rise Ahead Of Economic Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-economic-data-tesla-skids-on-q4-deliveries-miss/,2023-01-03 13:23:00,Dow Jones Futures Rise 150 Points Ahead Of Economic Data. Tesla ... Investor's Business Daily ...,AMGN,0.089685,0.027602,Neutral
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2042210/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-01-20 22:45:21,"In the latest trading session, Amgen (AMGN) closed at $263.24, marking a +0.46% move from the previous day.",AMGN,0.653386,0.347592,Somewhat-Bullish
Mirati  ( MRTX )  KRAS Candidate MRTX1133 to Enter Clinical Stage,https://www.zacks.com/stock/news/2042025/mirati-mrtx-kras-candidate-mrtx1133-to-enter-clinical-stage,2023-01-20 15:11:00,"Mirati Therapeutics (MRTX) announces IND clearance for oral KRASG12D selective inhibitor, MRTX1133, by the FDA. It is set to initiate phase I/II study in early 2023.",AMGN,0.158519,0.213926,Somewhat-Bullish
Amgen  ( AMGN )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2041652/amgen-amgn-dips-more-than-broader-markets-what-you-should-know,2023-01-19 22:50:19,"Amgen (AMGN) closed at $262.03 in the latest trading session, marking a -0.89% move from the prior day.",AMGN,0.640349,0.10576,Neutral
Horizon  ( HZNP )  Dazodalibep Meets Goal in Sjogren's Syndrome Study,https://www.zacks.com/stock/news/2041575/horizon-hznp-dazodalibep-meets-goal-in-sjogrens-syndrome-study,2023-01-19 17:59:00,"Horizon Therapeutics (HZNP) announces that a phase II Sjogren's syndrome study of its candidate, dazodalibep, meets the primary endpoint for the second population.",AMGN,0.117774,0.123682,Neutral
Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide,https://www.benzinga.com/analyst-ratings/analyst-color/23/01/30487796/analyst-views-novo-nordisks-upcoming-obesity-drug-data-to-lay-grounds-for-eli-lilly,2023-01-19 17:19:18,"Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's NVO SELECT CV outcomes study, which is guided to complete in ~mid-2023. In large-cap land, there two two obesity leaders - Eli Lilly And Co LLY and Novo Nordisk.",AMGN,0.31282,0.0,Neutral
AMGN: 3 Stocks to Help You Start the New Year off Right,https://stocknews.com/news/amgn-pii-infa-3-stocks-to-help-you-start-the-new-year-off/,2023-01-19 15:48:36,"Sky-high inflation moderated for the sixth consecutive month in December. In line with the Dow Jones estimate, CPI increased by 6.5% year-over-year and dipped 0.1% over the prior month.",AMGN,0.275867,0.142318,Neutral
Stocks Lower After Jobless Claims; Netflix Earnings Due,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-netflix-earnings-due/,2023-01-19 15:00:00,Dow Jones Falls 225 Points After Jobless Claims. Netflix Earnings Due Investor's Business Daily ...,AMGN,0.138943,0.086509,Neutral
Futures Rise Ahead Of Wholesale Inflation Report; Tesla Extends Gains,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-inflation-report-united-airlines-jumps-on-earnings-tesla-stock-races-higher/,2023-01-18 13:25:00,Dow Jones Futures Rise Ahead Of Key Inflation Report. Tesla Stock ... Investor's Business Daily ...,AMGN,0.122737,0.118063,Neutral
StockNews.com Upgrades Amgen  ( NASDAQ:AMGN )  to Strong-Buy,https://www.etfdailynews.com/2023/01/18/stocknews-com-upgrades-amgen-nasdaqamgn-to-strong-buy/,2023-01-18 07:38:43,StockNews.com upgraded shares of Amgen ( NASDAQ:AMGN - Get Rating ) from a buy rating to a strong-buy rating in a report issued on Tuesday morning. Other equities analysts have also issued research reports about the stock.,AMGN,0.7464,0.230011,Somewhat-Bullish
"Futures Drop Ahead Of Manufacturing, Inflation Data",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-drop-ahead-of-manufacturing-inflation-data-goldman-sachs-falls-on-earnings-miss/,2023-01-17 13:17:00,"Dow Jones futures dropped Tuesday morning ahead of New York regional manufacturing data, and another round of key inflation numbers due out Wednesday. Fourth-quarter earnings season continues Tuesday, with results from Dow Jones stock Goldman Sachs ( GS ) and Morgan Stanley ( MS ) .",AMGN,0.130571,0.1216,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2039887/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-01-17 11:20:08,Smart Beta ETF report for ...,AMGN,0.12013,0.062124,Neutral
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises,https://www.zacks.com/stock/news/2039564/how-to-find-strong-medical-stocks-slated-for-positive-earnings-surprises,2023-01-16 13:50:06,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,AMGN,0.366061,0.345166,Somewhat-Bullish
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2039301/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-01-13 22:45:19,"Amgen (AMGN) closed at $271.73 in the latest trading session, marking a +0.3% move from the prior day.",AMGN,0.697241,0.223996,Somewhat-Bullish
"Drug companies favor biotech meds over pills, citing new U.S. law",https://www.reuters.com/business/healthcare-pharmaceuticals/drug-companies-favor-biotech-meds-over-pills-citing-new-us-law-2023-01-13/,2023-01-13 12:10:00,"[1/2] Eli Lilly & Co CEO Dave Ricks poses for a picture at the J.P. Morgan Healthcare Conference in San Francisco, California, U.S., January 9, 2018. REUTERS/Caroline Humer",AMGN,0.043979,0.329029,Somewhat-Bullish
Dow Jones Rallies; Tesla Faces China Fear; AMC Stock Lags APE,https://www.investors.com/market-trend/stock-market-today/dow-jones-rallies-tesla-stock-reverses-amid-elon-musk-fear-amc-stock-lags-ape-stock-bed-bath-beyond-bbby-stock/,2023-01-12 20:13:00,Dow Jones Rallies. Tesla Faces China Fear. AMC Stock Lags APE Investor's Business Daily ...,AMGN,0.086556,-0.131859,Neutral
Will 2023 be the year that pharma M&A makes a comeback?,https://www.marketwatch.com/story/will-2023-be-the-year-that-pharma-m-a-makes-a-comeback-11673548184,2023-01-12 18:29:00,A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies.,AMGN,0.123526,0.080674,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAL, HZNP, TIG, QUMU - Horizon Therapeutics  ( NASDAQ:HZNP ) , Qumu  ( NASDAQ:QUMU ) ",https://www.benzinga.com/pressreleases/23/01/g30390854/shareholder-investigation-halper-sadeh-llc-investigates-sal-hznp-tig-qumu,2023-01-12 14:40:05,"NEW YORK, Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Salisbury Bancorp, Inc.",AMGN,0.140076,0.095066,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2037707/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-01-11 11:20:09,Sector ETF report for ...,AMGN,0.136113,0.07192,Neutral
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years,https://www.benzinga.com/news/earnings/23/01/30622872/heres-how-much-you-would-have-made-owning-amgen-stock-in-the-last-15-years,2023-01-30 14:32:31,"Amgen AMGN has outperformed the market over the past 15 years by 4.34% on an annualized basis producing an average annual return of 11.95%. Currently, Amgen has a market capitalization of $135.34 billion.",AMGN,0.983605,0.387251,Bullish
"Global Pharmaceutical Drug Delivery Market worth $2,206.5 billion by 2026 - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/01/g30622827/global-pharmaceutical-drug-delivery-market-worth-2-206-5-billion-by-2026-exclusive-report-by-marke,2023-01-30 14:30:00,"Chicago, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report ""Pharmaceutical Drug Delivery Market Size, Growth by Route of Administration ( Oral, Injectors, Implantable, Syrups, Gels, Pulmonary, Solutions, Tablets, Syringes ) , Application ( Cancer, Diabetes ) , ...",AMGN,0.087503,0.021576,Neutral
Is a Surprise Coming for Amgen  ( AMGN )  This Earnings Season?,https://www.zacks.com/stock/news/2046150/is-a-surprise-coming-for-amgen-amgn-this-earnings-season,2023-01-30 13:34:00,Amgen (AMGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,AMGN,0.906257,0.608664,Bullish
Drugmaker Amgen lays off 300 U.S. employees,https://www.reuters.com/business/amgen-lays-off-300-employees-2023-01-30/,2023-01-30 13:16:00,"Jan 30 ( Reuters ) - Drugmaker Amgen Inc ( AMGN.O ) said on Monday that it let go about 300 U.S. employees or about 1.2% of its total workforce, citing recent organizational changes to its commercial team.",AMGN,0.299478,0.0,Neutral
AMGN: 4 Biotech Stocks to Keep an Eye on in 2023,https://stocknews.com/news/amgn-bntx-exel-taipy-4-biotech-stocks-to-keep-an-eye-on-in-2023/,2023-01-30 12:59:53,AMGN: 4 Biotech Stocks to Keep an Eye on in ...,AMGN,0.26217,0.008002,Neutral
"With 14.1% CAGR, Monoclonal Antibody Therapy Market Size Worth USD 451.89 Billion by 2028",https://www.benzinga.com/pressreleases/23/01/g30618366/with-14-1-cagr-monoclonal-antibody-therapy-market-size-worth-usd-451-89-billion-by-2028,2023-01-30 10:54:18,"Pune, India, Jan. 30, 2023 ( GLOBE NEWSWIRE ) -- The global monoclonal antibody therapy market size was USD 157.33 billion in 2020. The market is projected to grow from USD 178.50 billion in 2021 to USD 451.89 billion in 2028 at a CAGR of 14.1% in the 2021-2028 period.",AMGN,0.035983,0.406781,Bullish
"Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch",https://www.benzinga.com/news/earnings/23/01/30616031/can-market-sustain-upward-momentum-in-tech-heavy-earnings-week-apple-amazon-amd-alphabet-ford-among,2023-01-29 22:25:32,"With a full week of earnings behind us, it's time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. Some of the big tech names that fell short are Intel Corp. INTC and Texas Instruments, Inc.",AMGN,0.081092,0.236315,Somewhat-Bullish
Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead,2023-01-29 12:17:00,Jobs report to give further clues about where economy is headed ...,AMGN,0.057907,0.045965,Neutral
Jobs report to give further clues about where economy is headed | Business,https://www.cnn.com/2023/01/29/investing/stocks-week-ahead/index.html,2023-01-29 12:17:00,Jobs report to give further clues about where economy is headed ...,AMGN,0.057907,0.045965,Neutral
StockNews.com Downgrades Amgen  ( NASDAQ:AMGN )  to Buy,https://www.defenseworld.net/2023/01/28/stocknews-com-downgrades-amgen-nasdaqamgn-to-buy.html,2023-01-28 06:14:48,"Amgen ( NASDAQ:AMGN - Get Rating ) was downgraded by analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Thursday.",AMGN,0.885652,0.384705,Bullish
"Investing Action Plan - January Wrap: Apple, OPEC, Exxon And The Fed",https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-january-wrap-apple-opec-exxon-and-the-fed/,2023-01-27 23:20:00,"Investing Action Plan - January Wrap: Apple, OPEC, Exxon And ... Investor's Business Daily ...",AMGN,0.082167,0.00207,Neutral
Rule 15 ( c )  Announcement - Rule 15 Proposal to Horizon Equity Award Holders and Participants in the Horizon Employee Share Purchase Plan,https://www.prnewswire.com/news-releases/rule-15c-announcement---rule-15-proposal-to-horizon-equity-award-holders-and-participants-in-the-horizon-employee-share-purchase-plan-301732733.html,2023-01-27 21:05:00,Rule 15 ( c ) Announcement - Rule 15 Proposal to Horizon Equity ... PR ...,AMGN,0.015063,0.00681,Neutral
T: 3 Stocks That Could Make You a Millionaire in the Long Term,https://stocknews.com/news/t-amgn-hum-3-stocks-that-could-make-you-a-millionaire-in-the/,2023-01-27 19:13:00,"As per yesterday's report by the Commerce Department, the U.S. economy demonstrated its robustness with a better-than-expected GDP growth rate of 2.9% during the fourth quarter of 2022. Despite shouldering the burden of progressive interest-rate hikes by the Federal Reserve, economic growth ...",AMGN,0.240965,0.183545,Somewhat-Bullish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2045043/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-01-26 22:45:20,"Amgen (AMGN) closed the most recent trading day at $254.88, moving -0.65% from the previous trading session.",AMGN,0.570165,0.251538,Somewhat-Bullish
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2044698/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-01-26 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.209819,0.11704,Neutral
2 Top Biotech Stocks to Buy for the Long Haul,https://www.fool.com/investing/2023/01/26/2-top-biotech-stocks-to-buy-for-the-long-haul/,2023-01-26 13:23:00,Developing new products will be key to the success of both of these biotech leaders.,AMGN,0.482982,0.328328,Somewhat-Bullish
Earnings Preview: GSK  ( GSK )  Q4 Earnings Expected to Decline,https://www.zacks.com/stock/news/2044121/earnings-preview-gsk-gsk-q4-earnings-expected-to-decline,2023-01-25 15:00:46,Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMGN,0.176502,0.02414,Neutral
Amgen  ( AMGN )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2043986/amgen-amgn-to-report-q4-earnings-whats-in-the-cards,2023-01-25 13:59:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.",AMGN,0.519739,0.310462,Somewhat-Bullish
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer,https://www.benzinga.com/pressreleases/23/01/g30532774/codexis-announces-appointment-of-sri-ryali-as-chief-financial-officer,2023-01-23 21:05:00,"REDWOOD CITY, Calif., Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Codexis, Inc. CDXS, a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately. Mr. Ryali brings 20 years of finance and commercial experience in life sciences to ...",AMGN,0.052226,0.023913,Neutral
"Global Obesity Drugs Market valued at $2.3 billion  ( 2022 ) , is Projected to Witness a Significant Growth Rate of 25% by 2027",https://www.benzinga.com/pressreleases/23/01/g30524086/global-obesity-drugs-market-valued-at-2-3-billion-2022-is-projected-to-witness-a-significant-growt,2023-01-23 14:30:00,"BRUSSELS, BELGIUM, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by using body mass index ( BMI ) as a baseline. A BMI of over 30 is considered obese and over 25 is ...",AMGN,0.051003,0.0,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2042463/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-01-23 11:20:08,Sector ETF report for ...,AMGN,0.133841,0.071297,Neutral
2 Top Passive-Income Stocks to Own in 2023,https://www.fool.com/investing/2023/01/22/2-top-passive-income-stocks-to-own-in-2023/,2023-01-23 00:05:00,These dividend stocks can deliver both downside protection and capital appreciation.,AMGN,0.390613,0.065625,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMRA, AGFS, SAL, HZNP",https://www.benzinga.com/pressreleases/23/01/g30515785/shareholder-investigation-halper-sadeh-llc-investigates-imra-agfs-sal-hznp,2023-01-22 15:03:54,"NEW YORK, Jan. 22, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Imara Inc.",AMGN,0.143415,0.096318,Neutral
3 Dividend Stocks You Can Safely Hold for Years,https://www.fool.com/investing/2023/01/21/3-dividend-stocks-safely-hold-for-years/,2023-01-21 14:00:00,Look for the top companies in businesses the world perpetually needs.,AMGN,0.162255,0.135053,Neutral
"Biotech Stock Roundup: AMGN, GILD, BMY, REGN's Q4 Results, KPRX Up on Study Update",https://www.zacks.com/stock/news/2052486/biotech-stock-roundup-amgn-gild-bmy-regns-q4-results-kprx-up-on-study-update,2023-02-09 17:00:00,"Earnings results from Amgen (AMGN), Gilead (GILD) and others are the key highlights from the biotech sector during the past week.",AMGN,0.128135,0.116537,Neutral
"AbbVie  ( ABBV )  Beats Q4 Earnings Estimates, Misses on Sales",https://www.zacks.com/stock/news/2052457/abbvie-abbv-beats-q4-earnings-estimates-misses-on-sales,2023-02-09 16:37:00,"AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.",AMGN,0.203386,0.063117,Neutral
AbbVie Kicks Off Humira Battle Year With Light Profit Guidance,https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q4-2022/,2023-02-09 15:53:00,AbbVie Stock: Profit Outlook Widely Misses As U.S. Humira Battle ... Investor's Business Daily ...,AMGN,0.136499,0.087423,Neutral
How To Profit From Amgen Stock's Plunge Using Options,https://www.investors.com/research/options/how-to-profit-from-amgen-stocks-plunge-using-options/,2023-02-09 14:37:00,"Amgen ( AMGN ) stock has had a difficult few weeks, with the stock dropping from 295 to 240. It is currently the most oversold stock in the Dow Jones Industrial Average. When a quality company has a big drop like this, I like to use a strategy called a diagonal put spread.",AMGN,0.521465,0.107473,Neutral
AbbVie's 2023 profit forecast misses as Humira faces heat from rivals,https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-2023-profit-forecast-misses-humira-faces-heat-rivals-2023-02-09/,2023-02-09 12:51:00,"Feb 9 ( Reuters ) - AbbVie Inc ( ABBV.N ) on Thursday forecast 2023 profit below Wall Street expectations, in the first outlook since its blockbuster arthritis drug Humira faced competition from cheaper biosimilars in the United States early this year.",AMGN,0.116914,0.14859,Neutral
AMGN: 5 Biotech Stocks That Could Make You Rich in 10 Years,https://stocknews.com/news/amgn-vrtx-uthr-jazz-exel-5-biotech-stocks-that-could-make-you-rich-in-10/,2023-02-08 18:54:11,"Despite the lingering macroeconomic headwinds, mergers and acquisitions in the biotech industry are getting back to normal levels as larger companies are making acquisitions to realize their growth plans and gain access to innovative technologies.",AMGN,0.241204,0.064129,Neutral
Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/02/08/beat-the-dow-with-this-unstoppable-dividend-stock/,2023-02-08 10:50:00,This pharmaceutical company has outperformed the Dow Jones index over the last 10 years.,AMGN,0.549581,0.356292,Bullish
StockNews.com has downgraded Amgen  ( NASDAQ:AMGN )  to Buy.,https://beststocks.com/stocknews-com-has-downgraded-amgen-nasdaqamgn-t/,2023-02-08 04:21:09,"Amgen ( NASDAQ: AMGN ) was downgraded from a ""strong-buy"" rating to a ""buy"" rating by StockNews.com in a research note that was made available to investors on Friday. StockNews.com recommended investors purchase the company's stock. Several other research companies have also recently published ...",AMGN,0.615462,0.134174,Neutral
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2050918/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-02-07 14:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.207127,0.115872,Neutral
Sandoz Biologics License Application for proposed biosimilar denosumab accepted by US FDA,https://www.globenewswire.com/news-release/2023/02/06/2601765/0/en/Sandoz-Biologics-License-Application-for-proposed-biosimilar-denosumab-accepted-by-US-FDA.html,2023-02-06 06:15:00,"Basel, February 06, 2023 - Sandoz, a global leader in off-patent ( generic and biosimilar ) medicines, today announced that the US Food and Drug Administration ( FDA ) has accepted its Biologics License Application ( BLA ) for proposed biosimilar denosumab.",AMGN,0.106384,0.038033,Neutral
StockNews.com Downgrades Amgen  ( NASDAQ:AMGN )  to Buy,https://www.defenseworld.net/2023/02/05/stocknews-com-downgrades-amgen-nasdaqamgn-to-buy-2.html,2023-02-05 08:02:44,"Amgen ( NASDAQ:AMGN - Get Rating ) was downgraded by research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued to investors on Friday. AMGN has been the subject of a number of other reports.",AMGN,0.858597,0.465409,Bullish
"Amgen  ( NASDAQ:AMGN )  Downgraded to ""Buy"" at StockNews.com",https://reporter.am/2023/02/05/amgen-nasdaqamgn-downgraded-to-buy-at-stocknews-com.html,2023-02-05 08:02:41,"Amgen ( NASDAQ:AMGN - Get Rating ) was downgraded by equities research analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research report issued to clients and investors on Friday. A number of other research analysts have also commented on the stock.",AMGN,0.839664,0.463751,Bullish
Will These 3 Potential Blockbuster Drugs Lift Bristol Myers Squibb?,https://www.fool.com/investing/2023/02/04/will-these-3-potential-blockbuster-drugs-lift-bris/,2023-02-04 14:26:00,Bristol Myers Squibb has solid replacements for its blockbusters that are facing a patent cliff.,AMGN,0.052455,0.129582,Neutral
"Age-related macular degeneration  ( AMD )  market size to increase by USD 4,360.68 million: Evolving Opportunities with Amgen Inc and Apellis Pharmaceuticals Inc among others - Technavio",https://www.prnewswire.com/news-releases/age-related-macular-degeneration-amd-market-size-to-increase-by-usd-4-360-68-million-evolving-opportunities-with-amgen-inc-and-apellis-pharmaceuticals-inc-among-others---technavio-301737365.html,2023-02-04 00:15:00,Age-related macular degeneration ( AMD ) market size to increase by ... PR ...,AMGN,0.042571,-0.038461,Neutral
"Market Rally Powers Higher On Tame Fed, Meta: Weekly Review",https://www.investors.com/news/market-rally-powers-higher-on-tame-fed-meta-earnings-apple-google-amazon/,2023-02-03 18:43:00,"The stock market rally marched higher as the Fed took a slightly more dovish stance, even though it said rate hikes will continue. Friday's superhot jobs report failed to derail the uptrend. Big earnings or guidance continued to be mixed, but Meta Platforms ( META ) skyrocketed on cost cuts, ...",AMGN,0.061263,-0.177453,Somewhat-Bearish
"Top 5 Health Care Stocks That May Rally - AstraZeneca  ( NASDAQ:AZN ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/02/30711755/top-5-health-care-stocks-that-may-rally,2023-02-03 18:35:21,"The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",AMGN,0.25168,-0.092788,Neutral
Why Amgen Stock Wilted on Wednesday,https://www.fool.com/investing/2023/02/01/why-amgen-stock-wilted-on-wednesday/,2023-02-01 22:06:19,The company's latest quarter wasn't its most impressive.,AMGN,0.688096,0.147331,Neutral
Why Amgen Shares Are Falling,https://www.benzinga.com/news/earnings/23/02/30671264/why-amgen-shares-are-falling,2023-02-01 16:35:17,"Amgen, Inc. AMGN shares are trading lower by 3.85% to $242.69 Wednesday morning after the company reported fourth-quarter financial results and issued FY23 revenue guidance below estimates. Amgen reported quarterly earnings of $4.09 per share which met the analyst consensus estimate.",AMGN,0.810649,0.044935,Neutral
"Amgen  ( AMGN )  Beats on Q4 Earnings, 2023 Sales View Disappoints",https://www.zacks.com/stock/news/2047780/amgen-amgn-beats-on-q4-earnings-2023-sales-view-disappoints,2023-02-01 15:31:00,"Amgen (AMGN) beats Q4 estimates for earnings and sales. It launches Amjevita in the United States, which is the first biosimilar of Humira to be launched in the country.",AMGN,0.440459,0.21468,Somewhat-Bullish
"Stocks Lower Ahead Of Fed Rate Hike Decision, Powell Comments",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-fed-rate-hike-decision-powell-comments-tesla-stock-rallies/,2023-02-01 15:13:00,"The Dow Jones Industrial Average briefly fell more than 225 points Wednesday ahead of the Federal Reserve's rate hike decision, due in the afternoon. Social media company Snap ( SNAP ) plunged as much as 13% after falling short of revenue estimates.",AMGN,0.058976,-0.060987,Neutral
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2047605/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-02-01 14:10:05,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.213988,0.118854,Neutral
"Futures dip on jitters ahead of ADP report, Fed decision",https://www.reuters.com/markets/us/futures-dip-jitters-ahead-adp-report-fed-decision-2023-02-01/,2023-02-01 13:01:49,Feb 1 ( Reuters ) - U.S. stock index futures slipped on Wednesday as investors cautiously waited for the Federal Reserve's decision on interest rates later in the day and a reading on private job additions last month.,AMGN,0.074926,-0.276831,Somewhat-Bearish
Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline,https://www.benzinga.com/general/biotech/23/02/30662304/amgen-records-slight-fall-in-quarterly-earnings-lower-covid-19-manufacturing-pacts-impact-bottoml,2023-02-01 12:42:41,"Amgen Inc's AMGN fourth-quarter revenues were $6.84 billion, beating the consensus of $6.76 billion, largely unchanged from Q4 2021, and benefited from a 4% increase in product sales, offset by lower COVID-19 manufacturing collaboration revenues.",AMGN,0.79415,0.390581,Bullish
"Compared to Estimates, Amgen  ( AMGN )  Q4 Earnings: A Look at Key Metrics",https://www.zacks.com/stock/news/2047355/compared-to-estimates-amgen-amgn-q4-earnings-a-look-at-key-metrics,2023-02-01 09:24:00,"While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",AMGN,0.327366,0.082926,Neutral
AMGEN POSTS FULL TRANSCRIPT AND AUDIO REPLAY OF FOURTH QUARTER AND FULL YEAR 2022 EARNINGS WEBCAST,https://investingnews.com/amgen-posts-full-transcript-and-audio-replay-of-fourth-quarter-and-full-year-2022-earnings-webcast/,2023-02-01 04:54:05,- Amgen ( NASDAQ : AMGN ) posted the full transcript and audio replay of the company's 2022 fourth quarter and full year financial results webcast from earlier today.,AMGN,0.83383,0.0,Neutral
Amgen  ( AMGN )  Surpasses Q4 Earnings and Revenue Estimates,https://www.zacks.com/stock/news/2047247/amgen-amgn-surpasses-q4-earnings-and-revenue-estimates,2023-01-31 22:25:07,"Amgen (AMGN) delivered earnings and revenue surprises of 1.24% and 1.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.404563,0.143992,Neutral
"Amgen's Q4 tops views, but 2023 guidance falls on lower end of expectations",https://www.marketwatch.com/story/amgens-q4-tops-views-but-2023-guidance-falls-on-lower-end-of-expectations-11675201439,2023-01-31 21:44:00,"Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of Wall Street's expectations.",AMGN,0.9973,0.057812,Neutral
Amgen revenue falls slightly as Lilly COVID deal contributes less,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-revenue-falls-slightly-lilly-covid-deal-contributes-less-2023-01-31/,2023-01-31 21:38:00,Jan 31 ( Reuters ) - Amgen Inc ( AMGN.O ) on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.,AMGN,0.092569,-0.066788,Neutral
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS,https://investingnews.com/amgen-reports-fourth-quarter-and-full-year-2022-financial-results/,2023-01-31 21:29:41,Amgen ( NASDAQ: AMGN ) today announced financial results for the fourth quarter and full year 2022 versus comparable periods in 2021.,AMGN,0.240769,0.128417,Neutral
"Amgen Sinks On Mixed Earnings, Light Outlook",https://www.investors.com/news/technology/amgen-stock-amgen-earning-q4-2022/,2023-01-31 21:15:00,"Amgen Stock Dips On Mixed Quarterly Report, Light Guidance Investor's Business Daily ...",AMGN,0.94375,0.265201,Somewhat-Bullish
The Key Element Missing From Amgen's 2023 Outlook,https://www.investors.com/amgen-stock-amgen-earning-q4-2022/,2023-01-31 21:15:00,"Amgen Stock Dips On Mixed Quarterly Report, Light Guidance ... Investor's Business Daily ...",AMGN,0.67831,-0.06744,Neutral
First Humira Biosimilar Price Highlights Cost-Saving Challenges,https://www.barrons.com/articles/humira-amgen-abbvie-drug-generic-51675188334,2023-01-31 18:07:00,"AbbVie 's anti-inflammatory drug Humira, one of the top-selling prescription drugs in history, is facing generic-style competition for the first time this week since its introduction 20 years ago.",AMGN,0.779232,0.590864,Bullish
"AbbVIe's Two-Decade Humira Monopoly Ends; So, What's Next?",https://www.investors.com/news/technology/abbvie-stock-the-20-year-humira-monopoly-ends-so-what-is-next/,2023-01-31 17:12:00,"AbbVie Stock: The 20-Year Humira Monopoly Ends. So, What's Next ... Investor's Business Daily ...",AMGN,0.419153,-0.076223,Neutral
"Pfizer  ( PFE )  Q4 Earnings Top, 2023 View Disappoints, Stock Down",https://www.zacks.com/stock/news/2047097/pfizer-pfe-q4-earnings-top-2023-view-disappoints-stock-down,2023-01-31 15:49:00,Pfizer (PFE) beats estimates for Q4 earnings and sales. Its 2023 financial outlook falls short of expectations. Stock down in pre-market trading.,AMGN,0.06171,0.080197,Neutral
This newsletter editor has been recommending stocks and bonds this year and says the rally has room to run,https://www.marketwatch.com/story/this-newsletter-editor-has-been-recommending-stocks-and-bonds-this-year-and-says-the-rally-has-room-to-run-11675165998,2023-01-31 11:53:00,"Our contrarian call of the day from founder and editor-in-chief of The Kobeissi Letter, Adam Kobeissi is not buying any of the market angst on Wall Street right now.",AMGN,0.087503,-0.065551,Neutral
"Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times",https://www.benzinga.com/news/earnings/23/01/30636919/nasdaq-s-p-futures-lower-as-powell-team-kick-off-2-day-fed-meeting-analyst-says-positive-january-ha,2023-01-31 11:37:36,Trading in the major U.S. index futures suggests stocks may extend their losses for a second straight session. Caution will likely be the watchword as Fed Chairman Jerome Powell and his team kickstart a two-day monetary policy meeting on Tuesday.,AMGN,0.10607,0.0,Neutral
Amgen launches biosimilar version of AbbVie's Humira,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-launches-biosimilar-version-abbvies-humira-2023-01-31/,2023-01-31 11:19:00,Amgen launches biosimilar version of ...,AMGN,0.247838,0.033967,Neutral
"AbbVie's Humira gets a U.S. rival, but costs could stay high",https://www.reuters.com/business/healthcare-pharmaceuticals/abbvies-humira-gets-us-rival-costs-could-stay-high-2023-01-31/,2023-01-31 11:18:00,"Jan 31 ( Reuters ) - U.S. patients will finally get access to cheaper versions of AbbVie Inc's ( ABBV.N ) blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.",AMGN,0.041466,-0.054937,Neutral
Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S.,https://www.wsj.com/articles/blockbuster-arthritis-drug-humira-faces-competition-from-first-lower-price-copycat-in-u-s-11675146649,2023-01-31 11:00:00,"The arthritis therapy is coming up against its first so-called biosimilar, after more than $135 billion in sales and fights over how long its patents last.",AMGN,0.407844,0.339138,Somewhat-Bullish
Stock Market Today: Stocks Close Mostly Lower Amid Rate-Hike Worries,https://www.kiplinger.com/investing/stocks/stock-market-today-021723-stocks-close-lower-amid-rate-hike-worries,2023-02-17 21:15:34,Stock Market Today: Stocks Close Mostly Lower Amid Rate-Hike ... Kiplinger's Personal Finance ...,AMGN,0.141726,0.087498,Neutral
Best Stocks To Buy Now? 2 Dow Jones Stocks To Watch In 2023,https://stockmarket.com/featured/best-stocks-to-buy-now-2-dow-jones-stocks-to-watch-in-2023-2023-02-17,2023-02-17 19:07:06,"The Dow Jones Industrial Average, also known as the Dow Jones, is one of the most widely followed stock market indices in the world. Comprised of 30 large-cap companies, it is often used as a barometer for the overall health of the stock market and the broader economy.",AMGN,0.393771,0.068494,Neutral
"Dow Jones Battles At Key Support; Sellers Hit Chevron And Salesforce; DraftKings, Deere, Kinsale, HubSpot Surge On Earnings",https://www.investors.com/market-trend/stock-market-today/dow-jones-battles-key-support-level-sellers-hit-chevron-salesforce/,2023-02-17 15:50:00,Dow Jones Battles At Key Support. Sellers Hit Chevron And ... Investor's Business Daily ...,AMGN,0.118354,0.012792,Neutral
'Biosimilars' Were Supposed to Tame Costs for Drugs Like Humira. It Isn't Working.,https://www.barrons.com/articles/biosimilar-drug-costs-humira-a5f42f37,2023-02-17 06:45:00,"This was expected to be the year that Humira, AbbVie 's blockbuster $90,000-a-year arthritis treatment and the best-selling biopharmaceutical in history, loses its chokehold on the healthcare system. After more than 20 years, the patents protecting AbbVie 's ( ticker: ABBV ) cash cow expired at ...",AMGN,0.716023,-0.143749,Neutral
"DDevon Energy, Broadcom, Amgen And This Company Report Earnings Next Week: CNBC's 'Final Trades' - Broadcom  ( NASDAQ:AVGO ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/02/30937180/devon-energy-broadcom-amgen-and-this-company-report-earnings-next-week-cnbcs-final-trades,2023-02-16 14:31:29,"On CNBC's ""Halftime Report Final Trades,"" Requisite Capital Management's Bryn Talkington praised Devon Energy Corporation DVN for its free cash flow. ""Take advantage of the opportunity,"" she added. Jason Snipe of Odyssey Capital Advisors said Broadcom Inc.",AMGN,0.524949,-0.608273,Bearish
Is This the Start of a Nightmare for AbbVie Stock?,https://www.fool.com/investing/2023/02/16/is-this-the-start-of-a-nightmare-for-abbvie-stock/,2023-02-16 14:10:00,"With a competitor set to devour market share, stormy waters might be ahead.",AMGN,0.058903,0.071026,Neutral
2 Market-Beating Dividend Stocks to Buy With $500,https://www.fool.com/investing/2023/02/16/2-market-beating-dividend-stocks-to-buy-with-500/,2023-02-16 12:45:00,These two leading healthcare stocks have been rewarding shareholders with dividends for a while.,AMGN,0.391158,0.364032,Bullish
Amgen to raise $24 billion after seeing about $90 billion in demand for mega bond deal,https://www.marketwatch.com/story/amgen-sees-about-56-billion-in-demand-for-mega-bond-deal-3c5fbf15,2023-02-15 19:21:00,"Amgen looks to raise $24 billion on Wednesday, ranking in the top 10 in terms of largest U.S. corporate bond deals ever, according to Informa Global Markets.",AMGN,0.331765,0.293752,Somewhat-Bullish
"Amgen Nearing Buy Point With Great Dividend and Fundamentals - Amgen  ( NASDAQ:AMGN ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/23/02/30929683/amgen-nearing-buy-point-with-great-dividend-and-fundamentals,2023-02-15 18:01:13,"Amgen Inc. AMGN is right near the bottom of a more than 6-year trend channel. That presents a potentially good buy point. The stock also has a long history of strong fundamentals. Therefore, this could be a trade that lasts two to six months, or it could be a long-term hold.",AMGN,0.47379,0.233006,Somewhat-Bullish
5 Least-Hurt Biotech ETFs of the Last Week,https://www.zacks.com/stock/news/2054858/5-least-hurt-biotech-etfs-of-the-last-week,2023-02-15 18:00:00,"Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.",AMGN,0.121343,0.166173,Somewhat-Bullish
"Entera Bio Announces FDA's Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis",https://www.globenewswire.com/news-release/2023/02/15/2608935/0/en/Entera-Bio-Announces-FDA-s-Acceptance-of-a-Type-D-Meeting-Review-to-Affirm-Design-of-the-Pivotal-Phase-3-Protocol-for-EB613-PTH-Mini-Tablets-as-the-First-Oral-Osteoanabolic-Treatme.html,2023-02-15 15:00:00,"JERUSALEM, Feb. 15, 2023 ( GLOBE NEWSWIRE ) -- Entera Bio Ltd. ( NASDAQ: ENTX ) , ( ""Entera"" or the ""Company"" ) a leader in the development of orally delivered peptides and therapeutic proteins, today announced that a Type D meeting protocol review has been accepted by the U.S.",AMGN,0.027164,0.044744,Neutral
Billionaires Loaded Up on These 3 Stocks in the Fourth Quarter of 2022,https://www.fool.com/investing/2023/02/15/billionaires-loaded-up-on-these-3-stocks-in-the-fo/,2023-02-15 15:00:00,"Billionaire-led investing firms scooped up shares of Paramount Global, Bank of America, and Horizon Therapeutics in Q4.",AMGN,0.12546,-0.016574,Neutral
"The Zacks Analyst Blog Highlights Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics",https://www.zacks.com/stock/news/2054525/the-zacks-analyst-blog-highlights-chevron-novo-nordisk-amgen-starbucks-and-general-dynamics,2023-02-15 13:29:00,"Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics are part of the Zacks top Analyst Blog.",AMGN,0.724687,0.0,Neutral
Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition,https://www.marketwatch.com/story/amgen-plans-mega-bond-deal-to-help-fund-28-billion-horizon-therapeutics-acquisition-50c5636e,2023-02-14 19:38:00,"Amgen Inc. plans to finance its acquisition of Horizon Therapeutics in the corporate bond market, underscoring how the Federal Reserve's inflation fight isn't drying up mega deals on Wall Street.",AMGN,0.588876,0.192357,Somewhat-Bullish
"Top Research Reports for Chevron, Novo Nordisk & Amgen",https://www.zacks.com/research-daily/2054049/top-research-reports-for-chevron-novo-nordisk-amgen,2023-02-14 16:10:00,"Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).",AMGN,0.389889,0.293576,Somewhat-Bullish
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2053379/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-02-13 14:10:04,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.204072,0.11455,Neutral
"Top 5 Health Care Stocks That Could Blast Off This Month - Azenta  ( NASDAQ:AZTA ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/02/30875515/top-5-health-care-stocks-that-could-blast-off-this-month,2023-02-13 13:28:07,"The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",AMGN,0.323078,0.080336,Neutral
Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules,https://www.benzinga.com/pressreleases/23/02/g30873748/hexagon-bio-raises-77-3-million-series-b-financing-and-strengthens-leadership-to-expand-novel-comp,2023-02-13 12:00:46,"Hexagon's interdisciplinary platform enables broad opportunities across multiple therapeutic areas; company initially focused on oncology and infectious diseases Tara Arvedson, Ph.D., former Executive Director of Oncology Research at Amgen, who joined Hexagon last year as SVP, Research, has been ...",AMGN,0.039944,0.061795,Neutral
AbbVie Sidesteps 'Draconian' Expectations For Humira Downfall,https://www.investors.com/news/technology/abbvie-stock-sidesteps-draconian-expectations-for-humira-dropoff/,2023-02-10 15:52:00,AbbVie Stock Sidesteps 'Draconian' Expectations For Humira ... Investor's Business Daily ...,AMGN,0.205807,-0.089984,Neutral
A Look Into Amgen's Debt - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/03/31136348/a-look-into-amgens-debt,2023-03-01 19:26:24,"Shares of Amgen Inc. AMGN fell by 17.83% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials. One key aspect of a companies financials is its debt, but before we understand the importance of debt, ...",AMGN,0.287762,-0.113081,Neutral
"New Month, Old News? Stocks Retreat on Mixed Economic Data, China Signals - Tesla  ( NASDAQ:TSLA ) , Kohl's  ( NYSE:KSS ) ",https://www.benzinga.com/markets/23/03/31134116/new-month-old-news-stocks-retreat-on-mixed-economic-data-china-signals,2023-03-01 17:55:44,"( Wednesday market open ) The new month looked a lot like the old one early Wednesday as an overnight rally in stock futures pulled back ahead of the open. Recent rallies, including one that faded yesterday, haven't demonstrated staying power.",AMGN,0.035138,0.119016,Neutral
AMGEN TO PRESENT NEW REPATHA® AND OLPASIRAN DATA AT ACC,https://investingnews.com/amgen-to-present-new-repatha-r-and-olpasiran-data-at-acc/,2023-03-01 14:32:20,"Amgen ( NASDAQ: AMGN ) today announced new Repatha ® ( evolocumab ) combined data from the Phase 3 FOURIER and FOURIER Open Label Extension ( OLE ) studies and the Phase 2 OCEAN ( a ) -DOSE study of investigational olpasiran, an siRNA that reduces lipoprotein ( a ) [Lp ( a ) ] by more than 90%.",AMGN,0.313876,0.191948,Somewhat-Bullish
3 Value Stocks You'll Regret Not Buying on the Dip,https://www.fool.com/investing/2023/03/01/3-value-stocks-youll-regret-not-buying-on-the-dip/,2023-03-01 13:45:00,These three undervalued healthcare stocks are solid picks for patient investors.,AMGN,0.200688,0.096585,Neutral
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2059274/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-02-27 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.207571,0.116065,Neutral
Biosimilars Market Size Worth  ( $136+ Billion by 2028 )  Lead by Intravenous Segment  ( 36% CAGR )  - Exclusive Research Study by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31066933/biosimilars-market-size-worth-136-billion-by-2028-lead-by-intravenous-segment-36-cagr-exclusive-re,2023-02-27 12:39:55,"New York, Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Biosimilars Market Size, Share, Growth, Strategy & Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Indication ( Cancer, Diabetes, Autoimmune Diseases, and Other Diseases ) , Drug Class ( ...",AMGN,0.022181,0.139643,Neutral
KO: 2 Large-Cap Stocks You Can Buy for Under $100,https://stocknews.com/news/ko-azn-amgn-2-large-cap-stocks-you-can-buy-for-under-100/,2023-02-24 15:42:52,KO: 2 Large-Cap Stocks You Can Buy for Under ...,AMGN,0.087824,0.006308,Neutral
AZN: 1 Pharma Stock Poised for a Promising 2023,https://stocknews.com/news/azn-nvo-bmy-nvs-1-pharma-stock-poised-for-a-promising-2023/,2023-02-23 11:10:58,AZN: 1 Pharma Stock Poised for a Promising ...,AMGN,0.075754,0.006138,Neutral
AMGN: 3 Biotech Stocks to Buy and Hold for the Next 20 Years,https://stocknews.com/news/amgn-biib-fold-3-biotech-stocks-to-buy-and-hold-for-the-next/,2023-02-22 15:21:22,"The biotech industry has witnessed significant growth in recent years, primarily driven by sustained demand amid an increasing prevalence of chronic diseases and an aging population. The COVID-19 pandemic has further catalyzed the industry with enormous breakthroughs.",AMGN,0.300477,0.202116,Somewhat-Bullish
Want More Reliable Dividend Income? Buy This Dividend King.,https://www.fool.com/investing/2023/02/22/want-more-reliable-dividend-income-buy-abbv-stock/,2023-02-22 12:30:00,This big pharma company possesses a deep drug portfolio and pipeline.,AMGN,0.057628,0.070008,Neutral
This Recession-Proof Company Has a Best-in-Class Dividend,https://www.fool.com/investing/2023/02/22/this-recession-proof-company-has-a-best-in-class-d/,2023-02-22 12:30:00,"Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.",AMGN,0.339046,0.41866,Bullish
Want Growing Passive Income? Buy This Dow Jones Stock,https://www.fool.com/investing/2023/02/22/want-rising-passive-income-buy-this-dow-stock-amgn/,2023-02-22 11:05:00,This big pharma company possesses a solid drug pipeline.,AMGN,0.401331,0.338678,Somewhat-Bullish
How Are Biotech ETFs Reacting to Q4 Earnings Releases?,https://www.zacks.com/stock/news/2057067/how-are-biotech-etfs-reacting-to-q4-earnings-releases,2023-02-21 19:21:00,The latest earnings from some of the big biotech players came in at mixed this reporting season.,AMGN,0.144563,-0.060782,Neutral
"Nervous Consumers Make for Nervous Market as Walmart, Home Depot Share Disappointing Outlooks - Home Depot  ( NYSE:HD ) , Walmart  ( NYSE:WMT ) ",https://www.benzinga.com/news/earnings/23/02/30991127/nervous-consumers-make-for-nervous-market-as-walmart-home-depot-share-disappointing-outlooks,2023-02-21 16:31:40,( Tuesday market open ) Wall Street's recent resilience could be tested today. Disappointing tidings from Walmart WMT and Home Depot HD joined pressure from the fixed income market and a rising dollar to push stock index futures into the red.,AMGN,0.033167,0.117744,Neutral
AMGN: 3 Biotech Stocks to Buy in 2023 That Could Help Set You up for Life,https://stocknews.com/news/amgn-gild-uthr-3-biotech-stocks-to-buy-in-2023-that-could-help/,2023-02-21 14:03:17,AMGN: 3 Biotech Stocks to Buy in 2023 That Could Help Set You up ... ...,AMGN,0.260838,0.169863,Somewhat-Bullish
PFE: 4 Pharma Stocks to Buy Now for the Long Haul,https://stocknews.com/news/pfe-azn-bmy-zts-4-pharma-stocks-to-buy-now-for-the-long-haul/,2023-02-20 14:53:40,"The pharmaceutical sector has thrived in recent years and is anticipated to reach $1.5 trillion this year. The integration of innovative technologies has opened a new world of possibilities for the industry. Moreover, customized medicine should potentially bolster the healthcare sector, ...",AMGN,0.052455,-0.019066,Neutral
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2056323/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-02-20 14:10:03,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.208017,0.114663,Neutral
Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio,https://www.prnewswire.com/news-releases/cancer-supportive-care-market-to-grow-at-a-cagr-of-4-62-by-2027-north-america-to-account-for-39-of-market-growth---technavio-301749739.html,2023-02-20 04:15:00,Cancer supportive care market to grow at a CAGR of 4.62% by 2027 ... PR ...,AMGN,0.036926,0.21926,Somewhat-Bullish
"BCL-2  ( b-cell lymphoma 2 )  inhibitors market size to increase by USD 1,657.08 million between 2022 and 2027; Growing approval of combination therapy identified as key trend - Technavio",https://www.prnewswire.com/news-releases/bcl-2-b-cell-lymphoma-2-inhibitors-market-size-to-increase-by-usd-1-657-08-million-between-2022-and-2027-growing-approval-of-combination-therapy-identified-as-key-trend---technavio-301768138.html,2023-03-10 22:45:00,BCL-2 ( b-cell lymphoma 2 ) inhibitors market size to increase by ... PR ...,AMGN,0.04111,-0.035496,Neutral
"Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs - bluebird bio  ( NASDAQ:BLUE ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/03/31300483/hefty-listing-price-of-new-drugs-for-cancer-rare-diseases-put-pressure-on-annual-hike-for-older-d,2023-03-10 18:10:42,"New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's ( NASDAQ: AMGN ) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per patient monthly when it launched in 2021.",AMGN,0.310843,-0.149909,Neutral
Esperion Therapeutics  ( ESPR )  Down 24% in a Week: Here's Why,https://www.zacks.com/stock/news/2064252/esperion-therapeutics-espr-down-24-in-a-week-heres-why,2023-03-10 16:05:00,Shares of Esperion Therapeutics (ESPR) fell last week as the company's cardiovascular outcome CLEAR study results failed to meet investor expectations.,AMGN,0.099271,0.008738,Neutral
"Dow Jones Dips, Tech Stocks Pressured; First Republic Plunges 60% As Contagion Fears Hammer Financials",https://www.investors.com/market-trend/stock-market-today/dow-jones-dips-tech-stocks-pressured-contagion-fears-hammer-financial-stocks-first-republic-plunges/,2023-03-10 15:36:00,"Dow Jones Dips, Tech Stocks Pressured. First Republic Plunges 60 ... Investor's Business Daily ...",AMGN,0.136888,0.0,Neutral
Esperion Therapeutics  ( ESPR )  Down 24% in a Week: Here's Why,https://www.zacks.com/stock/news/2064252/esperion-therapeutics-espr-down-24-in-a-week-heres-why,2023-03-10 15:05:00,Shares of Esperion Therapeutics (ESPR) fell last week as the company's cardiovascular outcome CLEAR study results failed to meet investor expectations.,AMGN,0.099271,0.008738,Neutral
VZ: 3 Dow Stocks to Buy More of in March 2023,https://stocknews.com/news/vz-amgn-ibm-3-dow-stocks-to-buy-more-of-in-march-2023/,2023-03-10 14:37:14,VZ: 3 Dow Stocks to Buy More of in March ...,AMGN,0.230114,0.171756,Somewhat-Bullish
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields - Gilead Sciences  ( NASDAQ:GILD ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/03/31295242/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-delivering-high-dividend-yie,2023-03-10 13:36:13,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.10607,0.144132,Neutral
U.S. FDA approves Pfizer's nasal spray for migraine,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-nasal-spray-migraine-2023-03-10/,2023-03-10 11:59:00,"March 10 ( Reuters ) - The U.S. Food and Drug Administration ( FDA ) on Friday approved Pfizer Inc's ( PFE.N ) nasal spray for migraine, giving patients access to a potentially fast-acting option to treat their headaches.",AMGN,0.199037,-0.09541,Neutral
New drugs are coming to market at sky-high prices,https://www.foxbusiness.com/healthcare/new-drugs-coming-market-sky-high-prices,2023-03-09 19:08:03,"A new Amgen Inc. lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly. Just over a year later, in December 2022, a second drug for the same type of cancer, Krazati from Mirati Therapeutics Inc., had an even higher price: $19,750 a month ...",AMGN,0.033052,0.040906,Neutral
News Exclusive | New Drugs Are Coming to Market at Sky-High Prices,https://www.wsj.com/articles/new-drugs-are-coming-to-market-at-sky-high-prices-4736372e,2023-03-09 14:00:00,Companies are under pressure to rein in annual or repeat price hikes for older pharmaceuticals.,AMGN,0.651499,0.155623,Somewhat-Bullish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2063184/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-03-08 22:45:22,"Amgen (AMGN) closed the most recent trading day at $228.43, moving -0.13% from the previous trading session.",AMGN,0.675573,0.220623,Somewhat-Bullish
A Bull Market Is Coming: 3 Stocks Near Their 52-Week Lows to Buy Now,https://www.fool.com/investing/2023/03/08/a-bull-market-is-coming-3-stocks-near-their-52-wee/,2023-03-08 10:15:00,It may only be a matter of time before these stocks start to rally.,AMGN,0.384608,0.208482,Somewhat-Bullish
Death Cross Looms Over Amgen Investors - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/23/03/31239103/death-cross-looms-over-amgen-investors,2023-03-07 14:47:48,"If history is any guide, there may be trouble ahead for shares of Amgen AMGN. A so-called ""death cross"" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",AMGN,0.570165,-0.461617,Bearish
PFE: 4 Stocks to Buy in Any Market Climate,https://stocknews.com/news/pfe-bmy-amgn-elv-jnj-azn-4-stocks-to-buy-in-any-market-climate/,2023-03-07 12:18:04,"The stock market remains volatile ahead of Fed chair Jerome Powell's Semiannual Monetary Policy Report delivery to Congress. Moreover, as recessionary fears are high, quality healthcare stocks Pfizer Inc. ( PFE ) , Bristol-Myers Squibb Company ( BMY ) , Amgen Inc. ( AMGN ) , and Elevance Health ...",AMGN,0.167654,-0.014306,Neutral
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2062061/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-03-06 14:10:03,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.21686,0.120105,Neutral
Investing Action Plan: Feeling March Momentum,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-from-powell-to-payrolls-a-busy-week/,2023-03-03 23:23:00,"Stock Market Investing Action Plan: From Powell To Payrolls, A Busy ... Investor's Business Daily ...",AMGN,0.059785,0.079999,Neutral
"U.S. companies embark on record borrowing spree, despite paying highest rates since 2009",https://www.marketwatch.com/story/u-s-companies-embark-on-record-borrowing-spree-despite-paying-highest-rates-since-2009-94e74157,2023-03-03 20:09:00,Higher interest rates aren't deterring companies with high credit ratings from borrowing in the U.S. corporate bond market at a record clip in 2023.,AMGN,0.154951,0.305576,Somewhat-Bullish
AMGN: 3 Biotech Stocks With Potential to Be Big Winners in 2023,https://stocknews.com/news/amgn-biib-jazz-ibb-zyme-3-biotech-stocks-with-potential-to-be-big-winners-in/,2023-03-03 16:24:05,AMGN: 3 Biotech Stocks With Potential to Be Big Winners in ...,AMGN,0.313484,0.151436,Somewhat-Bullish
Type 2 diabetes market size to increase by USD 39.37 billion between 2022 and 2027; Growth driven by increasing prevalence of diabetes - Technavio,https://www.prnewswire.com/news-releases/type-2-diabetes-market-size-to-increase-by-usd-39-37-billion-between-2022-and-2027-growth-driven-by-increasing-prevalence-of-diabetes---technavio-301760895.html,2023-03-03 15:30:00,Type 2 diabetes market size to increase by USD 39.37 billion ... PR ...,AMGN,0.040416,-0.011781,Neutral
Could This Humira Biosimilar Be a Winner for Amgen?,https://www.fool.com/investing/2023/03/03/could-this-humira-biosimilar-be-a-winner-for-amgen/,2023-03-03 11:00:00,This Humira biosimilar just launched in the U.S. several weeks ago.,AMGN,0.351558,0.123676,Neutral
"StockNews.com Upgrades Amgen  ( NASDAQ:AMGN )  to ""Strong-Buy""",https://www.defenseworld.net/2023/03/03/stocknews-com-upgrades-amgen-nasdaqamgn-to-strong-buy.html,2023-03-03 09:30:54,"Amgen ( NASDAQ:AMGN - Get Rating ) was upgraded by StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a note issued to investors on Wednesday. A number of other equities research analysts also recently issued reports on the stock.",AMGN,0.845786,0.340228,Somewhat-Bullish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2061260/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-03-02 22:45:21,"Amgen (AMGN) closed the most recent trading day at $234.74, moving -0.61% from the previous trading session.",AMGN,0.561606,0.300262,Somewhat-Bullish
Why Is Amgen  ( AMGN )  Down 4.2% Since Last Earnings Report?,https://www.zacks.com/stock/news/2061144/why-is-amgen-amgn-down-42-since-last-earnings-report,2023-03-02 16:30:55,Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AMGN,0.380012,-0.013467,Neutral
Horizon's  ( HZNP )  Q4 Earnings and Revenues Surpass Estimates,https://www.zacks.com/stock/news/2060909/horizons-hznp-q4-earnings-and-revenues-surpass-estimates,2023-03-02 13:43:00,Horizon Therapeutics (HZNP) reports better-than-expected fourth-quarter 2022 results as it beats the Zacks Consensus Estimate for both revenues and earnings.,AMGN,0.135347,0.146372,Neutral
AZN: 2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling,https://stocknews.com/news/azn-bmy-sndl-amgn-2-pharma-stocks-to-buy-right-now-and-1-you/,2023-03-02 11:23:37,AZN: 2 Pharma Stocks to Buy Right Now and 1 You Might Want to ... ...,AMGN,0.059194,0.006012,Neutral
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2068734/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-03-21 21:50:21,"In the latest trading session, Amgen (AMGN) closed at $232.95, marking a -0.75% move from the previous day.",AMGN,0.551622,0.275516,Somewhat-Bullish
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment',https://www.investors.com/news/technology/nvidia-stock-chatgpt-is-just-the-start-for-artificial-intelligence/,2023-03-21 16:09:35,Nvidia Stock: ChatGPT Is Just The Start For Artificial Intelligence Investor's Business Daily ...,AMGN,0.109705,0.0,Neutral
"The Zacks Analyst Blog Highlights Alphabet, Tesla, Amgen, FedEx and Capital One Financial",https://www.zacks.com/stock/news/2068404/the-zacks-analyst-blog-highlights-alphabet-tesla-amgen-fedex-and-capital-one-financial,2023-03-21 11:43:00,"Alphabet, Tesla, Amgen, FedEx and Capital One Financial are part of the Zacks top Analyst Blog.",AMGN,0.724687,0.0,Neutral
"Amgen Inc.: Please contact the Portnoy Law Firm to recover your losses; May 12, 2023 deadline. - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31429699/amgen-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-may-12-2023-deadline,2023-03-20 21:53:53,"Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 20, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Amgen Inc.",AMGN,0.744646,-0.203884,Somewhat-Bearish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31429698/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-03-20 21:53:20,"NEW YORK, March 20, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/03/31428528/looking-at-amgens-recent-unusual-options-activity,2023-03-20 20:45:51,"A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and ...",AMGN,0.701875,0.05702,Neutral
"Top Analyst Reports for Alphabet, Tesla & Amgen",https://www.zacks.com/research-daily/2067872/top-analyst-reports-for-alphabet-tesla-amgen,2023-03-20 20:12:00,"Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Tesla, Inc. (TSLA) and Amgen Inc. (AMGN).",AMGN,0.293038,0.213105,Somewhat-Bullish
"Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc.  ( AMGN )  Investors of Class Action and to Actively Participate - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31425355/bronstein-gewirtz-grossman-llc-notifies-amgen-inc-amgn-investors-of-class-action-and-to-actively-p,2023-03-20 17:29:00,"NEW YORK, March 20, 2023 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN and certain of its officers, on behalf of all persons and entities that ...",AMGN,0.740604,-0.110354,Neutral
AMGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Amgen Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Lawsuit - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31422714/amgn-investor-alert-robbins-geller-rudman-dowd-llp-files-class-action-lawsuit-against-amgen-inc-an,2023-03-20 15:10:03,"SAN DIEGO, March 20, 2023 ( GLOBE NEWSWIRE ) -- Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers or acquirers of Amgen Inc. AMGN common stock between July 29, 2020 and April 27, 2022, inclusive ( the ""Class Period"" ) .",AMGN,0.861018,-0.037915,Neutral
3 Dow Jones Stocks To Watch Today,https://stockmarket.com/featured/3-dow-jones-stocks-to-watch-today-2023-03-20,2023-03-20 14:43:49,"The Dow Jones Industrial Average ( DJIA ) is one of the world's most widely followed and recognized stock market indices. As a result, it is frequently used as a barometer for the overall health of the US economy. The index tracks the performance of 30 large, established, and financially sound ...",AMGN,0.316846,0.408106,Bullish
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2067904/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-03-20 13:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.204936,0.114924,Neutral
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now,https://www.fool.com/investing/2023/03/20/3-dow-stocks-near-52-week-lows-that-look-like-barg/,2023-03-20 10:23:00,These businesses are performing much better than their stock prices would suggest.,AMGN,0.159922,0.060306,Neutral
AMGEN INC.  ( NASDAQ: AMGN )  SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc.  ( NASDAQ: AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31414012/amgen-inc-nasdaq-amgn-shareholder-class-action-alert-bernstein-liebhard-llp-reminds-investors-of-t,2023-03-20 05:45:00,"Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at ( 212 ) 951-2030 or pallocco@bernlieb.com to discuss your rights.",AMGN,0.765012,-0.035843,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, Credit Suisse, SVB, and Amgen and Encourages Investors to Contact the Firm - Credit Suisse Group  ( NYSE:CS ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31408381/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-match,2023-03-18 01:00:00,"NEW YORK, March 17, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Match Group, Inc. MTCH, Credit Suisse Group AG CS, SVB Financial Group SIVB SIVBP ...",AMGN,0.420483,-0.130831,Neutral
"AMGEN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Amgen Inc.",https://www.prnewswire.com/news-releases/amgen-class-action-announcement-kessler-topaz-meltzer--check-llp-announces-securities-class-action-lawsuit-filed-against-amgen-inc-301773553.html,2023-03-17 20:04:00,AMGEN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer ... PR ...,AMGN,0.737923,-0.187394,Somewhat-Bearish
Amgen Inc.  ( AMGN )  Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31403223/amgen-inc-amgn-shareholder-alert-robbins-llp-reminds-investors-of-class-action-against-amgen-inc,2023-03-17 19:15:31,"SAN DIEGO, March 17, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Amgen Inc. AMGN common stock between July 29, 2020 and April 27, 2022, for violations of the ...",AMGN,0.749619,-0.055804,Neutral
"DEADLINE ALERT for SIVB, AMGN, and SBNY: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Signature Bank  ( NASDAQ:SBNY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31400221/deadline-alert-for-sivb-amgn-and-sbny-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a,2023-03-17 16:00:00,"LOS ANGELES, March 17, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.080188,0.0,Neutral
Amgen to cut about 450 jobs in second round of layoffs this year,https://www.marketwatch.com/story/amgen-to-cut-about-450-jobs-in-second-round-of-layoffs-this-year-a8904b3e,2023-03-17 02:08:00,"Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as it faces increasing pressure from drug prices and high inflation.",AMGN,0.514619,-0.474028,Bearish
Amgen to cut 450 jobs in second round of layoffs this year,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-cut-450-jobs-second-round-layoffs-this-year-2023-03-17/,2023-03-17 00:47:00,"March 16 ( Reuters ) - Amgen Inc ( AMGN.O ) said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices and high inflation.",AMGN,0.175859,-0.237685,Somewhat-Bearish
Amgen Shareholder Action Reminder,https://investingnews.com/amgen-shareholder-action-reminder/,2023-03-17 00:05:48,"Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Amgen To Contact Him Directly To Discuss Their Options",AMGN,0.845009,-0.128546,Neutral
Is It Time to Buy the Dow Jones' 3 Worst-Performing February  ( and Now March )  Stocks?,https://www.fool.com/investing/2023/03/16/time-to-buy-dow-jones-3-worst-performing-stocks/,2023-03-16 10:50:00,"Several blue chips have been routed lately, but most of their sell-offs were way overdone.",AMGN,0.197735,-0.182596,Somewhat-Bearish
Amgen  ( NASDAQ:AMGN )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/03/16/amgen-nasdaqamgn-research-coverage-started-at-stocknews-com.html,2023-03-16 09:40:41,Amgen ( NASDAQ:AMGN ) Research Coverage Started at ... Defense World ...,AMGN,0.924218,0.300655,Somewhat-Bullish
Amgen  ( AMGN )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2066372/amgen-amgn-gains-as-market-dips-what-you-should-know,2023-03-15 21:45:23,"In the latest trading session, Amgen (AMGN) closed at $234.90, marking a +1.87% move from the previous day.",AMGN,0.606946,0.1684,Somewhat-Bullish
Amgen Unusual Options Activity For March 15 - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/03/31370466/amgen-unusual-options-activity-for-march-15,2023-03-15 20:45:41,"Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.699089,0.345138,Somewhat-Bullish
Dow Jones Falls Sharply As Bank Fears Reboot; First Republic Gets Slammed With Junk Rating,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-bank-fears-reboot-as-first-republic-gets-slashed-to-junk-by-s-credit-suisse-divesdow/,2023-03-15 17:51:39,Dow Jones Falls Sharply As Bank Fears Reboot. First Republic Gets ... Investor's Business Daily ...,AMGN,0.134968,0.22331,Somewhat-Bullish
"Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31362559/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-filed-against-amgen-inc,2023-03-15 14:31:37,"RADNOR, Pa., March 15, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.680543,-0.177187,Somewhat-Bearish
Price Over Earnings Overview: Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/03/31361388/price-over-earnings-overview-amgen,2023-03-15 13:45:29,"In the current session, Amgen Inc. AMGN is trading at $229.08, after a 0.65% drop. Over the past month, the stock fell by 4.58%, and in the past year, by 2.87%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio.",AMGN,0.448842,-0.299841,Somewhat-Bearish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2065750/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-03-14 21:50:19,"Amgen (AMGN) closed at $230.58 in the latest trading session, marking a -1.12% move from the prior day.",AMGN,0.624172,0.253856,Somewhat-Bullish
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/03/31346628/amgen-faces-lawsuit-for-hiding-its-stupendous-tax-bill-of-10b,2023-03-14 18:40:23,"In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc AMGN concealed the dispute over its international tax strategy between July 2020 and April 2022 and had its investors wait for too long on disclosing taxes and penalties bill of $10.7 billion.",AMGN,0.760593,-0.236089,Somewhat-Bearish
Amgen's Debt Overview - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/03/31346339/amgens-debt-overview,2023-03-14 17:15:59,"Shares of Amgen Inc. AMGN decreased by 13.78% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.",AMGN,0.374312,0.016122,Neutral
2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market,https://www.fool.com/investing/2023/03/14/2-stocks-to-buy-near-their-52-week-low-that-could/,2023-03-14 13:45:00,Let's follow one of the most basic investment tips: Buy low.,AMGN,0.496475,0.362793,Bullish
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2065154/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-03-14 10:20:11,Sector ETF report for ...,AMGN,0.135347,0.071708,Neutral
AMGN: 2 Top Biotech Stocks to Buy in March,https://stocknews.com/news/amgn-biib-azn-2-top-biotech-stocks-to-buy-in-march/,2023-03-13 14:59:11,"Despite macroeconomic uncertainties, the biotech industry has performed relatively well over the last year, owing to breakthrough advancements and inelastic demand for healthcare products and services. So, investors could consider buying shares of Amgen Inc. ( AMGN ) and Biogen Inc. ( BIIB ) now.",AMGN,0.492446,0.107451,Neutral
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2064670/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-03-13 13:10:05,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.218325,0.120745,Neutral
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,https://www.benzinga.com/pressreleases/23/03/g31315741/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,2023-03-13 11:00:00,Visiongain has published a new report entitled Regenerative Medicine Market 2023-2033.,AMGN,0.028798,0.0,Neutral
"Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/markets/futures/23/03/31315454/nasdaq-futures-climb-solidly-after-past-weeks-rout-analyst-flags-key-s-p-500-support-to-stay-abov,2023-03-13 10:55:11,"After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government's move to assuage concerns in response to the banking crisis. The mood is likely to remain nervous as headlines on the banking fiasco continue to drop in.",AMGN,0.090989,-0.148842,Neutral
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2073328/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-03-31 21:45:22,"Amgen (AMGN) closed the most recent trading day at $241.75, moving +0.1% from the previous trading session.",AMGN,0.654859,0.354851,Bullish
"ROSEN, A LONGSTANDING LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31615092/rosen-a-longstanding-law-firm-encourages-amgen-inc-investors-with-losses-to-secure-counsel-before-,2023-03-31 18:45:00,"NEW YORK, March 31, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.04827,Neutral
1 Dividend Growth Stock to Buy Hand Over Fist,https://www.fool.com/investing/2023/03/31/1-dividend-growth-stock-to-buy-hand-over-fist/,2023-03-31 13:37:00,"Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time.",AMGN,0.538939,0.479543,Bullish
"Alimera Sciences  ( ALIM )  Reports Q4 Loss, Misses Revenue Estimates",https://www.zacks.com/stock/news/2072927/alimera-sciences-alim-reports-q4-loss-misses-revenue-estimates,2023-03-31 13:15:03,"Alimera Sciences (ALIM) delivered earnings and revenue surprises of -92.86% and 11.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.139265,0.0,Neutral
Amgen's Debt Overview - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/03/31608144/amgens-debt-overview,2023-03-31 13:00:43,"Shares of Amgen Inc. AMGN moved lower by 7.70% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.",AMGN,0.285526,-0.088183,Neutral
"Amgen Equity Alert: Kessler Topaz Meltzer & Check, LLP Reminds Amgen Inc. Shareholders of Securities Fraud Class Action Lawsuit - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31601600/amgen-equity-alert-kessler-topaz-meltzer-check-llp-reminds-amgen-inc-shareholders-of-securities-fr,2023-03-31 00:36:00,"RADNOR, Pa., March 30, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.681615,-0.177312,Somewhat-Bearish
Amgen Inc.  ( AMGN )  Equity Alert: Contact Robbins LLP for Information About Your Rights Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31600533/amgen-inc-amgn-equity-alert-contact-robbins-llp-for-information-about-your-rights-against-amgen-in,2023-03-30 23:02:30,"SAN DIEGO, March 30, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Amgen Inc.",AMGN,0.749619,-0.055853,Neutral
A Look Into Amgen Inc's Price Over Earnings - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/03/31592465/a-look-into-amgen-incs-price-over-earnings,2023-03-30 18:15:19,"In the current market session, Amgen Inc. AMGN share price is at $240.62, after a 0.17% decrease. Over the past month, the stock went up by 2.50%, but over the past year, it actually decreased by 1.03%.",AMGN,0.419153,-0.028427,Neutral
"DEADLINE ALERT for SIVB, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31588201/deadline-alert-for-sivb-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inves,2023-03-30 15:58:00,"LOS ANGELES, March 30, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2072323/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings,2023-03-30 12:50:06,Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.,AMGN,0.374312,0.352881,Bullish
Amgen Options Traders Betting On Stock Rising This Much By April Expiration - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/trading-ideas/long-ideas/23/03/31573257/amgen-options-traders-betting-on-stock-rising-this-much-by-april-expiration,2023-03-30 12:30:12,"Within the next month, Amgen Inc. AMGN is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say. On CNBC's ""Options Action,"" Kelly Intelligence's Kevin Kelly said there were 1.84x more calls than puts on Amgen on Wednesday.",AMGN,0.900719,0.112593,Neutral
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips,https://www.fool.com/investing/2023/03/30/this-blue-chip-dividend-stock-should-return-to-for/,2023-03-30 11:30:00,"T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.",AMGN,0.44809,0.281547,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31567555/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-03-30 00:44:13,"NEW YORK, March 29, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
The Government Move That Could Further Stoke Obesity Drugs,https://www.investors.com/news/technology/eli-lilly-stock-the-government-move-that-could-drive-obesity-treatments-to-the-forefront/,2023-03-29 16:51:00,Eli Lilly Stock: The Government Move That Could Drive Obesity ... Investor's Business Daily ...,AMGN,0.16171,0.211676,Somewhat-Bullish
"Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run",https://www.fool.com/investing/2023/03/29/up-463-this-sizzling-growth-stock-could-have-a-lot/,2023-03-29 11:45:00,Viking Therapeutics stock might in the midst of a historic run.,AMGN,0.141171,0.171906,Somewhat-Bullish
Amgen  ( AMGN )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2071579/amgen-amgn-gains-as-market-dips-what-you-should-know,2023-03-28 21:50:21,"Amgen (AMGN) closed at $238.48 in the latest trading session, marking a +0.73% move from the prior day.",AMGN,0.665097,0.129001,Neutral
"Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says - Viking Therapeutics  ( NASDAQ:VKTX ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31536056/viking-therapeutics-initial-vk2735-data-resoundingly-beat-expectations-analyst-says,2023-03-28 19:00:00,"Earlier today, Viking Therapeutics Inc VKTX announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735. All cohorts showed up to 7.8% reductions in body weight from baseline and 6% reductions relative to placebo.",AMGN,0.327366,-0.397418,Bearish
"Bristol Myers Squibb Receives European Commission Approval of Sotyktu , a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis",https://investingnews.com/bristol-myers-squibb-receives-european-commission-approval-of-sotyktu-a-once-daily-oral-treatment-for-adults-with-moderate-to-severe-plaque-psoriasis/,2023-03-28 11:33:17,"Bristol Myers Squibb ( NYSE:BMY ) today announced that the European Commission has approved Sotyktu ( deucravacitinib ) , a first-in-class, selective tyrosine kinase 2 ( TYK2 ) inhibitor, for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic ...",AMGN,0.012718,0.0,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31522691/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-match,2023-03-28 01:00:00,"NEW YORK, March 27, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Match Group, Inc. MTCH, DraftKings Inc. DKNG, SVB Financial Group SIVB SIVBP ) ) ) ...",AMGN,0.523451,-0.150206,Somewhat-Bearish
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields - Baxter Intl  ( NYSE:BAX ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/03/31511986/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields,2023-03-27 13:27:26,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.099476,-0.104,Neutral
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2070736/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-03-27 13:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.207127,0.115872,Neutral
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2070609/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-03-27 10:20:08,Sector ETF report for ...,AMGN,0.136113,0.07192,Neutral
Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court,https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-bid-revive-cholesterol-drug-patents-comes-us-supreme-court-2023-03-27/,2023-03-27 10:04:00,Amgen bid to revive cholesterol drug patents comes to U.S. ... ...,AMGN,0.072435,0.066305,Neutral
"ROSEN, SKILLED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31504598/rosen-skilled-investor-counsel-encourages-amgen-inc-investors-to-secure-counsel-before-important-d,2023-03-26 20:28:00,"NEW YORK, March 26, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.04827,Neutral
Novo Hits Record High On Scorching Ozempic Obesity Battle,https://www.investors.com/news/technology/novo-nordisk-stock-hits-a-record-high-as-ozempic-obesity-battle-heats-up/,2023-03-24 18:37:38,Novo Nordisk Stock Hits A Record As Ozempic Obesity Battle Heats ... Investor's Business Daily ...,AMGN,0.245339,-0.009344,Neutral
Amgen Inc.  ( AMGN )  Class Action Notice: Robbins LLP Urges Shareholders with Large Losses to Contact the Firm Regarding Their Rights Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/03/g31495284/amgen-inc-amgn-class-action-notice-robbins-llp-urges-shareholders-with-large-losses-to-contact-the,2023-03-24 17:12:01,"SAN DIEGO, March 24, 2023 ( GLOBE NEWSWIRE ) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Amgen Inc. AMGN common stock between July 29, 2020 and April 27, 2022, for violations of the ...",AMGN,0.749619,-0.055804,Neutral
AbbVie  ( ABBV )  Provides Clinical Updates on Inflammatory Drugs,https://www.zacks.com/stock/news/2070329/abbvie-abbv-provides-clinical-updates-on-inflammatory-drugs,2023-03-24 16:56:00,AbbVie???s (ABBV) two studies evaluating Skyrizi in ulcerative colitis and Rinvoq in systemic lupus erythematosus meet their primary endpoints.,AMGN,0.331024,0.102625,Neutral
"DEADLINE ALERT for SIVB, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31494655/deadline-alert-for-sivb-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inves,2023-03-24 16:30:00,"LOS ANGELES, March 24, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
AMGN Investors Have Opportunity to Lead Amgen Inc. Securities Fraud Lawsuit,https://www.prnewswire.com/news-releases/amgn-investors-have-opportunity-to-lead-amgen-inc-securities-fraud-lawsuit-301780463.html,2023-03-24 00:34:00,AMGN Investors Have Opportunity to Lead Amgen Inc. Securities ... PR ...,AMGN,0.824067,0.016663,Neutral
V: 3 High-Quality Stocks to Add to Your Watchlist Now,https://stocknews.com/news/v-amgn-box-3-high-quality-stocks-to-add-to-your-watchlist-now/,2023-03-23 13:13:38,"The Federal Reserve raised interest rates by 25 basis points, bringing the benchmark funds rate to a range of 4.75% to 5%, the highest since October 2007. The Fed's monetary policy tightening, along with the expected tighter lending by banks, could lead to a recession this year.",AMGN,0.208336,0.223485,Somewhat-Bullish
Biopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partners,https://www.benzinga.com/pressreleases/23/03/g31473568/biopharmaceuticals-market-growth-worth-700bn-by-2028-led-by-monoclonal-antibodies-held-market-shar,2023-03-23 12:46:11,"New York, March 23, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Biopharmaceuticals Market Size, Share, Trends, Growth and Report Forecasts to 2028 - COVID-19 Impact and Global Analysis By Product Type ( Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, ...",AMGN,0.0362,0.086993,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2069416/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-03-23 10:20:07,Smart Beta ETF report for ...,AMGN,0.122894,0.068464,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31468313/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-draft,2023-03-23 01:00:00,"NEW YORK, March 22, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DraftKings Inc. DKNG, SVB Financial Group SIVB SIVBP ) ) ) , Amgen Inc.",AMGN,0.701476,-0.1744,Somewhat-Bearish
Amgen  ( AMGN )  Stock Moves -1.34%: What You Should Know,https://www.zacks.com/stock/news/2069277/amgen-amgn-stock-moves--134-what-you-should-know,2023-03-22 21:45:26,"In the latest trading session, Amgen (AMGN) closed at $229.83, marking a -1.34% move from the previous day.",AMGN,0.672055,0.159636,Somewhat-Bullish
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street,https://www.investors.com/news/technology/nvda-stock-nvidia-artificial-intelligence-strategy-impresses-analysts/,2023-03-22 16:13:28,NVDA Stock: Nvidia Artificial Intelligence Strategy Impresses ... Investor's Business Daily ...,AMGN,0.146469,0.196883,Somewhat-Bullish
"AMGN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/03/g31457757/amgn-class-action-announcement-kessler-topaz-meltzer-check-llp-announces-securities-class-action-l,2023-03-22 14:15:00,"RADNOR, Pa., March 22, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.681615,-0.177312,Somewhat-Bearish
"Here's one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.",https://www.marketwatch.com/story/heres-one-for-the-battered-bulls-the-second-largest-sector-in-the-s-p-500-is-stirring-to-life-says-this-strategist-5e179744,2023-03-22 10:52:00,"Everyone is watching the banks, but what about healthcare. It's breaking out, says this strategist.",AMGN,0.077593,0.0,Neutral
Here's What is Driving Amgen  ( AMGN )  Stock's Outperformance,https://www.zacks.com/stock/news/2068852/heres-what-is-driving-amgen-amgn-stocks-outperformance,2023-03-22 09:51:00,"Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline.",AMGN,0.612521,0.289094,Somewhat-Bullish
"Lowey Dannenberg Notifies Amgen, Inc.  ( NASDAQ: AMGN )  Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31733478/lowey-dannenberg-notifies-amgen-inc-nasdaq-amgn-investors-of-securities-class-action-lawsuit-and-u,2023-04-10 20:13:25,"NEW YORK, April 10, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Amgen, Inc.",AMGN,0.773257,-0.239267,Somewhat-Bearish
UnitedHealth  ( UNH )  to Post Q1 Earnings: What You Should Expect,https://www.zacks.com/stock/news/2076353/unitedhealth-unh-to-post-q1-earnings-what-you-should-expect,2023-04-10 14:49:00,UnitedHealth's (UNH) first-quarter results are likely to reflect growing premiums and memberships.,AMGN,0.139804,0.087624,Neutral
"Bronstein, Gewirtz & Grossman, LLC Notifies Amgen Inc.  ( AMGN )  Investors of Class Action and to Actively Participate - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31726683/bronstein-gewirtz-grossman-llc-notifies-amgen-inc-amgn-investors-of-class-action-and-to-actively-p,2023-04-10 14:00:00,"NEW YORK, April 10, 2023 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN and certain of its officers, on behalf of all persons and entities that ...",AMGN,0.740604,-0.110354,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2076193/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-04-10 13:10:04,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.205807,0.1153,Neutral
Can You Still Buy the Dow Jones' Best-Performing April Stocks?,https://www.fool.com/investing/2023/04/10/can-you-still-buy-the-dow-jones-best-performing-ap/,2023-04-10 13:05:00,"Each is benefiting from recent good news, but there's also a theme-based tailwind brewing that could last a while.",AMGN,0.079656,0.279936,Somewhat-Bullish
"TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors",https://www.globenewswire.com/news-release/2023/04/10/2643534/0/en/TScan-Therapeutics-Announces-Appointment-of-Barbara-Klencke-M-D-to-its-Board-of-Directors.html,2023-04-10 11:00:00,Deepens the Board's clinical oncology and commercialization expertise as programs for hematologic malignancies and solid tumors advance ...,AMGN,0.023464,0.063995,Neutral
"TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors - TScan Therapeutics  ( NASDAQ:TCRX ) ",https://www.benzinga.com/pressreleases/23/04/g31723078/tscan-therapeutics-announces-appointment-of-barbara-klencke-m-d-to-its-board-of-directors,2023-04-10 11:00:00,"Deepens the Board's clinical oncology and commercialization expertise as programs for hematologic malignancies and solid tumors advance Company also announces key leadership promotions WALTHAM, Mass., April 10, 2023 ( GLOBE NEWSWIRE ) -- TScan Therapeutics, Inc.",AMGN,0.023013,0.063819,Neutral
Love Dividends? These 3 Stocks Are Smart Buys Right Now,https://www.fool.com/investing/2023/04/09/love-dividends-these-3-stocks-are-smart-buys-right/,2023-04-09 09:27:00,"With yields of 3.1%, 3.4%, and 14.3%, these stocks are hard to pass up right now.",AMGN,0.256179,0.218621,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31719338/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-04-09 00:42:24,"NEW YORK, April 08, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31716199/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-draft,2023-04-08 01:00:00,"NEW YORK, April 07, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DraftKings Inc. DKNG, SVB Financial Group SIVB SIVBP ) ) ) , Amgen Inc.",AMGN,0.701476,-0.174386,Somewhat-Bearish
"Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action against Amgen Inc. and Urges Investors with Substantial Losses to Contact the Firm - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31713441/kessler-topaz-meltzer-check-llp-reminds-investors-of-securities-fraud-class-action-against-amgen-i,2023-04-07 16:16:00,"RADNOR, Pa., April 07, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.680543,-0.177187,Somewhat-Bearish
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc.  ( AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31712600/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-04-07 14:30:00,"LOS ANGELES, April 07, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming May 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Amgen Inc. ( ""Amgen"" or the ...",AMGN,0.699089,-0.019312,Neutral
"Renal Anemia Therapeutics Market size to grow by USD 1.97 billion from 2021 to 2026, Driven by the presence of a large pool of CKD patients - Technavio",https://www.prnewswire.com/news-releases/renal-anemia-therapeutics-market-size-to-grow-by-usd-1-97-billion-from-2021-to-2026--driven-by-the-presence-of-a-large-pool-of-ckd-patients---technavio-301790685.html,2023-04-07 13:00:00,Renal Anemia Therapeutics Market size to grow by USD 1.97 billion ... PR ...,AMGN,0.05257,-0.014894,Neutral
"ROSEN, A LEADING LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31707868/rosen-a-leading-law-firm-encourages-amgen-inc-investors-with-losses-to-secure-counsel-before-impor,2023-04-06 22:15:00,"NEW YORK, April 06, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.045009,Neutral
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2075834/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-04-06 21:50:19,"Amgen (AMGN) closed at $253.35 in the latest trading session, marking a -0.01% move from the prior day.",AMGN,0.627711,0.301782,Somewhat-Bullish
"DEADLINE ALERT for SIVB, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31701222/deadline-alert-for-sivb-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inves,2023-04-06 16:00:00,"LOS ANGELES, April 06, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
Here's Why You Should Add Ligand  ( LGND )  Stock to Your Portfolio,https://www.zacks.com/stock/news/2075611/heres-why-you-should-add-ligand-lgnd-stock-to-your-portfolio,2023-04-06 14:23:00,"Ligand's (LGND) proprietary platforms enable it to form partnerships with several leading drug companies, providing it with funds through milestone and royalty payments.",AMGN,0.103554,0.156676,Somewhat-Bullish
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years,https://www.fool.com/investing/2023/04/06/income-investors-these-2-stocks-have-quadrupled-th/,2023-04-06 09:44:00,These two stocks have generated massive dividend growth for shareholders in the last decade.,AMGN,0.282234,0.287164,Somewhat-Bullish
"DEADLINE ALERT for AMGN, SBNY, GOOG, NSC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31683713/deadline-alert-for-amgn-sbny-goog-nsc-law-offices-of-howard-g-smith-reminds-investors-of-class-act,2023-04-05 16:37:32,"BENSALEM, Pa., April 05, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.314374,-0.104683,Neutral
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,https://www.benzinga.com/pressreleases/23/04/g31675058/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,2023-04-05 11:00:13,Visiongain has published a new report entitled Regenerative Medicine Market 2023-2033.,AMGN,0.028798,0.0,Neutral
"Amgen Inc.: Please contact the Portnoy Law Firm to recover your losses; May 2, 2023 deadline - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31669438/amgen-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-may-2-2023-deadline,2023-04-04 21:38:23,"Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 04, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Amgen Inc.",AMGN,0.744646,-0.203884,Somewhat-Bearish
Will Amgen  ( AMGN )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2074400/will-amgen-amgn-beat-estimates-again-in-its-next-earnings-report,2023-04-04 16:10:13,Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,AMGN,0.415927,0.507946,Bullish
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2074180/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-04-04 12:50:07,The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,AMGN,0.258351,0.233512,Somewhat-Bullish
AMGN LAWSUIT ALERT: Levi & Korsinsky Notifies Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31639223/amgn-lawsuit-alert-levi-korsinsky-notifies-amgen-inc-investors-of-a-class-action-lawsuit-and-upcom,2023-04-03 17:00:00,"NEW YORK, April 03, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.765213,-0.154751,Somewhat-Bearish
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2073658/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-04-03 13:10:02,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.217346,0.120318,Neutral
3 Dow Stocks With Above-Average Dividends Yields to Buy in April,https://www.fool.com/investing/2023/04/03/3-dow-stocks-with-above-average-dividends-yields-t/,2023-04-03 09:39:00,Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.,AMGN,0.217346,0.137049,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, Signature, and Norfolk Southern and Encourages Investors to Contact the Firm - Amgen  ( NASDAQ:AMGN ) , Norfolk Southern  ( NYSE:NSC ) ",https://www.benzinga.com/pressreleases/23/04/g31625102/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-svb-a,2023-04-03 01:00:00,"NEW YORK, April 02, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of SVB Financial Group SIVB SIVBP ) ) ) , Amgen Inc.",AMGN,0.464393,-0.139655,Neutral
"AMGN Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Amgen Inc. of Securities Class Action Lawsuit",https://markets.businessinsider.com/news/stocks/amgn-shareholder-alert-kessler-topaz-meltzer-check-llp-reminds-shareholders-of-amgen-inc.-of-securities-class-action-lawsuit-1032208594,2023-04-02 00:25:00,"Radnor, Pennsylvania-- ( Newsfile Corp. - April 1, 2023 ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Amgen Inc. ( ""Amgen"" ) ( NASDAQ: AMGN ) .",AMGN,0.735697,-0.213484,Somewhat-Bearish
Amgen  ( AMGN )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?,https://www.zacks.com/stock/news/2082079/amgen-amgn-expected-to-beat-earnings-estimates-can-the-stock-move-higher,2023-04-20 14:03:12,Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMGN,0.257442,0.144926,Neutral
Amgen  ( AMGN )  Wins Patent Appeal for Blockbuster Psoriasis Drug,https://www.zacks.com/stock/news/2081905/amgen-amgn-wins-patent-appeal-for-blockbuster-psoriasis-drug,2023-04-20 12:13:00,The Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug Otezla will prevent drug-makers from selling a generic version till February 2028.,AMGN,0.405651,0.013748,Neutral
"ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31904401/rosen-a-leading-investor-rights-law-firm-encourages-amgen-inc-investors-with-losses-to-secure-coun,2023-04-19 22:05:00,"NEW YORK, April 19, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.045009,Neutral
Amgen  ( AMGN )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2081626/amgen-amgn-gains-as-market-dips-what-you-should-know,2023-04-19 21:50:24,"In the latest trading session, Amgen (AMGN) closed at $246.21, marking a +0.05% move from the previous day.",AMGN,0.672055,0.219558,Somewhat-Bullish
"AMGN ALERT: The Klein Law Firm Reminds Investors of a Lead Plaintiff Deadline of May 12, 2023 in the Class Action Filed on Behalf of Amgen Inc. Shareholders - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31896914/amgn-alert-the-klein-law-firm-reminds-investors-of-a-lead-plaintiff-deadline-of-may-12-2023-in-the,2023-04-19 16:54:44,"NEW YORK, April 19, 2023 ( GLOBE NEWSWIRE ) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amgen Inc. AMGN alleging that the Company violated federal securities laws.",AMGN,0.791876,-0.08937,Neutral
AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31865684/amgn-lawsuit-alert-levi-korsinsky-reminds-amgen-inc-investors-of-a-class-action-lawsuit-and-upcomi,2023-04-18 17:50:00,"NEW YORK, April 18, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.765213,-0.154751,Somewhat-Bearish
A Look Into Amgen's Debt - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/04/31864691/a-look-into-amgens-debt,2023-04-18 17:15:41,"Shares of Amgen Inc. AMGN fell by 6.26% in the past three months. Before having a look at the importance of debt, let's look at how much debt Amgen has. Based on Amgen's balance sheet as of February 9, 2023, long-term debt is at $37.35 billion and current debt is at $1.59 billion, amounting to ...",AMGN,0.306963,-0.21033,Somewhat-Bearish
HCA Healthcare  ( HCA )  to Post Q1 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2080631/hca-healthcare-hca-to-post-q1-earnings-whats-in-the-cards,2023-04-18 15:33:00,HCA Healthcare's (HCA) first-quarter results are likely to reflect the impacts of increased inpatient and outpatient surgery cases.,AMGN,0.143987,0.085344,Neutral
"As Its Stock Gets Set For Upgrade, Boan Biotech Still Faces Two Big Risks - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/23/04/31857045/as-its-stock-gets-set-for-upgrade-boan-biotech-still-faces-two-big-risks,2023-04-18 13:30:25,"With two products now generating revenue, Boan Biotech will soon have the ""B"" marker for high-risk tickers removed from its stock symbol Boan faces stiff competition in its main area of biosimilar drugs, and could also face price pressure if its products are included in China's centralized drug ...",AMGN,0.072655,0.026139,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Match, DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31845060/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-match,2023-04-18 01:00:00,"NEW YORK, April 17, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Match Group, Inc. MTCH, DraftKings Inc. DKNG, SVB Financial Group SIVB SIVBP ) ) ) ...",AMGN,0.52395,-0.14705,Neutral
Price Over Earnings Overview: Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/04/31834210/price-over-earnings-overview-amgen,2023-04-17 15:15:26,"In the current market session, Amgen Inc. AMGN share price is at $249.25, after a 0.30% drop. Over the past month, the stock went up by 7.00%, but over the past year, it actually decreased by 1.63%.",AMGN,0.399204,-0.079639,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2079547/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-04-17 13:10:05,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.217834,0.120531,Neutral
AMGEN INC.  ( NASDAQ: AMGN )  SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc.  ( NASDAQ: AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31822773/amgen-inc-nasdaq-amgn-shareholder-class-action-alert-bernstein-liebhard-llp-reminds-investors-of-t,2023-04-17 05:45:00,"Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at ( 212 ) 951-2030 or pallocco@bernlieb.com to discuss your rights.",AMGN,0.765818,-0.035858,Neutral
"Amgen Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Important Lead Plaintiff Deadline on May 12, 2023 in Securities Fraud Class Action Lawsuit - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31820173/amgen-inc-deadline-reminder-kessler-topaz-meltzer-check-llp-reminds-investors-of-important-lead-pl,2023-04-16 00:34:00,"RADNOR, Pa., April 15, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.680543,-0.177187,Somewhat-Bearish
AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31812708/amgn-lawsuit-alert-levi-korsinsky-reminds-amgen-inc-investors-of-a-class-action-lawsuit-and-upcomi,2023-04-14 19:14:01,"NEW YORK, April 14, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.765213,-0.154751,Somewhat-Bearish
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2078574/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-04-13 21:50:22,"Amgen (AMGN) closed the most recent trading day at $251.44, moving +0.78% from the previous trading session.",AMGN,0.620664,0.288133,Somewhat-Bullish
"ROSEN,A LONGSTANDING LAW FIRM, Encourages Amgen Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31793363/rosen-a-longstanding-law-firm-encourages-amgen-inc-investors-with-losses-to-secure-counsel-before-,2023-04-13 17:00:00,"NEW YORK, April 13, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.04827,Neutral
"DEADLINE ALERT for SIVB, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31791993/deadline-alert-for-sivb-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inves,2023-04-13 15:56:00,"LOS ANGELES, April 13, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
Novo Hits Another Record On Boosted Obesity Sales Outlook,https://www.investors.com/news/technology/novo-nordisk-stock-notches-another-record-as-obesity-treatments-spark-sales-profits/,2023-04-13 14:25:00,Novo Nordisk Stock Notches Another Record As Obesity Treatments ... Investor's Business Daily ...,AMGN,0.193465,-0.014568,Neutral
Elevance Health  ( ELV )  to Post Q1 Earnings: What's in Store?,https://www.zacks.com/stock/news/2078315/elevance-health-elv-to-post-q1-earnings-whats-in-store,2023-04-13 14:06:00,"Elevance Health's (ELV) first-quarter results are likely to reflect higher premiums, commercial and government sales figures and total expenses.",AMGN,0.137934,0.083347,Neutral
"The Glioblastoma Multiforme  ( GBM )  Treatment Market Overview: Market Size, Expected CAGR, Growth Driver And Major Players",https://www.prnewswire.com/news-releases/the-glioblastoma-multiforme-gbm-treatment-market-overview-market-size-expected-cagr-growth-driver-and-major-players-301796434.html,2023-04-13 09:31:00,The Glioblastoma Multiforme ( GBM ) Treatment Market Overview ... PR ...,AMGN,0.056275,-0.067905,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31780747/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-draft,2023-04-13 01:00:00,"NEW YORK, April 12, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DraftKings Inc. DKNG, SVB Financial Group SIVB SIVBQ ) ) ) , Amgen Inc.",AMGN,0.700679,-0.170569,Somewhat-Bearish
Red-Hot Obesity Name Soars To Record On $725 Million Deal,https://www.investors.com/news/technology/novo-nordisk-stock-hits-record-high-on-a-deal-in-diabetes-obesity-treatment/,2023-04-12 16:52:00,Novo Nordisk Stock Hits Record High On A $725 Million Deal In ... Investor's Business Daily ...,AMGN,0.3007,0.084415,Neutral
"These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - Cardinal Health  ( NYSE:CAH ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/31768582/these-3-health-care-stocks-delivering-high-dividend-yields-are-recommended-by-wall-stree,2023-04-12 13:24:08,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.105141,0.0,Neutral
Horizon's  ( HZNP )  Tepezza Meets Goals in TED Expanded Use Study,https://www.zacks.com/stock/news/2077011/horizons-hznp-tepezza-meets-goals-in-ted-expanded-use-study,2023-04-11 14:09:00,Horizon Therapeutics (HZNP) announces positive top-line data from its phase IV study of Tepezza to expand its indication to include TED in adult patients with chronic/low clinical activity scores.,AMGN,0.120733,0.128396,Neutral
UnitedHealth's  ( UNH )  UnitedHealthcare Unit to Drive Q1 Earnings,https://www.zacks.com/stock/news/2076998/unitedhealths-unh-unitedhealthcare-unit-to-drive-q1-earnings,2023-04-11 13:46:00,An increase in the total number of people served in commercial domestic business of UnitedHealth (UNH) is likely to have boosted its first-quarter performance.,AMGN,0.150278,0.092602,Neutral
"StockNews.com Upgrades Amgen  ( NASDAQ:AMGN )  to ""Strong-Buy""",https://www.defenseworld.net/2023/04/30/stocknews-com-upgrades-amgen-nasdaqamgn-to-strong-buy.html,2023-04-30 05:44:47,"Amgen ( NASDAQ:AMGN - Get Rating ) was upgraded by analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research report issued to clients and investors on Friday.",AMGN,0.876064,0.418294,Bullish
"ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g32100545/rosen-national-investor-counsel-encourages-amgen-inc-investors-to-secure-counsel-before-important-,2023-04-29 20:03:00,"NEW YORK, April 29, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.499254,-0.045242,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DraftKings, SVB, and Amgen and Encourages Investors to Contact the Firm - DraftKings  ( NASDAQ:DKNG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g32098394/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-draft,2023-04-29 01:00:00,"NEW YORK, April 28, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of DraftKings Inc. DKNG, SVB Financial Group SIVPQ SIVBQ ) ) ) , and Amgen Inc.",AMGN,0.770749,-0.18134,Somewhat-Bearish
"DEADLINE ALERT for AMGN, SBNY, GOOG, NSC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g32097589/deadline-alert-for-amgn-sbny-goog-nsc-law-offices-of-howard-g-smith-reminds-investors-of-class-act,2023-04-28 22:53:19,"BENSALEM, Pa., April 28, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.314374,-0.104683,Neutral
AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g32097480/amgn-lawsuit-alert-levi-korsinsky-reminds-amgen-inc-investors-of-a-class-action-lawsuit-and-upcomi,2023-04-28 22:34:52,"NEW YORK, April 28, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.765213,-0.154751,Somewhat-Bearish
"Amgen  ( AMGN )  Q1 Earnings Beat Estimates, 2023 View Raised",https://www.zacks.com/stock/news/2087027/amgen-amgn-q1-earnings-beat-estimates-2023-view-raised,2023-04-28 15:52:00,Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for 2023.,AMGN,0.428632,0.286631,Somewhat-Bullish
Why Amgen  ( AMGN )  Shares Are Trading Lower Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/04/32080092/why-amgen-shares-are-trading-lower-today,2023-04-28 12:58:41,"Amgen Inc AMGN reported Q1 FY23 sales of $6.11 billion, down 2% Y/Y, resulting from lower revenue from COVID-19 manufacturing collaboration, partially offset by a 2% increase in product sales. The consensus estimate stood at $6.17 billion.",AMGN,0.757528,-0.015734,Neutral
Government Drug Price Curbs Could Sound A Death Knell For Industry,https://www.investors.com/news/technology/biotech-stocks-brace-for-the-worst-as-government-drug-price-negotiations-loom/,2023-04-28 12:00:00,Biotech Stocks Brace For The Worst As Government Drug Price ... Investor's Business Daily ...,AMGN,0.027118,-0.076847,Neutral
Amgen  ( AMGN )  Q1 Earnings Beat Estimates,https://www.zacks.com/stock/news/2086418/amgen-amgn-q1-earnings-beat-estimates,2023-04-27 21:35:14,"Amgen (AMGN) delivered earnings and revenue surprises of 3.65% and 0.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.406745,0.120744,Neutral
Futures: Amazon Erases Gains On Cloud Fears; These Techs Dive,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-amazon-continues-earnings-surge-for-tech-titans-but-cloudflare-snap-plunge/,2023-04-27 21:32:00,"Futures: Amazon Jumps On Earnings, But These Techs Plunge Investor's Business Daily ...",AMGN,0.046184,-0.156323,Somewhat-Bearish
AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS,https://investingnews.com/amgen-reports-first-quarter-financial-results/,2023-04-27 20:43:13,Amgen ( NASDAQ:AMGN ) today announced financial results for the first quarter of 2023.,AMGN,0.093836,0.044844,Neutral
AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS,https://investingnews.com/amgen-reports-first-quarter-financial-results-2659922399/,2023-04-27 20:43:13,Amgen ( NASDAQ:AMGN ) today announced financial results for the first quarter of 2023.,AMGN,0.093836,0.044844,Neutral
"Gilead Posts Bullish Cancer Drug Sales, But Profit Questions Linger",https://www.investors.com/news/technology/gild-stock-gilead-earnings-amgen-stock-amgen-earnings-q1-2023/,2023-04-27 20:17:00,"GILD Stock: Cancer Treatments Surge, But Profit Questions Linger Investor's Business Daily ...",AMGN,0.398781,-0.230628,Somewhat-Bearish
"Amgen 1st quarter profit falls as costs rise, sales up 2%",https://www.reuters.com/business/healthcare-pharmaceuticals/amgen-1st-quarter-profit-falls-costs-rise-sales-flatten-2023-04-27/,2023-04-27 20:12:11,"Amgen 1st quarter profit falls as costs rise, sales flatten ...",AMGN,0.089129,0.017019,Neutral
AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS,https://www.prnewswire.com/news-releases/amgen-reports-first-quarter-financial-results-301810090.html,2023-04-27 20:01:00,"THOUSAND OAKS, Calif., April 27, 2023 /PRNewswire/ -- Amgen ( NASDAQ:AMGN ) today announced financial results for the first quarter of 2023.",AMGN,0.013361,0.05887,Neutral
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/04/32057580/check-out-what-whales-are-doing-with-amgn,2023-04-27 19:16:07,"Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.784481,0.343713,Somewhat-Bullish
"AbbVie  ( ABBV )  Q1 Earnings Beat, Skyrizi Sales Underperform",https://www.zacks.com/stock/news/2086355/abbvie-abbv-q1-earnings-beat-skyrizi-sales-underperform,2023-04-27 16:33:00,"AbbVie's (ABBV) first-quarter 2023 earnings and sales beat estimates. However, share price dives as some key drugs miss sales estimates.",AMGN,0.16849,0.078911,Neutral
AbbVie's weak newer drug sales fan worries as Humira faces rivals,https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-raises-annual-profit-forecast-humira-demand-holds-steady-2023-04-27/,2023-04-27 12:58:00,"April 27 ( Reuters ) - AbbVie Inc ( ABBV.N ) on Thursday missed quarterly revenue estimates for its newer treatments, fueling concerns over the drugmaker's attempts to cushion the blow to sales from blockbuster Humira losing patent exclusivity.",AMGN,0.110973,0.064642,Neutral
Eli Lilly's Obesity Treatment Hopeful Just Crushed Sales Estimates,https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q1-2023/,2023-04-27 12:57:00,Eli Lilly Stock Jumps As Diabetes Newcomer Crushes Sales ... Investor's Business Daily ...,AMGN,0.290607,0.104201,Neutral
"Why US Stocks Are Poised To Open Higher Thursday - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/23/04/32041361/us-stocks-eye-higher-open-as-meta-q1-uplifts-tech-sector-analyst-says-no-earnings-recession-in-card,2023-04-27 11:04:48,"Tech earnings could come to the market's rescue on Thursday, with all major index futures currently trading higher. Traders could also weigh in on the first-quarter GDP report to take stock of how the economy fared amid a housing market downturn, banking crisis, and rising rate environment.",AMGN,0.092927,0.0,Neutral
"AMGN ALERT: The Klein Law Firm Reminds Investors of a Lead Plaintiff Deadline of May 12, 2023 in the Class Action Filed on Behalf of Amgen Inc. Shareholders - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g32018218/amgn-alert-the-klein-law-firm-reminds-investors-of-a-lead-plaintiff-deadline-of-may-12-2023-in-the,2023-04-26 18:16:41,"NEW YORK, April 26, 2023 ( GLOBE NEWSWIRE ) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Amgen Inc. AMGN alleging that the Company violated federal securities laws.",AMGN,0.833329,-0.091066,Neutral
"If You Invested $100 In This Stock 15 Years Ago, You Would Have $600 Today - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/earnings/23/04/32015814/if-you-invested-100-in-this-stock-15-years-ago-you-would-have-600-today,2023-04-26 16:30:20,"Amgen AMGN has outperformed the market over the past 15 years by 4.78% on an annualized basis producing an average annual return of 12.1%. Currently, Amgen has a market capitalization of $128.19 billion.",AMGN,0.983605,0.387251,Bullish
Why Investors Need to Take Advantage of These 2 Medical Stocks Now,https://www.zacks.com/stock/news/2084801/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now,2023-04-26 12:50:06,The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.,AMGN,0.390904,0.463929,Bullish
"ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amgen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31997354/rosen-a-global-and-leading-law-firm-encourages-amgen-inc-investors-to-secure-counsel-before-import,2023-04-25 19:15:00,"NEW YORK, April 25, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023.",AMGN,0.495015,-0.04827,Neutral
Why Shares of Arrowhead Pharmaceuticals Are Up Tuesday,https://www.fool.com/investing/2023/04/25/why-shares-of-arrowhead-pharmaceuticals-are-up-tue/,2023-04-25 15:20:36,The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.,AMGN,0.116348,0.133218,Neutral
"DEADLINE ALERT for SIVBQ, AMGN, SBNY, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31991941/deadline-alert-for-sivbq-amgn-sbny-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-investors,2023-04-25 15:15:00,"LOS ANGELES, April 25, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075874,0.0,Neutral
"Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance",https://www.globenewswire.com/news-release/2023/04/25/2653492/0/en/Novartis-delivers-strong-sales-growth-robust-margin-expansion-and-major-innovation-milestones-Raises-FY-guidance.html,2023-04-25 05:00:00,Ad hoc announcement pursuant to Art. 53 LR ...,AMGN,0.015512,0.0,Neutral
Will Humana's  ( HUM )  Q1 Earnings Beat on Insurance Unit Strength?,https://www.zacks.com/stock/news/2083626/will-humanas-hum-q1-earnings-beat-on-insurance-unit-strength,2023-04-24 16:58:00,Humana's (HUM) first-quarter results are likely to reflect surging premiums and investment income.,AMGN,0.149346,0.044102,Neutral
Can Rising Expenses Hurt Teladoc Health's  ( TDOC )  Q1 Earnings?,https://www.zacks.com/stock/news/2083617/can-rising-expenses-hurt-teladoc-healths-tdoc-q1-earnings,2023-04-24 16:47:00,Teladoc Health's (TDOC) first-quarter results are likely to reflect growth in Access Fees revenues and total visits.,AMGN,0.13873,0.042294,Neutral
Bristol-Myers  ( BMY )  to Report Q1 Earnings: What+'s in Store?,https://www.zacks.com/stock/news/2083607/bristol-myers-bmy-to-report-q1-earnings-what-s-in-store,2023-04-24 15:57:00,Investors are likely to focus on the demand for Eliquis and Opdivo along with an incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q1 results.,AMGN,0.151858,0.076523,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31961579/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-04-24 15:52:25,"NEW YORK, April 24, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
Can Amgen  ( AMGN )  Keep the Earnings Streak Alive in Q1?,https://www.zacks.com/stock/news/2083497/can-amgen-amgn-keep-the-earnings-streak-alive-in-q1,2023-04-24 14:51:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially offset by biosimilar/generic competition for mature drugs.",AMGN,0.598151,0.506365,Bullish
Eli Lilly  ( LLY )  to Report Q1 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2083494/eli-lilly-lly-to-report-q1-earnings-will-it-beat-estimates,2023-04-24 14:40:00,Higher demand for its key drugs is likely to have offset generic competition for several drugs and may have boosted Lilly's (LLY) first-quarter sales.,AMGN,0.183546,-0.02216,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2083316/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-04-24 13:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.215894,0.119684,Neutral
"4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates",https://www.zacks.com/stock/news/2083259/4-pharma-biotech-stocks-poised-to-beat-q1-earnings-estimates,2023-04-24 12:38:00,"We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.",AMGN,0.348103,0.075985,Neutral
"AMGN Announcement: Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Amgen Inc. - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31950336/amgn-announcement-kessler-topaz-meltzer-check-llp-announces-investor-securities-fraud-class-action,2023-04-24 02:21:00,"RADNOR, Pa., April 23, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.680543,-0.177187,Somewhat-Bearish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - Signature Bank  ( OTC:SBNY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31950236/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-svb-a,2023-04-24 01:00:00,"NEW YORK, April 23, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of SVB Financial Group SIVPQ SIVBQ ) ) ) , Amgen Inc.",AMGN,0.754911,-0.179853,Somewhat-Bearish
Cancer Immunotherapy Market Size Worth USD 388.25 Billion in 2030 - Emergen Research,https://markets.businessinsider.com/news/stocks/cancer-immunotherapy-market-size-worth-usd-388-25-billion-in-2030-%E2%80%93-emergen-research-1032251605,2023-04-23 13:22:00,"The global Cancer Immunotherapy Market size was USD 119.39 Billion in 2021 and is expected to register a revenue CAGR of 14.0% during the forecast period, according to latest analysis by Emergen Research Cancer immunotherapy, also known as immuno-oncology, is a fast expanding specialty in cancer ...",AMGN,0.034282,-0.109525,Neutral
"Amgen Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Amgen Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit",https://markets.businessinsider.com/news/stocks/amgen-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-amgen-inc.-shareholders-of-deadline-in-securities-fraud-class-action-lawsuit-1032251075,2023-04-22 14:06:00,"Radnor, Pennsylvania-- ( Newsfile Corp. - April 22, 2023 ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Amgen Inc. ( ""Amgen"" ) ( NASDAQ: AMGN ) .",AMGN,0.741276,-0.214139,Somewhat-Bearish
Will HIV and Oncology Propel Gilead's  ( GILD )  Q1 Earnings?,https://www.zacks.com/stock/news/2082974/will-hiv-and-oncology-propel-gileads-gild-q1-earnings,2023-04-21 16:55:00,Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports its first-quarter 2023 results.,AMGN,0.135602,0.0,Neutral
"CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Amgen Investors of a Lead Plaintiff Deadline of May 12, 2023 - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/04/g31937601/class-action-alert-the-law-offices-of-vincent-wong-remind-amgen-investors-of-a-lead-plaintiff-dead,2023-04-21 15:21:47,"NEW YORK, April 21, 2023 ( GLOBE NEWSWIRE ) -- Attention Amgen Inc. ( ""Amgen"" ) AMGN shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors.",AMGN,0.879272,-0.242665,Somewhat-Bearish
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc.  ( AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/04/g31936874/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-04-21 15:00:00,"LOS ANGELES, April 21, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming May 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Amgen Inc. ( ""Amgen"" or the ...",AMGN,0.699089,-0.019312,Neutral
Will Lower Managed Care Profits Hurt Centene's  ( CNC )  Q1 Earnings?,https://www.zacks.com/stock/news/2082676/will-lower-managed-care-profits-hurt-centenes-cnc-q1-earnings,2023-04-21 12:14:00,Centene's (CNC) first-quarter results are likely to reflect growth in premiums and lower costs.,AMGN,0.141448,0.042744,Neutral
AMGN: 2 Healthcare Stocks Showing Stability With A and B POWR Ratings,https://stocknews.com/news/amgn-otsky-2-healthcare-stocks-showing-stability-with-a-and-b-powr/,2023-04-21 11:39:47,AMGN: 2 Healthcare Stocks Showing Stability With A and B POWR ... ...,AMGN,0.364053,0.036098,Neutral
Biotech ETFs Pop on M&A Resurgence,https://www.zacks.com/stock/news/2093665/biotech-etfs-pop-on-ma-resurgence,2023-05-10 16:33:00,2023 could be a year of heightened biotech dealmaking activity ...,AMGN,0.199859,0.13748,Neutral
Looking Into Amgen's Recent Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/05/32319933/looking-into-amgens-recent-short-interest,2023-05-10 15:30:30,"Amgen's AMGN short percent of float has risen 8.7% since its last report. The company recently reported that it has 7.99 million shares sold short, which is 1.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.3 days to cover their short ...",AMGN,0.224903,0.158881,Somewhat-Bullish
Jacmel Growth Partners Appoints Mark Hardaway as Chief Financial Officer,https://www.prnewswire.com/news-releases/jacmel-growth-partners-appoints-mark-hardaway-as-chief-financial-officer-301820127.html,2023-05-10 12:01:00,Jacmel Growth Partners Appoints Mark Hardaway as Chief Financial ... PR ...,AMGN,0.083833,0.113663,Neutral
"Amgen Inc.: Please contact the Portnoy Law Firm to recover your losses; May 2, 2023 deadline - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32307676/amgen-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-may-2-2023-deadline,2023-05-10 03:30:01,"Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 09, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Amgen Inc.",AMGN,0.744646,-0.203884,Somewhat-Bearish
"Why Are TScan Therapeutics  ( TCRX )  Shares Are Shooting Higher Today - TScan Therapeutics  ( NASDAQ:TCRX ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/05/32290080/why-are-tscan-therapeutics-shares-are-shooting-higher-today,2023-05-09 15:29:20,"Amgen Inc AMGN and TScan Therapeutics Inc TCRX announced a multi-year collaboration to use TScan's proprietary target discovery platform, TargetScan, to identify the antigens recognized by T cells in patients with Crohn's disease.",AMGN,0.608634,0.433651,Bullish
"Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts - AbbVie  ( NYSE:ABBV ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/05/32289782/check-out-3-health-care-stocks-with-over-3-dividend-yields-from-wall-streets-most-accurate-analysts,2023-05-09 13:16:55,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.118064,0.0,Neutral
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - Signature Bank  ( OTC:SBNY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32278887/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-svb-a,2023-05-09 01:30:00,"NEW YORK, May 08, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of SVB Financial Group SIVB SIVBP ) ) ) , Amgen Inc.",AMGN,0.752304,-0.179602,Somewhat-Bearish
"DEADLINE ALERT for SIVBQ, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32274952/deadline-alert-for-sivbq-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inve,2023-05-08 20:45:50,"LOS ANGELES, May 08, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
What Does Amgen's Debt Look Like? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/05/32269590/what-does-amgens-debt-look-like,2023-05-08 17:00:49,"Over the past three months, shares of Amgen Inc. AMGN moved lower by 2.71%. Before having a look at the importance of debt, let's look at how much debt Amgen has. Based on Amgen's balance sheet as of April 28, 2023, long-term debt is at $60.76 billion and current debt is at $834.00 million, ...",AMGN,0.395012,-0.011209,Neutral
AMGN LAWSUIT ALERT: Levi & Korsinsky Notifies Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32268954/amgn-lawsuit-alert-levi-korsinsky-notifies-amgen-inc-investors-of-a-class-action-lawsuit-and-upcom,2023-05-08 16:30:00,"NEW YORK, May 08, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.76367,-0.154628,Somewhat-Bearish
"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN",https://markets.businessinsider.com/news/stocks/rosen-globally-respected-investor-counsel-encourages-amgen-inc.-investors-to-secure-counsel-before-important-may-12-deadline-in-securities-class-action-amgn-1032299067,2023-05-06 17:10:00,"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action ...",AMGN,0.554751,0.0,Neutral
2 Best Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/05/06/best-biotech-stocks-to-buy-right-now/,2023-05-06 11:55:00,Buying pharmaceutical companies with all-around drug portfolios and pipelines is the key to success as an investor.,AMGN,0.273552,0.103106,Neutral
AMGN NOTICE: TOP RANKED ROSEN LAW FIRM Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32248609/amgn-notice-top-ranked-rosen-law-firm-encourages-amgen-inc-investors-to-secure-counsel-before-impo,2023-05-05 20:27:00,"NEW YORK, May 05, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Amgen Inc. AMGN between July 29, 2020 and April 27, 2022, both dates inclusive ( the ""Class Period"" ) , of the important May 12, 2023 lead plaintiff deadline.",AMGN,0.491878,-0.028876,Neutral
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amgen Inc.  ( AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32240261/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains,2023-05-05 14:30:00,"LOS ANGELES, May 05, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( ""GPM"" ) reminds investors of the upcoming May 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Amgen Inc. ( ""Amgen"" or the ""Company"" ...",AMGN,0.699089,-0.019312,Neutral
2 Magnificent Dividend Stocks to Buy Before the Next Recession,https://www.fool.com/investing/2023/05/05/2-magnificent-dividend-stocks-to-buy-before-next/,2023-05-05 13:45:00,The healthcare sector is a good place to find recession-proof stocks.,AMGN,0.318309,0.274021,Somewhat-Bullish
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32231065/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-05-05 02:50:10,"NEW YORK, May 04, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
A Look Into Amgen Inc's Price Over Earnings - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/05/32220966/a-look-into-amgen-incs-price-over-earnings,2023-05-04 17:30:26,"In the current market session, Amgen Inc. AMGN price is at $231.03, after a 0.75% spike. However, over the past month, the stock fell by 8.80%, and in the past year, by 2.31%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par ...",AMGN,0.348919,-0.126931,Neutral
Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market,https://www.reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-rivals-see-room-compete-100-bln-weight-loss-drug-market-2023-05-04/,2023-05-04 10:17:00,Novo Nordisk rivals see room to compete in $100 bln weight-loss ... ...,AMGN,0.044801,0.189864,Somewhat-Bullish
"Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SVB, Amgen, and Signature and Encourages Investors to Contact the Firm - Signature Bank  ( OTC:SBNY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32204027/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-svb-a,2023-05-04 01:30:00,"NEW YORK, May 03, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of SVB Financial Group SIVPQ SIVBQ ) ) ) , Amgen Inc.",AMGN,0.754911,-0.179853,Somewhat-Bearish
Why Amgen Stock Was Sickly Today,https://www.fool.com/investing/2023/05/03/why-amgen-stock-was-sickly-today/,2023-05-03 22:27:10,The company's asset-to-be reported underwhelming first-quarter results.,AMGN,0.639616,0.185032,Somewhat-Bullish
"AMGN SHAREHOLDER ALERT: Jakubowitz Law Reminds Amgen Shareholders of a Lead Plaintiff Deadline of May 12, 2023 - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32201704/amgn-shareholder-alert-jakubowitz-law-reminds-amgen-shareholders-of-a-lead-plaintiff-deadline-of-m,2023-05-03 21:53:07,"NEW YORK, May 03, 2023 ( GLOBE NEWSWIRE ) -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Amgen Inc. AMGN. This lawsuit is on behalf of all persons who purchased or otherwise acquired Amgen common stock between July 29, 2020 ...",AMGN,0.810034,-0.321671,Somewhat-Bearish
"AMGN NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action - AMGN",https://markets.businessinsider.com/news/stocks/amgn-notice-rosen-trusted-investor-counsel-encourages-amgen-inc.-investors-to-secure-counsel-before-important-may-12-deadline-in-securities-class-action-amgn-1032288763,2023-05-03 18:09:00,"AMGN NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amgen Inc. Investors to Secure Counsel Before Important May 12 Deadline in Securities Class Action ...",AMGN,0.554751,0.0,Neutral
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/05/32194490/heres-how-much-you-would-have-made-owning-amgen-stock-in-the-last-15-years,2023-05-03 18:00:22,"Amgen AMGN has outperformed the market over the past 15 years by 4.59% on an annualized basis producing an average annual return of 12.1%. Currently, Amgen has a market capitalization of $124.51 billion.",AMGN,0.983605,0.387251,Bullish
Horizon  ( HZNP )  Q1 Earnings and Revenues Miss Estimates,https://www.zacks.com/stock/news/2089213/horizon-hznp-q1-earnings-and-revenues-miss-estimates,2023-05-03 15:55:00,Horizon Therapeutics (HZNP) reports lower-than-expected first-quarter 2023 results as it misses the Zacks Consensus Estimates for both revenues and earnings.,AMGN,0.154951,0.198341,Somewhat-Bullish
"Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents - Novartis  ( NYSE:NVS ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/05/32184876/amgen-vs-sandoz-legal-battle-erupts-over-bone-strengthening-drug-patents,2023-05-03 13:00:25,"Amgen Inc AMGN has reportedly sued Novartis AG's NVS Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several patents. Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva.",AMGN,0.758753,-0.34764,Somewhat-Bearish
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2088704/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe,2023-05-03 10:20:07,Sector ETF report for ...,AMGN,0.130571,0.07042,Neutral
An investment chief who manages $1 billion in assets shares 10 investments that will reduce your portfolio's volatility while this bear market lasts longer than expected.,https://www.businessinsider.com/how-to-invest-q1-earnings-bear-stock-market-recession-risk-2023-5,2023-05-03 10:00:00,10 Ways to Invest As Earnings Fall in a Bear Market: Landsberg - Business Insider ...,AMGN,0.088147,0.104463,Neutral
Vaccentis Appoints Dr. Ingrid Rauter as Chief Medical Officer and Head of Research & Development,https://www.benzinga.com/pressreleases/23/05/g32180034/vaccentis-appoints-dr-ingrid-rauter-as-chief-medical-officer-and-head-of-research-development,2023-05-03 07:00:00,"Zurich, Switzerland, May 3, 2023 - Vaccentis AG, a clinical-stage Swiss biopharmaceutical company developing patient-individualized medicines, today announced the appointment of the experienced life science executive Ingrid Rauter as Head of R&D and Chief Medical Officer.",AMGN,0.05749,0.162041,Somewhat-Bullish
Amgen sues Sandoz to block generic version of bone cancer and osteoporosis drugs | The Financial Express,https://www.financialexpress.com/healthcare/pharma-healthcare/amgen-sues-sandoz-to-block-generic-version-of-bone-cancer-and-osteoporosis-drugs/3072497/,2023-05-03 06:35:00,Amgen sues Sandoz to block generic version of bone cancer and ... The Financial Express ...,AMGN,0.401331,-0.39275,Bearish
AMGN LAWSUIT ALERT: Levi & Korsinsky Reminds Amgen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32170885/amgn-lawsuit-alert-levi-korsinsky-reminds-amgen-inc-investors-of-a-class-action-lawsuit-and-upcomi,2023-05-02 19:30:47,"NEW YORK, May 02, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Amgen investors who were adversely affected by ...",AMGN,0.765213,-0.154751,Somewhat-Bearish
"Pfizer  ( PFE )  Q1 Earnings Beat, COVID Jab Sales Down as Expected",https://www.zacks.com/stock/news/2088433/pfizer-pfe-q1-earnings-beat-covid-jab-sales-down-as-expected,2023-05-02 17:50:00,"Pfizer (PFE) beats estimates for Q1 earnings and sales. Revenues from its COVID-19 vaccine, Comirnaty declined, as expected.",AMGN,0.055686,0.080008,Neutral
2 Incredibly Cheap Dividend Stocks to Buy in May,https://www.fool.com/investing/2023/05/02/2-incredibly-cheap-dividend-stocks-to-buy-in-may/,2023-05-02 13:45:00,These two dividend-paying pharma stocks both screen as significantly undervalued right now.,AMGN,0.149656,0.232116,Somewhat-Bullish
"AMGEN DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Amgen Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32132689/amgen-deadline-reminder-kessler-topaz-meltzer-check-llp-reminds-investors-of-amgen-inc-of-deadline,2023-05-01 19:56:00,"RADNOR, Pa., May 01, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Amgen Inc. ( ""Amgen"" ) ...",AMGN,0.680543,-0.177187,Somewhat-Bearish
"Analyst Sees A Multibagger, Initiates Coverage On This 'Top Notch Biosimilar Business' - Coherus BioSciences  ( NASDAQ:CHRS ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/05/32128185/analyst-sees-a-multibagger-initiates-coverage-on-this-top-notch-biosimilar-business,2023-05-01 18:36:48,Truist initiated coverage on Coherus BioSciences Inc CHRS with a Buy rating and a price target of $24. The analyst notes the company's growing biosimilar franchise with a track record of taking share in competitive markets such as Amgen Inc's AMGN Neulasta.,AMGN,0.345674,0.474661,Bullish
"DEADLINE ALERT for SIVB, AMGN, SBNY/SBNYP, and GOOG/GOOGL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Alphabet  ( NASDAQ:GOOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/23/05/g32124666/deadline-alert-for-sivb-amgn-sbnysbnyp-and-googgoogl-the-law-offices-of-frank-r-cruz-reminds-inves,2023-05-01 15:43:00,"LOS ANGELES, May 01, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.",AMGN,0.075635,0.0,Neutral
The Targeted Therapy Market Is Projected To Grow At An 8% Rate Through The Forecast Period As Per The Business Research Company's Targeted Therapy Global Market Report 2023,https://www.benzinga.com/pressreleases/23/05/g32124311/the-targeted-therapy-market-is-projected-to-grow-at-an-8-rate-through-the-forecast-period-as-per-t,2023-05-01 15:30:00,"LONDON, May 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the targeted therapy market forecasts that the market is expected to expand from $97.3 billion in 2022 to $106.7 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 9%.The targeted therapy ...",AMGN,0.066047,0.087133,Neutral
3 Top Dividend Stocks to Maximize Your Retirement Income,https://www.zacks.com/stock/news/2087394/3-top-dividend-stocks-to-maximize-your-retirement-income,2023-05-01 13:10:04,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.215415,0.119475,Neutral
Galera Expands Commercial Leadership Team,https://www.globenewswire.com/news-release/2023/05/01/2658164/0/en/Galera-Expands-Commercial-Leadership-Team.html,2023-05-01 11:00:00,"Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products ...",AMGN,0.057536,0.069003,Neutral
AMGEN INC.  ( NASDAQ: AMGN )  SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amgen Inc.  ( NASDAQ: AMGN )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32107516/amgen-inc-nasdaq-amgn-shareholder-class-action-alert-bernstein-liebhard-llp-reminds-investors-of-t,2023-05-01 05:45:00,"Did you lose money on investments in Amgen Inc.? If so, please visit Amgen Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at ( 212 ) 951-2030 or pallocco@bernlieb.com to discuss your rights.",AMGN,0.765818,-0.035858,Neutral
"Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio",https://www.prnewswire.com/news-releases/autoimmune-drugs-market-size-to-grow-by-usd-29-314-5-million-between-2022-and-2027-abbvie-inc-and-advacare-pharma-among-others-identified-as-key-vendors--technavio-301828870.html,2023-05-19 23:15:00,"Autoimmune Drugs Market size to grow by USD 29,314.5 million ... PR ...",AMGN,0.075161,0.137715,Neutral
Here's How Much You Would Have Made Owning Amgen Stock In The Last 15 Years - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/05/32489034/heres-how-much-you-would-have-made-owning-amgen-stock-in-the-last-15-years,2023-05-19 16:00:30,"Amgen AMGN has outperformed the market over the past 15 years by 4.01% on an annualized basis producing an average annual return of 11.64%. Currently, Amgen has a market capitalization of $119.97 billion.",AMGN,0.983605,0.387251,Bullish
Market Rally Hits 2023 Highs As Big Techs Lead: Weekly Review,https://www.investors.com/news/stock-market-rally-hits-2023-highs-as-big-techs-lead-tesla-walmart-on-holding-in-focus-weekly-review/,2023-05-19 15:49:00,"The stock market rally gained momentum, with the Nasdaq and S&P 500 hitting 2023 highs. The Nasdaq 100 rallied to a 52-week high, as big techs dominate the uptrend. The Dow Jones rose modestly, after briefly undercutting the 50-day line. The small-cap Russell 2000 also rebounded, helped by bank ...",AMGN,0.099683,0.001122,Neutral
3 Safe Dividend Stocks to Beat Inflation,https://www.fool.com/investing/2023/05/19/3-safe-dividend-stocks-to-beat-inflation/,2023-05-19 09:35:00,Look for businesses that thrive in any economic environment.,AMGN,0.203729,0.213009,Somewhat-Bullish
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/05/19/2672401/0/en/Alvotech-Reports-Financial-Results-for-First-three-Months-of-2023-and-Provides-Business-Update.html,2023-05-19 09:00:00,"• Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8 million for the same period in 2022 • Confirmatory patient study for AVT05, a proposed biosimilar for Simponi® and Simponi Aria® ( golimumab ) initiated, marking the fifth internally developed portfolio ...",AMGN,0.012545,0.0,Neutral
Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/05/19/2672402/0/en/Alvotech-Reports-Financial-Results-for-First-three-Months-of-2023-and-Provides-Business-Update.html,2023-05-19 09:00:00,"REYKJAVIK, Iceland, May 19, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first three months of ...",AMGN,0.012512,0.0,Neutral
Buy The Dip On The FTC's Latest Victim,https://www.forbes.com/sites/greatspeculations/2023/05/18/buy-the-dip-on-the-ftcs-latest-victim/,2023-05-18 14:28:40,"Shares of Horizon Therapeutics (HZNP) are fresh off their lowest level since November, after the Federal Trade Commission (FTC) yesterday said it will block the acquis...",AMGN,0.271274,-0.21303,Somewhat-Bearish
Stocks Jump On Debt-Ceiling Hopes. These 6 Flash Buy Signals.,https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-on-debt-ceiling-deal-hopes-six-stocks-flash-buy-signals/,2023-05-17 20:59:00,"Dow Jones futures were steady after hours, along with S&P 500 futures and Nasdaq futures. Synopsys ( SNPS ) and Cisco Systems ( CSCO ) reported late Wednesday with Walmart ( WMT ) and Alibaba ( BABA ) due early Thursday.",AMGN,0.047324,-0.232697,Somewhat-Bearish
TScan Therapeutics Shares Fall After Preliminary Data Highlight In Leukemia Patients - TScan Therapeutics  ( NASDAQ:TCRX ) ,https://www.benzinga.com/general/biotech/23/05/32450160/tscan-therapeutics-shares-fall-after-preliminary-data-highlight-in-leukemia-patients,2023-05-17 18:35:05,TScan Therapeutics Inc TCRX announced a poster presentation highlighting preliminary data from the Phase 1 umbrella clinical trial evaluating TSC-100 and TSC-101 targeting minor histocompatibility antigens to prevent relapse after hematopoietic cell transplantation in leukemia patients.,AMGN,0.325208,-0.14117,Neutral
FTC Challenges Amgen's  ( AMGN )  $28B Acquisition of Horizon,https://www.zacks.com/stock/news/2096505/ftc-challenges-amgens-amgn-28b-acquisition-of-horizon,2023-05-17 18:10:00,"Per the FTC, Amgen's (AMGN) acquisition of Horizon (HZNP) would entrench the monopoly positions for the latter's medications for thyroid eye disease and chronic refractory gout.",AMGN,0.538084,0.006673,Neutral
The Turnaround For Weight Watchers Is Taking Shape - WW International  ( NASDAQ:WW ) ,https://www.benzinga.com/news/earnings/23/05/32441821/the-turnaround-for-weight-watchers-is-taking-shape,2023-05-17 14:35:54,Weight management meals and services provider WW International Inc. WW stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares collapsed ( 26% ) as Artal Group S.A. sold its remaining 14.8 million share stake.,AMGN,0.082535,0.048345,Neutral
Pfizer  ( PFE )  to Raise $31B in Debt to Fund Seagen  ( SGEN )  Deal,https://www.zacks.com/stock/news/2096263/pfizer-pfe-to-raise-31b-in-debt-to-fund-seagen-sgen-deal,2023-05-17 13:36:00,"Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN).",AMGN,0.339046,0.21045,Somewhat-Bullish
"FDA Signals Support For Pfizer's Maternal RSV Shot Ahead Of Adcomm, Pfizer Raises $31B In Debt To Fund Seagen Deal - Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/general/biotech/23/05/32440200/fda-signals-support-for-pfizers-maternal-rsv-shot-ahead-of-adcomm-pfizer-raises-31b-in-debt-to-fu,2023-05-17 12:17:34,"Pfizer Inc PFE plans to raise $31 billion from a debt offering to finance its proposed acquisition of Seagen Inc SGEN for $43 billion. The debt offering, which would be in eight tranches, is expected to close on May 19.",AMGN,0.265378,-0.284839,Somewhat-Bearish
FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?,https://www.fool.com/investing/2023/05/17/ftc-seeks-to-block-amgens-acquisition-of-horizon-t/,2023-05-17 09:13:00,Don't bank on the FTC winning in its attempt to stop Amgen's buyout of Horizon just yet.,AMGN,0.753867,0.035968,Neutral
Is This Dow Jones Stock a Buy for Income Investors?,https://www.fool.com/investing/2023/05/17/is-this-dow-jones-stock-a-buy-for-income-investors/,2023-05-17 09:06:00,This pharmaceutical company is dedicated to maintaining its track record of innovation.,AMGN,0.587133,0.309801,Somewhat-Bullish
Stocks Skid On Biden's Debt-Limit Move; Tesla Will 'Try' This,https://www.investors.com/market-trend/stock-market-today/dow-jones-breaks-support-as-president-biden-makes-debt-ceiling-move-elon-musk-tesla-cybertruck/,2023-05-17 00:37:00,Dow Jones Breaks Support As President Biden Makes This Debt ... Investor's Business Daily ...,AMGN,0.073247,-0.145825,Neutral
Why These 3 Nasdaq Stocks Buckled Today,https://www.fool.com/investing/2023/05/16/why-these-3-nasdaq-stocks-buckled-today/,2023-05-16 19:42:00,The FTC's decision to sue to block a high-profile merger is weighing on biotech valuations today.,AMGN,0.239698,-0.105509,Neutral
FTC May Reportedly Block Amgen's  ( AMGN )  $28B Horizon Buyout,https://www.zacks.com/stock/news/2096013/ftc-may-reportedly-block-amgens-amgn-28b-horizon-buyout,2023-05-16 19:16:00,Unconfirmed reports suggest that the FTC may challenge the $28-billion buyout of Horizon Therapeutics (HZNP) by Amgen.,AMGN,0.654859,0.022301,Neutral
"FTC Files Lawsuit To Stop Amgen Buying Horizon Therapeutics, Sending Shockwaves Through Biopharma M&A - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/05/32428869/ftc-files-lawsuit-to-stop-amgen-buying-horizon-therapeutics-sending-shockwaves-through-biopharma-,2023-05-16 18:37:11,"In a rare move to block a large pharma deal, the U.S. Federal Trade Commission would sue to stop Amgen Inc's AMGN $28 billion takeover of Horizon Therapeutics PLC HZNP.",AMGN,0.72844,-0.03577,Neutral
FTC sues to block Amgen's acquisition of Horizon Therapeutics,https://www.marketwatch.com/story/ftc-sues-to-block-amgens-acquisition-of-horizon-therapeutics-39a5cd1,2023-05-16 17:44:00,"Deal could allow Amgen to ""entrench the monopoly positions"" of two Horizon medications, regulators say.",AMGN,0.636698,0.099875,Neutral
"Stocks Dip, Nasdaq Bull Run Continues With Big Tech Speculation: Investors Eye Biden-McCarthy Debt Ceiling Talk - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Horizon Therapeutics  ( NASDAQ:HZNP ) , Baidu  ( NASDAQ:BIDU ) , Capital One Finl  ( NYSE:COF ) , Home Depot  ( NYSE:HD ) , Amgen  ( NASDAQ:AMGN ) , SPDR S&P 500  ( ARCA:SPY ) , Tencent Music Enter Gr  ( NYSE:TME ) , Tupperware Brands  ( NYSE:TUP ) ",https://www.benzinga.com/news/23/05/32417598/s-amp-p-500-futures-slip-after-home-depots-q1-print-analyst-says-retest-of-october-lows-likely-1,2023-05-16 17:26:00,"The markets were overall weaker on Tuesday, with a significant exception stemming from big gains reported by tech giants following 13F disclosures by hedge funds, which indicated that speculators raised their exposure to major tech firms. Alphabet, Inc. GOOG GOOGL, Advanced Micro Devices, Inc.",AMGN,0.089295,-0.243452,Somewhat-Bearish
Trade commission fights Amgen's $28B purchase of Horizon Therapeutics - .com,https://www.upi.com/Top_News/US/2023/05/16/FTC-Amgen-Horizon-monopoly/4331684252329/,2023-05-16 16:58:15,Trade commission fights Amgen's $28B purchase of Horizon Therapeutics UPI News ...,AMGN,0.098255,-0.004313,Neutral
Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday,https://www.fool.com/investing/2023/05/16/why-these-2-large-cap-stocks-dropped-10-plus-on-tu/,2023-05-16 16:36:00,Their declines weighed on the broader market.,AMGN,0.265378,-0.004154,Neutral
FTC Suing To Stop Amgen's $27.8 Billion Purchase Of Horizon Therapeutics,https://www.forbes.com/sites/mollybohannon/2023/05/16/ftc-suing-to-stop-amgens-278-billion-purchase-of-horizon-therapeutics/,2023-05-16 16:21:41,The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.,AMGN,0.642977,0.003752,Neutral
Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon,https://apnews.com/article/amgen-horizon-ftc-antitrust-monopoly-regulators-d20c418b2c5b0684fabb9cc22c2432b0,2023-05-16 15:57:20,Monopoly concerns push FTC to sue to block Amgen's more than ... The Associated Press ...,AMGN,0.09186,0.051832,Neutral
Why Horizon Therapeutics Stock Is Crashing Today,https://www.fool.com/investing/2023/05/16/why-horizon-therapeutics-stock-is-crashing-today/,2023-05-16 15:14:01,The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen.,AMGN,0.736015,-0.141426,Neutral
Stock Market Awaits Debt Ceiling Talks. Home Depot Tanks After Sales Miss.,https://www.investors.com/market-trend/stock-market-today/stock-market-awaits-debt-ceiling-talks-home-depot-tanks-after-sales-miss-and-gloomy-guidance/,2023-05-16 14:51:00,Stock Market Awaits Debt Ceiling Talks. Home Depot Tanks After ... Investor's Business Daily ...,AMGN,0.150906,-0.229939,Somewhat-Bearish
"Top Stories Tuesday, May 16: Former SVB CEO Blames Fed & Media Hype For Collapse, FTC Plans Lawsuit to Block Horizon Therapeutics $28B Takeover, Home Depot Lowers Annual Outlook - Amgen  ( NASDAQ:AMGN ) , Delta Air Lines  ( NYSE:DAL ) ",https://www.benzinga.com/general/biotech/23/05/32422751/former-svb-ceo-blames-fed-media-hype-for-collapse-ftc-plans-lawsuit-to-block-horizon-therapeutics,2023-05-16 13:56:40,"Greg Becker, the former CEO of SVB Financial Group, the parent company of Silicon Valley Bank, attributed the bank's collapse to a combination of factors, including rapid rate hikes by the Federal Reserve and negative sentiment amplified by social media.",AMGN,0.168785,-0.128259,Neutral
Jim Cramer's top things to watch in the stock market Tuesday,https://www.cnbc.com/2023/05/16/jim-cramers-top-things-to-watch-in-the-stock-market-tuesday.html,2023-05-16 13:13:45,Dow component Home Depot's decline on big revenue miss and guidance cut sets up the 30-stock average for a modestly lower open.,AMGN,0.163909,-0.073373,Neutral
Horizon Crashes - Taking Others With It - On Scrutiny In Amgen Deal,https://www.investors.com/news/technology/hznp-stock-crashes-on-reports-the-ftc-could-block-its-takeover-by-amgen/,2023-05-16 13:03:00,HZNP Stock Crashes On Reports The FTC Could Block Its Takeover ... Investor's Business Daily ...,AMGN,0.470894,0.154791,Somewhat-Bullish
"Why Horizon Therapeutics  ( HZNP )  Stock is Tanking Today? - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/05/32417018/amgen-horizon-therapeutics-deal-regulatory-overhang-ftc-plans-lawsuit-to-block-28b-takeover,2023-05-16 12:06:26,"The Federal Trade Commission is expected to file a lawsuit in a bid to block Amgen Inc's AMGN $28 billion takeover of Horizon Therapeutics PLC HZNP. In December, Amgen agreed to buy Horizon Therapeutics at $116.50/share, implying an enterprise value of approximately $28.3 billion, marking the ...",AMGN,0.810649,0.016314,Neutral
"S&P 500 Futures Slip After Home Depot's Q1 Print: Analyst Says Retest Of October Lows Likely - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Horizon Therapeutics  ( NASDAQ:HZNP ) , Baidu  ( NASDAQ:BIDU ) , Capital One Finl  ( NYSE:COF ) , Home Depot  ( NYSE:HD ) , Amgen  ( NASDAQ:AMGN ) , SPDR S&P 500  ( ARCA:SPY ) , Tencent Music Enter Gr  ( NYSE:TME ) , Tupperware Brands  ( NYSE:TUP ) ",https://www.benzinga.com/news/23/05/32417598/s-amp-p-500-futures-slip-after-home-depots-q1-print-analyst-says-retest-of-october-lows-likely,2023-05-16 11:03:13,"The see-sawing mood and tight trading ranges that have been characteristic of recent sessions will likely hold in the near term. The major stock futures point to a mostly lower opening on Tuesday as Home Depot, Inc.'s HD disappointing first-quarter results cast a cloud on the economic outlook.",AMGN,0.08687,-0.242151,Somewhat-Bearish
"Here's the big thing holding up the stock market, says Bank of America",https://www.marketwatch.com/story/heres-the-big-thing-holding-up-the-stock-market-says-bank-of-america-e5a2d2c5,2023-05-16 11:00:00,"Investors want to see the economy land softly softly, and that is the main thing that will keep assets resilient, say BofA managers.",AMGN,0.073546,-0.073259,Neutral
"Capital One stock rallies and Home Depot shares dip, and other companies on the move",https://www.marketwatch.com/story/capital-one-stock-rallies-and-home-depot-shares-dips-and-other-companies-on-the-move-fb5b254e,2023-05-16 10:23:00,Capital One Financial Corp.'s shares rose 6% after Warren Buffett's Berkshire Hathaway Inc. took a near $1 billion bet on the credit card and banking group ...,AMGN,0.42503,-0.249202,Somewhat-Bearish
Horizon shares sink on report that FTC will sue to block takeover by Amgen,https://www.marketwatch.com/story/horizon-shares-sink-on-report-that-ftc-will-sue-to-block-takeover-by-amgen-544909b0,2023-05-16 01:51:00,Shares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen Inc.'s $27.8 billion acquisition of Horizon.,AMGN,0.933751,0.025643,Neutral
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2095203/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-05-15 13:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.214462,0.11906,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2095065/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-05-15 10:20:09,Sector ETF report for ...,AMGN,0.137671,0.072354,Neutral
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amgen Inc. - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/05/g32376443/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amgen-inc-amgn,2023-05-12 23:16:55,"NEW YORK, May 12, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. ( ""Amgen"" or the ""Company"" ) AMGN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.",AMGN,0.658003,-0.100244,Neutral
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/pain-relief-therapeutics-market-to-grow-significantly-by-2029--brandessence-market-research-301836608.html,2023-05-29 15:15:00,Pain Relief Therapeutics Market to Grow Significantly by 2029 ... PR ...,AMGN,0.023487,0.099264,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2100835/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-05-29 13:10:04,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.20279,0.112432,Neutral
Global Recombinant DNA Technology Market Report 2023: Increasing Number of Chronic Diseases Drives Growth,https://www.prnewswire.com/news-releases/global-recombinant-dna-technology-market-report-2023-increasing-number-of-chronic-diseases-drives-growth-301835829.html,2023-05-27 01:45:00,Global Recombinant DNA Technology Market Report 2023 ... PR ...,AMGN,0.033006,0.110153,Neutral
AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT,https://investingnews.com/amgen-to-present-at-the-td-cowen-4th-annual-oncology-innovation-summit/,2023-05-26 21:11:14,"Amgen ( NASDAQ: AMGN ) will present at the TD Cowen 4th Annual Oncology Innovation Summit at 11:00 a.m. ET on Wednesday May 31, 2023. David M. Reese M.D., executive vice president of Research and Development at Amgen will present at the conference.",AMGN,0.856646,0.251172,Somewhat-Bullish
Is the Options Market Predicting a Spike in Amgen  ( AMGN )  Stock?,https://www.zacks.com/stock/news/2100115/is-the-options-market-predicting-a-spike-in-amgen-amgn-stock,2023-05-26 12:34:00,Investors need to pay close attention to Amgen (AMGN) stock based on the movements in the options market lately.,AMGN,0.558244,0.108528,Neutral
A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know.,https://www.fool.com/investing/2023/05/26/a-challenger-to-jjs-top-blockbuster-is-on-the-way/,2023-05-26 09:30:00,Biotech-giant Amgen aims to launch a rival.,AMGN,0.165409,0.019369,Neutral
Sandoz Marketing Authorization Applications for proposed biosimilar denosumab accepted by EMA,https://www.globenewswire.com/news-release/2023/05/25/2675804/0/en/Sandoz-Marketing-Authorization-Applications-for-proposed-biosimilar-denosumab-accepted-by-EMA.html,2023-05-25 05:15:00,"Basel, May 25, 2023 - Sandoz, a global leader in off-patent ( generic and biosimilar ) medicines, today announced that the European Medicines Agency ( EMA ) has accepted the marketing authorization applications ( MAA ) for proposed biosimilar denosumab for regulatory review.",AMGN,0.03178,0.0,Neutral
"FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?",https://www.fool.com/investing/2023/05/24/ftc-block-amgen-horizon-deal-pfizer-seagen-risk/,2023-05-24 09:15:00,Should Pfizer and Seagen investors be worried?,AMGN,0.471718,-0.068107,Neutral
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/05/32537932/check-out-what-whales-are-doing-with-amgn,2023-05-23 18:16:39,"A whale with a lot of money to spend has taken a noticeably bullish stance on Amgen. Looking at options history for Amgen AMGN we detected 11 strange trades. If we consider the specifics of each trade, it is accurate to state that 54% of the investors opened trades with bullish expectations and ...",AMGN,0.864442,0.313977,Somewhat-Bullish
There's An Overlooked Caveat To Pfizer's Ozempic Rival,https://www.investors.com/news/technology/pfizer-stock-the-one-caveat-investors-missed-with-its-ozempic-rival/,2023-05-23 14:43:00,Pfizer Stock: The One Caveat Investors Missed With Its Ozempic Rival Investor's Business Daily ...,AMGN,0.149656,0.0,Neutral
AMGN: 4 Best Biotech Stocks According to POWR Ratings,https://stocknews.com/news/amgn-regn-uthr-vnda-4-best-biotech-stocks-according-to-powr-ratings/,2023-05-23 14:31:04,"The biotech industry has diversified and thrived, especially during the pandemic, owing to the advanced innovations and incessant efforts to curb the deadly virus. Moreover, the inelastic demand enjoyed by the industry makes it well-grounded to maintain its buoyancy in the upcoming times.",AMGN,0.247334,0.09851,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2098310/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-05-23 10:20:08,Smart Beta ETF report for ...,AMGN,0.123526,0.068619,Neutral
Pfizer Next Blockbuster Act? It Might Be In Obesity,https://www.investors.com/news/technology/pfizer-stock-jumps-after-oral-drug-outperforms-novo-superstar-ozempic-in-weight-loss/,2023-05-22 16:58:00,Pfizer Stock Jumps After Oral Drug Outperforms Novo Superstar ... Investor's Business Daily ...,AMGN,0.160633,0.067338,Neutral
Amgen's Debt Overview - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/05/32510537/amgens-debt-overview,2023-05-22 15:01:00,"Shares of Amgen Inc. AMGN moved lower by 6.11% in the past three months. Before having a look at the importance of debt, let's look at how much debt Amgen has.",AMGN,0.304428,-0.158499,Somewhat-Bearish
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2097899/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-05-22 13:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.219312,0.121176,Neutral
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2097783/should-you-invest-in-the-invesco-dynamic-pharmaceuticals-etf-pjp,2023-05-22 10:20:07,Sector ETF report for ...,AMGN,0.129516,0.063099,Neutral
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2106648/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-06-09 21:50:23,"Amgen (AMGN) closed at $218.82 in the latest trading session, marking a -0.88% move from the prior day.",AMGN,0.615462,0.180086,Somewhat-Bullish
Is AbbVie or Amgen the Better Bargain Buy Right Now?,https://www.fool.com/investing/2023/06/08/is-abbvie-or-amgen-the-better-bargain-buy-right-no/,2023-06-08 16:15:00,These elite drugmakers are both working through a number of headwinds.,AMGN,0.334978,0.105665,Neutral
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields - AbbVie  ( NYSE:ABBV ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/06/32778040/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields,2023-06-08 13:07:35,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.110973,0.0,Neutral
"StockNews.com Upgrades Amgen  ( NASDAQ:AMGN )  to ""Strong-Buy""",https://www.defenseworld.net/2023/06/08/stocknews-com-upgrades-amgen-nasdaqamgn-to-strong-buy.html,2023-06-08 05:32:45,"Amgen ( NASDAQ:AMGN - Get Rating ) was upgraded by equities research analysts at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report released on Thursday. AMGN has been the topic of a number of other reports.",AMGN,0.899545,0.351278,Bullish
"The Zacks Analyst Blog Highlights JPMorgan Chase, McDonald's, Comcast, T-Mobile US and Amgen",https://www.zacks.com/stock/news/2105108/the-zacks-analyst-blog-highlights-jpmorgan-chase-mcdonalds-comcast-t-mobile-us-and-amgen,2023-06-07 13:07:00,"JPMorgan Chase, McDonald's, Comcast, T-Mobile US and Amgen are part of the Zacks top Analyst Blog.",AMGN,0.724687,0.0,Neutral
Is Invesco Dynamic Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2104843/is-invesco-dynamic-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2023-06-07 10:20:06,Smart Beta ETF report for ...,AMGN,0.11894,0.061867,Neutral
"Top Analyst Reports for JPMorgan Chase, McDonald's & Comcast",https://www.zacks.com/research-daily/2104505/top-analyst-reports-for-jpmorgan-chase-mcdonalds-comcast,2023-06-06 19:23:00,"Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), McDonald's Corporation (MCD) and Comcast Corporation (CMCSA).",AMGN,0.12645,0.20905,Somewhat-Bullish
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2104424/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick,2023-06-06 13:40:07,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,AMGN,0.383905,0.202066,Somewhat-Bullish
"Dow Stocks Like Microsoft, Apple, Disney, and Verizon Reveal Two Sides of the Market",https://www.fool.com/investing/2023/06/06/dow-stocks-microsoft-apple-disney-verizon-buy-sell/,2023-06-06 13:00:00,Many well-known stocks are missing out on the market's epic 2023 rally.,AMGN,0.034882,-0.035597,Neutral
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma,https://www.globenewswire.com/news-release/2023/06/05/2682408/33333/en/Coherus-Announces-Positive-Final-Overall-Survival-Results-of-JUPITER-02-Phase-3-Trial-Evaluating-Toripalimab-in-Nasopharyngeal-Carcinoma.html,2023-06-05 21:30:00,"- Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients ...",AMGN,0.018187,0.0,Neutral
Dow Jones Falls As Apple Unveils These Products; This Stock Soars After Cathie Wood Sells It,https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-even-as-apple-unveils-ios-17-vr-headset-vision-pro-this-stock-soars-after-cathie-wood-sells-it/,2023-06-05 19:15:00,Dow Jones Falls As Apple Unveils These Products. This Stock Soars ... Investor's Business Daily ...,AMGN,0.099476,-0.078554,Neutral
Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.,https://www.marketwatch.com/story/biotech-stocks-could-soon-get-a-m-a-boost-here-are-3-likely-takeover-plays-206b79c3,2023-06-05 19:05:00,Big pharma will be looking to acquire companies with promsing new medicines.,AMGN,0.19295,0.065446,Neutral
Here's How Much $1000 Invested In Amgen 15 Years Ago Would Be Worth Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/06/32721151/heres-how-much-1000-invested-in-amgen-15-years-ago-would-be-worth-today,2023-06-05 17:30:20,"Amgen AMGN has outperformed the market over the past 15 years by 3.48% on an annualized basis producing an average annual return of 11.44%. Currently, Amgen has a market capitalization of $118.92 billion.",AMGN,0.983605,0.387251,Bullish
3 Top Dividend Stocks to Maximize Your Retirement Income,https://www.zacks.com/stock/news/2103755/3-top-dividend-stocks-to-maximize-your-retirement-income,2023-06-05 13:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.210731,0.115826,Neutral
Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 revenue forecast,https://www.reuters.com/business/healthcare-pharmaceuticals/stelara-patent-deal-puts-jj-back-path-57-bln-2025-revenue-forecast-2023-06-05/,2023-06-05 10:14:00,Analysis: Stelara patent deal puts J&J back on path to $57 bln 2025 ... ...,AMGN,0.06697,0.064437,Neutral
Why The Biotech Buying Bonanza Will Likely Continue,https://www.investors.com/news/technology/biotech-stocks-are-in-blistering-ma-climate-ftc-could-change-that/,2023-06-02 17:17:00,Biotech Stocks Are In A 'Blistering' M&A Climate. The FTC Could ... Investor's Business Daily ...,AMGN,0.110028,-0.017979,Neutral
Autoinjectors Market worth $1.7 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/autoinjectors-market-worth-1-7-billion--marketsandmarkets-301840949.html,2023-06-02 17:00:00,"CHICAGO, June 2, 2023 /PRNewswire/ -- The autoinjectors industry is set to experience significant growth in the near future as a result of several factors. With the rise in chronic diseases and the increasing need for self-administration of medication, autoinjectors have emerged as a convenient ...",AMGN,0.021937,0.013872,Neutral
Coherus BioSciences to launch Humira biosimilar at 85% discount,https://www.reuters.com/business/healthcare-pharmaceuticals/coherus-biosciences-launch-humira-biosimilar-995-per-carton-2023-06-01/,2023-06-01 14:15:00,"June 1 ( Reuters ) - Coherus BioSciences Inc ( CHRS.O ) said on Thursday it plans to launch a biosimilar of AbbVie Inc's ( ABBV.N ) Humira in July at a list price of $995 per carton, representing a discount of about 85% from the blockbuster arthritis drug.",AMGN,0.156461,-0.015915,Neutral
2 Large Cap Biotech Stocks To Watch Right Now,https://stockmarket.com/featured/2-large-cap-biotech-stocks-to-watch-right-now-2023-05-31,2023-05-31 20:29:15,The biotechnology sector is a rapidly evolving and highly exciting area of the market. The sector focuses on the use of living organisms to make products or run processes. This sector is at the forefront of scientific advancement.,AMGN,0.319933,0.27745,Somewhat-Bullish
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2101737/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-05-31 10:20:06,Sector ETF report for ...,AMGN,0.134968,0.071604,Neutral
Amgen  ( NASDAQ:AMGN )  Downgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/06/17/amgen-nasdaqamgn-downgraded-by-stocknews-com-to-buy-2.html,2023-06-17 08:32:56,StockNews.com lowered shares of Amgen ( NASDAQ:AMGN - Get Rating ) from a strong-buy rating to a buy rating in a research note issued to investors on Friday morning. Several other equities research analysts have also issued reports on the company.,AMGN,0.85716,0.265167,Somewhat-Bullish
Amgen  ( AMGN )  Gains As Market Dips: What You Should Know,https://www.zacks.com/stock/news/2109682/amgen-amgn-gains-as-market-dips-what-you-should-know,2023-06-16 21:50:18,"In the latest trading session, Amgen (AMGN) closed at $229.66, marking a +0.53% move from the previous day.",AMGN,0.479683,0.134003,Neutral
AbbVie's  ( ABBV )  Skyrizi Meets Ulcerative Colitis Study Goals,https://www.zacks.com/stock/news/2109293/abbvies-abbv-skyrizi-meets-ulcerative-colitis-study-goals,2023-06-16 11:45:00,AbbVie's (ABBV) Skyrizi achieves statistical significance with its primary endpoint of clinical remission in a late-stage study as a maintenance treatment for ulcerative colitis.,AMGN,0.306963,0.101135,Neutral
Dow Jones Jumps As Market Shrugs Off Powell; Cava Stock Explodes On Trading Debut,https://www.investors.com/market-trend/stock-market-today/dow-jones-jumps-as-stock-market-shrugs-off-fed-chair-jerome-powell-cava-stock-explodes-on-trading-debut/,2023-06-15 19:14:00,Dow Jones Jumps As Market Shrugs Off Powell. Cava Stock ... Investor's Business Daily ...,AMGN,0.086245,0.349248,Somewhat-Bullish
"How Big Pharma, Including Lilly, Is Lending Cachet To Gene Editing",https://www.investors.com/news/technology/verv-stock-soars-as-eli-lilly-adds-pharma-cachet-to-gene-editing-program/,2023-06-15 18:13:00,VERV Stock Soars As Eli Lilly Adds Pharma Cachet To Gene-Editing ... Investor's Business Daily ...,AMGN,0.182506,0.160378,Somewhat-Bullish
Anaemia Drugs Market to Grow Exponentially by 2029 Says Brandessence Market Research,https://www.prnewswire.com/news-releases/anaemia-drugs-market-to-grow-exponentially-by-2029-says-brandessence-market-research-301851868.html,2023-06-15 10:22:00,"LONDON, June 15, 2023 /PRNewswire/ -- Anaemia is a disorder occurrence by the deficiency of red blood cells or decreasing amount of haemoglobin in the blood. It often leads to extreme weakness, fatigue, pale skin and irregular heartbeat, among others.",AMGN,0.028626,0.100156,Neutral
Biosimilars Market worth $66.9 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/biosimilars-market-worth-66-9-billion--marketsandmarkets-301851755.html,2023-06-15 10:00:00,"CHICAGO, June 15, 2023 /PRNewswire/ -- The biosimilars industry is poised for significant growth and innovation in the near future.",AMGN,0.05257,0.218011,Somewhat-Bullish
Longeveron Welcomes Three New Prominent Board Members,https://www.globenewswire.com/news-release/2023/06/13/2687120/0/en/Longeveron-Welcomes-Three-New-Prominent-Board-Members.html,2023-06-13 12:30:00,"Seasoned Biotechnology and Corporate Management Experts, Khoso Baluch, Jeffrey Pfeffer, and Wa'el Hashad, Elected to Board at Annual Meeting of Stockholders ...",AMGN,0.028764,-0.024573,Neutral
"Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck - Smith & Nephew  ( NYSE:SNN ) , TotalEnergies  ( NYSE:TTE ) , Morgan Stanley  ( NYSE:MS ) , iShares MSCI Hong Kong Index Fund  ( ARCA:EWH ) , Rio Tinto  ( NYSE:RIO ) , Novartis  ( NYSE:NVS ) , Amgen  ( NASDAQ:AMGN ) , WisdomTree Emerging Markets High Dividend Fund  ( ARCA:DEM ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/06/33063975/amgen-out-rio-tinto-in-as-morgan-stanley-shuffles-dividend-deck,2023-06-29 17:03:00,"Industry giant Morgan Stanley MS is shaking up its model for income-focused investors, indicating a strategic move towards robust and resilient players. The multinational investment bank told investors Thursday that it added new positions and adjusted weights in its dividend portfolio.",AMGN,0.312158,-0.094922,Neutral
What Will Amgen Buy Next?,https://www.fool.com/investing/2023/06/29/what-will-amgen-buy-next/,2023-06-29 16:45:00,The biotech could pursue these two budget-friendly targets.,AMGN,0.43816,0.233553,Somewhat-Bullish
5 High-Yielding Dividend Stocks That Are Bargain Buys,https://www.fool.com/investing/2023/06/29/5-high-yielding-dividend-stocks-that-are-bargain/,2023-06-29 14:00:00,This is a good time for investors to load up on healthcare companies.,AMGN,0.210092,0.166981,Somewhat-Bullish
How Is The Market Feeling About Amgen? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/06/33049519/how-is-the-market-feeling-about-amgen,2023-06-28 19:45:35,"Amgen's AMGN short percent of float has fallen 4.93% since its last report. The company recently reported that it has 7.20 million shares sold short, which is 1.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.0 days to cover their ...",AMGN,0.224903,0.085754,Neutral
Nasdaq Welcomed 60 IPOs in the First Half of 2023 - Nasdaq  ( NASDAQ:NDAQ ) ,https://www.benzinga.com/pressreleases/23/06/g33038980/nasdaq-welcomed-60-ipos-in-the-first-half-of-2023,2023-06-28 11:05:00,"NEW YORK, June 28, 2023 ( GLOBE NEWSWIRE ) -- Nasdaq NDAQ announced today that in the first half of 2023, it welcomed 60 initial public offerings ( IPOs ) , raising a total of $3.71 billion.",AMGN,0.051003,0.0,Neutral
Nasdaq Welcomed 60 IPOs in the First Half of 2023,https://www.globenewswire.com/news-release/2023/06/28/2696058/6948/en/Nasdaq-Welcomed-60-IPOs-in-the-First-Half-of-2023.html,2023-06-28 11:05:00,Secured an 88% Win-Rate for Listings in the U.S. Market ...,AMGN,0.049939,0.157355,Somewhat-Bullish
"Next-Gen Weight-Loss Drugs Set To Up The Game From Ozempic And Mounjaro: WSJ - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/06/33018678/next-gen-weight-loss-drugs-set-to-up-the-game-from-ozempic-and-mounjaro-wsj,2023-06-27 09:49:27,"The race to develop weight-loss drugs more potent than the popular Ozempic is heating up, with several promising contenders on the horizon, The Wall Street Journal reports.",AMGN,0.228073,0.331016,Somewhat-Bullish
Amgen  ( NASDAQ:AMGN )  Downgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/06/27/amgen-nasdaqamgn-downgraded-by-stocknews-com-to-buy.html,2023-06-27 05:16:42,"Amgen ( NASDAQ:AMGN - Get Rating ) was downgraded by analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Tuesday. A number of other equities analysts have also weighed in on AMGN. Argus lowered their price target on shares of Amgen from $270.00 to ...",AMGN,0.894176,0.249798,Somewhat-Bullish
Why Viking Therapeutics Stock Is Crashing Today,https://www.fool.com/investing/2023/06/26/why-viking-therapeutics-stock-is-crashing-today/,2023-06-27 03:39:11,Investors seem concerned about the company's competitive positioning in weight loss.,AMGN,0.146025,0.130021,Neutral
Why Amgen Stock Slumped on Monday,https://www.fool.com/investing/2023/06/26/why-amgen-stock-slumped-on-monday/,2023-06-26 21:03:00,"Already under fire on the regulatory front, the company is hit with a price-target cut.",AMGN,0.636698,-0.076903,Neutral
A Look Into Amgen Inc's Price Over Earnings - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/06/33009180/a-look-into-amgen-incs-price-over-earnings,2023-06-26 16:16:00,"In the current market session, Amgen Inc. AMGN share price is at $224.21, after a 1.28% decrease. Over the past month, the stock went up by 2.60%, but over the past year, it actually decreased by 7.93%.",AMGN,0.426225,0.051898,Neutral
"Russian Insurrection Crushed: 5 Stocks That Continue To Have Exposure To The Country - Procter & Gamble  ( NYSE:PG ) , Align Tech  ( NASDAQ:ALGN ) , Cloudflare  ( NYSE:NET ) , Amgen  ( NASDAQ:AMGN ) , Philip Morris Intl  ( NYSE:PM ) ",https://www.benzinga.com/markets/equities/23/06/32999737/russian-insurrection-crushed-5-stocks-that-continue-to-have-exposure-to-the-country,2023-06-25 21:52:41,"The political development in Russia over the weekend created a flutter in the international community, as Yevgeny Prigozhin, a close confidant of President Vladimir Putin and the leader of the paramilitary organization Wagner Group, revolted against the Russian military.",AMGN,0.215574,-0.16371,Somewhat-Bearish
"4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire",https://www.fool.com/investing/2023/06/24/4-growth-stocks-for-retirement/,2023-06-24 11:20:00,Buy 'em and then just get out of the way. Time and these companies' long-term strength will take care of the rest.,AMGN,0.171607,0.093262,Neutral
Amgen  ( AMGN )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2112634/amgen-amgn-dips-more-than-broader-markets-what-you-should-know,2023-06-23 21:50:23,"Amgen (AMGN) closed the most recent trading day at $227.11, moving -1.11% from the previous trading session.",AMGN,0.606946,0.092777,Neutral
UnitedHealth unit to add Boehringer's Humira biosimilar to reimbursement list,https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-unit-add-boehringers-humira-biosimilar-reimbursement-list-2023-06-23/,2023-06-23 16:23:00,"June 23 ( Reuters ) - Boehringer Ingelheim's biosimilar of AbbVie Inc's ( ABBV.N ) blockbuster arthritis drug Humira will be included in the reimbursement list of UnitedHealth Group Inc's ( UNH.N ) OptumRx unit, the German drugmaker said on Friday.",AMGN,0.211191,0.0,Neutral
Horizon's  ( HZNP )  Tepezza Study in Japan for TED Meets Goal,https://www.zacks.com/stock/news/2112421/horizons-hznp-tepezza-study-in-japan-for-ted-meets-goal,2023-06-23 13:15:00,Horizon (HZNP) announces positive top-line results from its phase III study evaluating Tepezza for treating Thyroid Eye Disease with high disease activity in Japan.,AMGN,0.143987,0.056615,Neutral
"Moderating Inflation, a Tasty IPO, Bull Market Talk, and More",https://www.fool.com/investing/2023/06/22/the-new-bull-market/,2023-06-22 17:06:00,We've also got two stocks worth watching: Chevron and Burford Capital.,AMGN,0.006075,-0.055728,Neutral
Amgen's  ( AMGN )  Blincyto sBLA Gets FDA Nod in Treating Leukemia,https://www.zacks.com/stock/news/2111850/amgens-amgn-blincyto-sbla-gets-fda-nod-in-treating-leukemia,2023-06-22 13:40:00,Amgen (AMGN) announces full approval of its sBLA for Blincyto as an immune-oncology therapy for treating adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.,AMGN,0.570165,0.411882,Bullish
Alleged Industrial Espionage Makes an Interesting Story,https://www.fool.com/investing/2023/06/21/alleged-industrial-espionage-makes-an-interesting/,2023-06-22 01:09:00,We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.,AMGN,0.02979,0.102635,Neutral
"If You Invested $1000 In This Stock 15 Years Ago, You Would Have $4,900 Today - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/earnings/23/06/32952860/if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-4-900-today,2023-06-21 17:30:23,"Amgen AMGN has outperformed the market over the past 15 years by 2.74% on an annualized basis producing an average annual return of 11.22%. Currently, Amgen has a market capitalization of $122.17 billion.",AMGN,0.983605,0.387251,Bullish
Amgen's Debt Overview - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/06/32930253/amgens-debt-overview,2023-06-20 17:01:08,"Over the past three months, shares of Amgen Inc. AMGN moved lower by 3.17%. Before having a look at the importance of debt, let's look at how much debt Amgen has.",AMGN,0.395012,-0.014024,Neutral
Don't Judge The Tax Cuts And Jobs Act's Anti-Profit-Shifting Measures Yet,https://www.forbes.com/sites/taxnotes/2023/06/20/dont-judge-the-tax-cuts-and-jobs-acts-anti-profit-shifting-measures-yet/,2023-06-20 13:42:11,Ryan Finley explains that casting the 2017 Tax Cuts and Jobs Act's anti-base-erosion measures as a failure is premature.,AMGN,0.031119,0.02602,Neutral
Amgen  ( NASDAQ:AMGN )  Downgraded by StockNews.com to Buy,https://www.defenseworld.net/2023/07/08/amgen-nasdaqamgn-downgraded-by-stocknews-com-to-buy-2.html,2023-07-08 07:42:43,StockNews.com cut shares of Amgen ( NASDAQ:AMGN - Free Report ) from a strong-buy rating to a buy rating in a research note released on Friday morning.,AMGN,0.823212,0.436159,Bullish
Amgen  ( AMGN )  Dips More Than Broader Markets: What You Should Know,https://www.zacks.com/stock/news/2118324/amgen-amgn-dips-more-than-broader-markets-what-you-should-know,2023-07-07 21:50:22,"In the latest trading session, Amgen (AMGN) closed at $218.65, marking a -1.94% move from the previous day.",AMGN,0.541943,0.138865,Neutral
What Does Amgen's Debt Look Like? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/07/33150858/what-does-amgens-debt-look-like,2023-07-07 17:15:51,"Over the past three months, shares of Amgen Inc. AMGN moved lower by 12.70%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.",AMGN,0.285526,-0.088183,Neutral
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/07/33150619/100-invested-in-this-stock-15-years-ago-would-be-worth-400-today,2023-07-07 17:00:25,"Amgen AMGN has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 10.23%. Currently, Amgen has a market capitalization of $117.46 billion.",AMGN,0.983605,0.387251,Bullish
Global 2000 List 2023: The Top 200,https://www.forbes.com/sites/forbesstaff/2023/07/07/forbes-global-2000-list-2023-the-top-200/,2023-07-07 15:45:31,"Two years after the start of the pandemic, Covid casualties like airlines and oil producers have reclaimed top spots among the largest companies in the world.",AMGN,0.010247,0.091379,Neutral
2 Struggling Dividend Growth Stocks That Could Make You Richer,https://www.fool.com/investing/2023/07/07/2-struggling-dividend-growth-stocks-could-make/,2023-07-07 13:45:00,Let's look beyond these drugmakers' ongoing issues.,AMGN,0.31197,0.136755,Neutral
"Treasury Yields Spiking As Market Looks Ahead To Jobs Data, Raising Valuation Concerns - Albertsons Companies  ( NYSE:ACI ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/markets/23/07/33135737/treasury-yields-spiking-as-market-looks-ahead-to-jobs-data-raising-valuation-concerns,2023-07-06 15:48:58,"( Thursday market open ) Things are heating up, and we're not just talking about the July weather. A week from the start of Q2 earnings season, Wall Street is on tenterhooks awaiting tomorrow's crucial June Nonfarm Payrolls report. In the meantime, there's a host of labor data to digest today ...",AMGN,0.043658,-0.033384,Neutral
"Global Lactose Intolerance Treatment Market Forecast 2023-2032 - Market Size, Drivers, Trends, And Competitors As Per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/07/g33135424/global-lactose-intolerance-treatment-market-forecast-2023-2032-market-size-drivers-trends-and-comp,2023-07-06 15:30:00,"LONDON, July 06, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023, the market will grow from $28.3 billion in 2022 to $30.3 billion in 2023, with a compound annual growth rate ( CAGR ) of more than 7%.",AMGN,0.051221,-0.053597,Neutral
"The Zacks Analyst Blog Highlights Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group",https://www.zacks.com/stock/news/2116904/the-zacks-analyst-blog-highlights-apple-verizon-communications-amgen-charles-schwab-and-the-cigna-group,2023-07-05 12:28:00,"Apple, Verizon Communications, Amgen, Charles Schwab and The Cigna Group are part of the Zacks top Analyst Blog.",AMGN,0.724687,0.0,Neutral
"Top Analyst Reports for Apple, Verizon & Amgen",https://www.zacks.com/research-daily/2115929/top-analyst-reports-for-apple-verizon-amgen,2023-07-03 16:49:00,"Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Verizon Communications Inc. (VZ) and Amgen Inc. (AMGN).",AMGN,0.357293,0.218088,Somewhat-Bullish
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2115804/should-you-invest-in-the-invesco-dynamic-biotechnology-genome-etf-pbe,2023-07-03 10:20:09,Sector ETF report for ...,AMGN,0.128478,0.069872,Neutral
Sandoz launches rival version of AbbVie's arthritis drug Humira,https://www.reuters.com/business/healthcare-pharmaceuticals/sandoz-launches-rival-version-abbvies-arthritis-drug-humira-2023-07-01/,2023-07-01 04:20:00,Sandoz launches rival version of AbbVie's arthritis drug ...,AMGN,0.141726,-0.082125,Neutral
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2115607/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-06-30 21:50:19,"In the latest trading session, Amgen (AMGN) closed at $222.02, marking a +0.39% move from the previous day.",AMGN,0.618922,0.183569,Somewhat-Bullish
"For AbbVie's blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say",https://www.marketwatch.com/story/for-abbvies-blockbuster-humira-cheaper-competitors-pose-surprisingly-little-threat-analysts-say-bf42114e,2023-06-30 17:28:00,Lower-price biosimilar competition for top-selling drug launching this weekend.,AMGN,0.074926,-0.039548,Neutral
What Is the Nasdaq?,https://www.kiplinger.com/investing/stocks/what-is-the-nasdaq,2023-07-19 20:28:04,"""The Nasdaq"" is a term market participants hear several times a day, but what exactly is ""the Nasdaq""? Typically, when an investor says ""the Nasdaq,"" they're referring to the Nasdaq Composite, or IXIC. This is an index that tracks the performance of the Nasdaq Stock Market, an electronic platform ...",AMGN,0.089797,0.086968,Neutral
Autolus Therapeutics announces appointment of Robert F. Dolski as Chief Financial Officer,https://www.globenewswire.com/news-release/2023/07/19/2707172/0/en/Autolus-Therapeutics-announces-appointment-of-Robert-F-Dolski-as-Chief-Financial-Officer.html,2023-07-19 11:00:00,"- Veronica Hersberger appointed as Senior Vice President, Medical Affairs- Miranda Neville promoted to Senior Vice President, Project Management and will continue to lead the obe-cel program ...",AMGN,0.024775,0.011725,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2123401/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-07-19 10:20:07,Sector ETF report for ...,AMGN,0.137278,0.072244,Neutral
"Softbank, Amgen-Backed Neumora Therapeutics Unveils Plans For Three Phase 3 Studies For Major Depressive Disorder - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/07/33271456/softbank-amgen-backed-neumora-therapeutics-unveils-plans-for-three-phase-3-studies-for-major-depr,2023-07-18 18:23:56,Neumora Therapeutics unveiled plans for three late-stage studies for its major depressive disorder ( MDD ) candidate Navacaprant. The U.S.-based clinical-stage biopharmaceutical is backed by Softbank Group Corp SFTBY SFTBF and Amgen Inc AMGN via a $100 million equity investment.,AMGN,0.331765,0.134183,Neutral
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2122411/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-07-17 21:50:21,"In the latest trading session, Amgen (AMGN) closed at $227.84, marking a +0.18% move from the previous day.",AMGN,0.553265,0.244339,Somewhat-Bullish
Venturing Beyond The Magic Kingdom: Former Disney CFO And Fortune 500 Veteran Takes The Reins At Lucy Scientific - Lucy Scientific Discovery  ( NASDAQ:LSDI ) ,https://www.benzinga.com/markets/cannabis/23/07/33235401/venturing-beyond-the-magic-kingdom-former-disney-cfo-and-fortune-500-veteran-takes-the-reins-at-,2023-07-14 20:17:06,"As of July 13, Lucy Scientific Discovery LSDI has a new principal. Current executive chairman, Richard Nanula, will retain this role while succeeding Chris McElvany as the company's CEO toward bringing ""significant strategic focus and leadership"" to Lucy.",AMGN,0.195814,0.036027,Neutral
MOORE KUEHN ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRM,https://www.prnewswire.com/news-releases/moore-kuehn-encourages-amgen-inc-investors-to-contact-law-firm-301877809.html,2023-07-14 19:59:00,"NEW YORK, July 14, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against: ** Please only contact if shares purchased before July 29, 2020",AMGN,0.909649,-0.135717,Neutral
 ( AMGN )  - Analyzing Amgen's Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/07/33233732/amgn-analyzing-amgens-short-interest,2023-07-14 16:45:46,"Amgen's AMGN short percent of float has fallen 3.7% since its last report. The company recently reported that it has 6.95 million shares sold short, which is 1.3% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.37 days to cover their ...",AMGN,0.224903,0.085754,Neutral
2 Best Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/07/14/2-best-biotech-stocks-to-buy-right-now/,2023-07-14 12:50:00,These two pharmaceutical titans look like convincing buys for income investors.,AMGN,0.191675,0.059056,Neutral
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2120958/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-07-13 22:00:20,"Amgen (AMGN) closed the most recent trading day at $227.66, moving +0.88% from the previous trading session.",AMGN,0.624172,0.286109,Somewhat-Bullish
Is Amgen's Dividend Safe?,https://www.fool.com/investing/2023/07/13/is-amgens-dividend-safe/,2023-07-13 18:10:53,"Despite multiple headwinds, the biotech's dividend appears to be a safe play for income investors.",AMGN,0.360098,0.343252,Somewhat-Bullish
Get Ready For A Slew Of New Weight-Loss Drugs,https://www.investors.com/news/technology/weight-loss-drugs-to-watch-rivals-ramp-up-to-unseat-the-undisputed-leaders/,2023-07-13 17:37:00,Weight Loss Drugs To Watch: New Rivals Are Ramping Up To Unseat The Undisputed Leaders Investor's Business Daily ...,AMGN,0.067309,-0.005041,Neutral
Biotech Stocks To Watch: Track The Latest News On Pharmaceutical Stocks And Drug Companies,https://www.investors.com/news/technology/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead/,2023-07-13 12:06:00,"One minute Dow Jones industrial average component Merck ( MRK ) might be doing battle with fellow drugmaker Bristol Myers Squibb ( BMY ) over drugs that can ward off cancer. The next, biotech giants like Amgen ( AMGN ) and Sanofi ( SNY ) are tussling in court over the fate of ...",AMGN,0.366061,0.043641,Neutral
"Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say",https://www.marketwatch.com/story/drugmakers-deal-making-will-plow-ahead-despite-antitrust-scrutiny-analysts-say-eb36f41b,2023-07-12 19:59:00,"Big pharma goes shopping as ""patent cliff"" puts more than $225 billion in revenues at risk.",AMGN,0.100729,-0.018454,Neutral
Is Now the Right Time to Embrace Biotech ETFs?,https://www.zacks.com/stock/news/2120021/is-now-the-right-time-to-embrace-biotech-etfs,2023-07-12 15:09:00,Look if it's the right time to invest in biotech ETFs to help diversify your portfolio.,AMGN,0.124164,0.04872,Neutral
Investors Heavily Search Amgen Inc.  ( AMGN ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2119772/investors-heavily-search-amgen-inc-amgn-here-is-what-you-need-to-know,2023-07-12 13:00:07,"Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",AMGN,0.482078,0.094731,Neutral
"European Regulator Expands Ozempic Probe To Include Other Weight Loss Drugs Over Suicide Risks - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , Amgen  ( NASDAQ:AMGN ) , Pfizer  ( NYSE:PFE ) ",https://www.benzinga.com/news/23/07/33192661/european-regulator-expands-ozempic-probe-to-include-other-weight-loss-drugs-over-suicide-risks,2023-07-12 02:33:47,"On Tuesday, the European Union's drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk NVO.",AMGN,0.210274,0.0,Neutral
Activision Stock Jumps As U.S. Judge Clears Hurdle To Microsoft Buyout,https://www.investors.com/news/technology/activision-stock-jumps-as-judge-clears-hurdle-to-microsoft-buyout/,2023-07-11 17:43:00,Activision Blizzard ( ATVI ) shares rocketed Tuesday after a federal court allowed Microsoft ( MSFT ) to proceed with its $69 billion acquisition of the video game publisher. Activision stock surged to a two-year high on the news. U.S.,AMGN,0.151539,0.067473,Neutral
Why This Biotech's Effort To Take On Horizon Fell Flat,https://www.investors.com/news/technology/vrdn-stock-collapses-why-this-horizon-rivaling-update-fell-flat/,2023-07-11 14:25:00,VRDN Stock Collapses. Why This Horizon-Rivaling Update Fell Flat | Investor's Business Daily Investor's Business Daily ...,AMGN,0.165031,0.160937,Somewhat-Bullish
"Stock Market Today: Stocks Tick Higher Ahead of June CPI, Q2 Earnings Season",https://www.kiplinger.com/investing/stocks/stock-market-today-stocks-tick-higher-ahead-of-june-cpi-q2-earnings-season,2023-07-10 20:15:20,Stocks failed to make any major moves Monday as investors looked ahead to this week's inflation data and the start of second-quarter earnings season.,AMGN,0.127795,0.144623,Neutral
Dow Jones Gains As Microsoft Stock Lags; Carl Icahn Stock Explodes Amid These Moves,https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-as-microsoft-stock-lags-carl-icahn-stock-explodes-amid-these-moves/,2023-07-10 19:18:00,Dow Jones Gains As Microsoft Stock Lags. Carl Icahn Stock Explodes Amid These Moves Investor's Business Daily ...,AMGN,0.085782,0.093458,Neutral
These companies have beaten the Rule of 40 year after year,https://www.marketwatch.com/story/these-companies-have-beaten-the-rule-of-40-year-after-year-8804d0e,2023-07-10 14:08:00,Morgan Stanley applied a VC filter to the stock market. Here's what it found.,AMGN,0.285526,0.025659,Neutral
"Investing Action Plan: Apple, Amazon And An Upturn In Optimism",https://www.investors.com/research/investing-action-plan/stock-market-action-plan-apple-amazon-and-an-upturn-in-optimism/,2023-07-28 22:25:00,"A good week for optimism left the stock market in strong standing as it heads into early August. Chips showed strength, riding the rising trend in AI computing. Department stores also soared as markets begin to look toward the back-to-school and holiday shopping seasons.",AMGN,0.04346,0.0,Neutral
"The Dow Breaks 13-Day Winning Streak, Fed Raises Interest Rates To 2001 Levels And AI Is The Buzzword For Big Tech Earnings: The Week In The Markets - PacWest Banc  ( NASDAQ:PACW ) , CVS Health  ( NYSE:CVS ) , JPMorgan Chase  ( NYSE:JPM ) , Merck & Co  ( NYSE:MRK ) , Amgen  ( NASDAQ:AMGN ) , Pfizer  ( NYSE:PFE ) , Peoples Trust Company  ( OTC:PPAL ) , Anheuser-Busch InBev  ( NYSE:BUD ) , Microsoft  ( NASDAQ:MSFT ) , Shopify  ( NYSE:SHOP ) , Starbucks  ( NASDAQ:SBUX ) , Qualcomm  ( NASDAQ:QCOM ) , Advanced Micro Devices  ( NASDAQ:AMD ) , Alibaba Gr Holding  ( NYSE:BABA ) , PayPal Holdings  ( NASDAQ:PYPL ) , Alphabet  ( NASDAQ:GOOG ) , Meta Platforms  ( NASDAQ:META ) , Bank of America  ( NYSE:BAC ) , ConocoPhillips  ( NYSE:COP ) , Banc of California  ( NYSE:BANC ) , HSBC Holdings  ( NYSE:HSBC ) , Intel  ( NASDAQ:INTC ) , Caterpillar  ( NYSE:CAT ) , Toyota Motor  ( NYSE:TM ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/07/33449979/the-dow-breaks-13-day-winning-streak-fed-raises-interest-rates-to-2001-levels-and-ai-is-the-buzz,2023-07-28 20:06:47,"The S&P 500 and other major indexes slid on Thursday but recovered on Friday to wrap up the week to the upside. The Dow Jones broke a 13-day winning streak Thursday, its best since 1987, and was up 0.65% on a weekly basis Friday. The Nasdaq Composite posted a weekly gain of 1.67%.",AMGN,0.114956,0.0,Neutral
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated - Biogen  ( NASDAQ:BIIB ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33444357/reatas-acquisition-fits-biogens-strategy-despite-high-cost-analyst-says-high-level-,2023-07-28 15:56:17,"Earlier today, Biogen Inc BIIB agreed to acquire Reata Pharmaceuticals Inc RETA for $172.50 per share in cash, reflecting an enterprise value of approximately $7.3 billion.",AMGN,0.280615,0.0,Neutral
"Price Pressure Eased In June, Fueling Early Wall Street Gains, But BoJ Rate Policy Move Rattles Market - Ford Motor  ( NYSE:F ) , Intel  ( NASDAQ:INTC ) ",https://www.benzinga.com/markets/23/07/33445247/price-pressure-eased-in-june-fueling-early-wall-street-gains-but-boj-rate-policy-move-rattles-market,2023-07-28 15:27:33,"( Friday market open ) Welcome signs of easing U.S. inflation propelled Wall Street to early gains Friday, but the market remains rattled following a policy tweak earlier from the Bank of Japan ( BoJ ) and worries about the Federal Reserve potentially tightening further.",AMGN,0.039128,0.0,Neutral
3 Things About Johnson & Johnson Every Smart Investor Knows,https://www.fool.com/investing/2023/07/28/3-things-about-johnson-johnson-every-smart-investo/,2023-07-28 12:37:00,The company has been a strong value stock but faces big changes this year.,AMGN,0.043421,0.168413,Somewhat-Bullish
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/07/33429061/check-out-what-whales-are-doing-with-amgn,2023-07-27 19:31:30,"Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.837089,0.335426,Somewhat-Bullish
"Stocks Begin Day With Strength, Propelled By Solid Earnings And Economic Data Including GDP - Bank of America  ( NYSE:BAC ) , Boeing  ( NYSE:BA ) ",https://www.benzinga.com/markets/23/07/33427159/stocks-begin-day-with-strength-propelled-by-solid-earnings-and-economic-data-including-gdp,2023-07-27 17:51:26,"( Thursday market open ) Major indexes turned green in premarket trading on Thursday following solid earnings from Meta Platforms META and McDonald's MCD, accompanied by a host of price target increases from Wall Street analysts.",AMGN,0.042685,0.0,Neutral
"AbbVie  ( ABBV )  Beats on Q2 Earnings & Sales, Raises '23 View",https://www.zacks.com/stock/news/2128992/abbvie-abbv-beats-on-q2-earnings-sales-raises-23-view,2023-07-27 17:05:00,AbbVie's (ABBV) second-quarter 2023 earnings and sales beat estimates. The company raises its EPS guidance. Stock rises post the announcement.,AMGN,0.182782,-0.019419,Neutral
"AbbVie Earnings, Revenue Fall Less Than Expected",https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q22023/,2023-07-27 12:27:00,"AbbVie Stock: AbbVie Earnings, Revenue Fall But Top Expectations Investor's Business Daily ...",AMGN,0.255641,-0.039924,Neutral
The Winning Strategy to Fade the Crowd Before Earnings,https://moneymorning.com/investing/the-winning-strategy-to-fade-the-crowd-before-earnings/,2023-07-26 18:31:29,"Last week, we discussed how I turn earnings season into the most lucrative time of the year by trading ahead of the crowd. If you missed that conversation, you can still catch the replay here. And while the focus was mostly on profiting from the run up into earnings announcements, a few traders ...",AMGN,0.18046,0.049989,Neutral
AbbVie's Skyrizi Achieves Superiority Versus Amgen's Drug In Head-to-Head Study In Moderate Plaque Psoriasis - AbbVie  ( NYSE:ABBV ) ,https://www.benzinga.com/general/biotech/23/07/33397063/abbvies-skyrizi-achieves-superiority-versus-amgens-drug-in-head-to-head-study-in-moderate-plaque-,2023-07-26 16:25:49,AbbVie Inc ABBV announced that the British Journal of Dermatology published results from the head-to-head Phase 4 IMMpulse study that evaluated the efficacy and safety of Skyrizi ( risankizumab ) compared to Amgen Inc's AMGN Otezla ( apremilast ) for moderate plaque psoriasis eligible for ...,AMGN,0.2872,0.12175,Neutral
AbbVie may see less pain from Humira sales decline as rival lags,https://www.reuters.com/business/healthcare-pharmaceuticals/abbvie-may-see-less-pain-humira-sales-decline-rival-lags-2023-07-26/,2023-07-26 16:06:00,July 26 ( Reuters ) - AbbVie Inc ( ABBV.N ) is likely to beat Wall Street sales estimates for Humira in the second quarter as the only copycat in the U.S. market for the blockbuster arthritis drug struggled to gain traction.,AMGN,0.09402,-0.061609,Neutral
Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries - AbbVie  ( NYSE:ABBV ) ,https://www.benzinga.com/general/biotech/23/07/33386891/seven-humira-biosimilars-increased-competition-in-arthritis-drug-market-sparks-need-for-reform-of,2023-07-26 13:06:34,Seven pharmaceutical companies recently launched their biosimilars of AbbVie Inc's ABBV top-selling arthritis drug Humira.,AMGN,0.328819,0.168786,Somewhat-Bullish
2 Cheap High-Yield Dividend Stocks to Buy Now,https://www.fool.com/investing/2023/07/25/2-cheap-high-yield-dividend-stocks-to-buy-now/,2023-07-25 15:15:00,These two pharma stocks are top-notch passive income vehicles.,AMGN,0.342487,0.223808,Somewhat-Bullish
Should You Invest in the Invesco Dynamic Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2126629/should-you-invest-in-the-invesco-dynamic-pharmaceuticals-etf-pjp,2023-07-25 10:20:08,Sector ETF report for ...,AMGN,0.131643,0.063605,Neutral
Amgen  ( AMGN )  Gains But Lags Market: What You Should Know,https://www.zacks.com/stock/news/2126475/amgen-amgn-gains-but-lags-market-what-you-should-know,2023-07-24 21:50:21,"Amgen (AMGN) closed the most recent trading day at $235.42, moving +0.26% from the previous trading session.",AMGN,0.608634,0.246374,Somewhat-Bullish
Mirati  ( MRTX )  Down 7% on CHMP's Opinion on Krazati Filing,https://www.zacks.com/stock/news/2126345/mirati-mrtx-down-7-on-chmps-opinion-on-krazati-filing,2023-07-24 15:23:00,"Per the CHMP, Mirati's (MRTX) regulatory filing for Krazati in KRASG12C mutated NSCLC does not fulfill certain requirements to support a conditional marketing authorization.",AMGN,0.097259,0.176669,Somewhat-Bullish
Horizon's  ( HZNP )  Daxdilimab Fails to Meet Goal in Lupus Study,https://www.zacks.com/stock/news/2126230/horizons-hznp-daxdilimab-fails-to-meet-goal-in-lupus-study,2023-07-24 15:12:00,Horizon (HZNP) fails to meet the primary endpoint in the mid-stage study of evaluating daxdilimab in the treatment of systemic lupus erythematosus.,AMGN,0.172919,0.063711,Neutral
Amgen Inc.  ( AMGN )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2126003/amgen-inc-amgn-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-07-24 13:00:06,"Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",AMGN,0.484798,0.098122,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2125862/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-07-24 10:20:08,Smart Beta ETF report for ...,AMGN,0.121959,0.061385,Neutral
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires - Genelux  ( NASDAQ:GNLX ) ,https://www.benzinga.com/pressreleases/23/07/g33312361/genelux-corporation-strengthens-senior-management-and-clinical-team-with-promotions-and-new-hires,2023-07-20 20:45:00,"WESTLAKE VILLAGE, Calif., July 20, 2023 ( GLOBE NEWSWIRE ) -- Genelux Corporation GNLX, a late clinical-stage immuno-oncology company, today announced two key management promotions, as well as the addition of two new members to its leadership team.",AMGN,0.059488,0.007009,Neutral
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires,https://www.globenewswire.com/news-release/2023/07/20/2708618/0/en/Genelux-Corporation-Strengthens-Senior-Management-and-Clinical-Team-with-Promotions-and-New-Hires.html,2023-07-20 20:45:00,"WESTLAKE VILLAGE, Calif., July 20, 2023 ( GLOBE NEWSWIRE ) -- Genelux Corporation ( NASDAQ: GNLX ) , a late clinical-stage immuno-oncology company, today announced two key management promotions, as well as the addition of two new members to its leadership team.",AMGN,0.045482,0.00795,Neutral
"Dow Off, Datadog Plunges 21%; These IPOs Buck Weak Market",https://www.investors.com/market-trend/stock-market-today/dow-jones-down-datadog-plunges-21-at-lows-2-new-ipo-stocks-buck-stock-market-weakness/,2023-08-08 19:21:00,"Dow Jones Down, Datadog Plunges 21% At Lows. 2 New IPO Stocks Buck Stock Market Weakness Investor's Business Daily ...",AMGN,0.114956,0.0,Neutral
Is Growth Priced Into Amgen Stock After Earnings Beat? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/08/33623812/is-growth-priced-into-amgen-stock-after-earnings-beat,2023-08-08 14:50:52,"Amgen Inc. AMGN delivered a solid earnings report after the market closed on August 3. Shareholders hope the results will be enough to reverse the fortunes of AMGN stock, down 12% in 2023. But heading into earnings, analyst sentiment suggests that all the growth may already be priced into the ...",AMGN,0.809093,-0.020358,Neutral
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/08/33631109/100-invested-in-this-stock-15-years-ago-would-be-worth-400-today,2023-08-08 14:01:03,"Amgen AMGN has outperformed the market over the past 15 years by 1.24% on an annualized basis producing an average annual return of 9.9%. Currently, Amgen has a market capitalization of $139.70 billion.",AMGN,0.983605,0.387251,Bullish
Is AbbVie Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/08/08/is-abbvie-still-a-good-dividend-stock-to-buy/,2023-08-08 09:37:00,Find out if AbbVie can overcome sinking sales of its top-selling product.,AMGN,0.067347,-0.032292,Neutral
"Stock Market Today: Dow Outperforms as Amgen, Boeing Gain Ground",https://www.kiplinger.com/investing/stocks/stock-market-today-dow-outperforms-as-amgen-boeing-gain-ground,2023-08-07 20:13:20,"Stock started the week on a positive note, with the main benchmarks closing higher Monday. Blue chip stocks outperformed thanks to strong gains for drugmaker Amgen ( AMGN ) and aircraft manufacturer Boeing ( BA ) , while Warren Buffett's Berkshire Hathaway ( BRK.B ) put in an impressive ...",AMGN,0.229149,0.451056,Bullish
Dow Jones Gains As Apple Crumbles; These Warren Buffett Stocks Are Near Buy Points,https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-as-apple-stock-crumbles-these-warren-buffett-stocks-are-near-buy-points-berkshire-hathaway-earnings-tesla-stock-falls-management-change-cfo-quits/,2023-08-07 19:14:00,Dow Jones Gains As Apple Crumbles. These Warren Buffett Stocks Are Near Buy Points Investor's Business Daily ...,AMGN,0.089629,0.11606,Neutral
"Company News for Aug 7, 2023",https://www.zacks.com/stock/news/2133112/company-news-for-aug-7-2023,2023-08-07 13:41:00,Companies in The News Are: ...,AMGN,0.546745,0.307255,Somewhat-Bullish
Ligand  ( LGND )  to Post Q2 Earnings: What's in Store?,https://www.zacks.com/stock/news/2133134/ligand-lgnd-to-post-q2-earnings-whats-in-store,2023-08-07 13:02:00,Ligand's (LGND) second-quarter 2023 performance is likely to have been driven by rising royalty revenues on the back of higher growth in sales of drugs developed using its pelican platform.,AMGN,0.1172,0.161884,Somewhat-Bullish
"Longeveron Announces Key Additions To Its Leadership Team and Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions - Longeveron  ( NASDAQ:LGVN ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/08/33598342/longeveron-announces-key-additions-to-its-leadership-team-and-board-as-it-gears-up-for-phase-2-tr,2023-08-07 12:02:15,"Longeveron, Inc. LGVN is a clinical-stage biopharmaceutical company focused on therapies for age-related and life-threatening diseases. Longeveron's primary drug is Lomecel-B™, which is being developed as a potential therapy for Alzheimer's disease, Aging-Frailty, and a rare pediatric disease, ...",AMGN,0.128135,0.0,Neutral
1 Top Dividend Growth Stock to Buy on the Dip,https://www.fool.com/investing/2023/08/05/1-top-dividend-growth-stock-to-buy-on-the-dip/,2023-08-05 12:45:00,Investors' patience will be rewarded.,AMGN,0.740604,0.326042,Somewhat-Bullish
Dow Jones Reverses Lower On Reports Of Cyberattack; Fortinet Slammed After Earnings,https://www.investors.com/market-trend/stock-market-today/dow-jones-reverses-lower-on-reports-of-cyberattack-fortinet-slammed-after-earnings/,2023-08-04 19:12:00,Dow Jones Reverses Lower On Reports Of Cyberattack. Fortinet Slammed After Earnings Investor's Business Daily ...,AMGN,0.16171,-0.002774,Neutral
Looking Into Amgen's Recent Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/08/33580802/looking-into-amgens-recent-short-interest,2023-08-04 18:45:41,"Amgen's AMGN short percent of float has risen 3.08% since its last report. The company recently reported that it has 7.18 million shares sold short, which is 1.34% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.21 days to cover their ...",AMGN,0.224903,0.158881,Somewhat-Bullish
"Amgen  ( AMGN )  Q2 Earnings Beat Estimates, 2023 View Raised",https://www.zacks.com/stock/news/2132815/amgen-amgn-q2-earnings-beat-estimates-2023-view-raised,2023-08-04 16:12:00,Amgen (AMGN) beats Q2 estimates for earnings and sales. It slightly raises its earnings and sales guidance for 2023.,AMGN,0.450733,0.259966,Somewhat-Bullish
Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... - PR Newswire,https://www.prnewswire.com/news-releases/bioprocess-validation-market-to-grow-at-a-cagr-of-11-39-from-2022-to-2027increasing-demand-for-biopharmaceuticals-to-boost-market-growth---technavio-301892736.html,2023-08-04 15:15:00,Bioprocess Validation Market to grow at a CAGR of 11.39% from 2022 to 2027|Increasing demand for ... PR ...,AMGN,0.031119,0.113286,Neutral
Dow Jones Rises Despite Apple's Hard Fall; Cybersecurity Stocks Tumble On This Warning,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-apple-fallsdow-jones-rises-cybersecurity-stocks-tumble/,2023-08-04 15:06:00,Dow Jones Rises Despite Apple's Hard Fall. Cybersecurity Stocks Tumble On This Warning Investor's Business Daily ...,AMGN,0.130571,-0.15561,Somewhat-Bearish
"If You Had Invested $5,000 in Amgen in 2013, This Is How Much You Would Have Today",https://www.fool.com/investing/2023/08/04/if-you-invested-5000-in-amgen-in-2013-this-is-how/,2023-08-04 13:45:00,The pharmaceutical company has significantly enriched shareholders over the past 10 years.,AMGN,0.636698,0.441149,Bullish
"Amgen Raises FY23 Outlook, Discloses Brief Readout From Tarlatamab Lung Cancer, Lumakras Colorectal Cancer Studies - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/08/33569920/amgen-raises-fy23-outlook-discloses-brief-readout-from-tarlatamab-lung-cancer-lumakras-colorectal,2023-08-04 13:20:44,"Amgen Inc AMGN reported Q2 FY23 sales of $6.99 billion, up 7% Y/Y, beating the consensus of $6.63 billion. Product sales increased 6%, driven by 11% volume growth, partially offset by a 2% lower net selling price, 1% lower inventory levels, and 1% negative impact from foreign exchange.",AMGN,0.716023,-0.187343,Somewhat-Bearish
Jim Cramer's top 10 things to watch in the stock market Friday,https://www.cnbc.com/2023/08/04/jim-cramers-top-10-things-to-watch-in-the-stock-market-friday.html,2023-08-04 13:08:54,"Amazon's (AMZN) second-quarter results Thursday gave investors exactly what they wanted, while Apple (AAPL) showed the power of its services business.",AMGN,0.16317,0.094841,Neutral
Futures Mixed Ahead Of Imminent Jobs Report,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobs-report-amazon-surges-on-earnings-apple-stock-falls/,2023-08-04 12:21:09,"Dow Jones Futures Drops Ahead Of Jobs Report. Amazon Surges On Earnings, But Apple Falls Investor's Business Daily ...",AMGN,0.093775,0.093022,Neutral
The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... - PR Newswire,https://www.prnewswire.com/news-releases/the-pulmonary-embolism-therapeutics-market-size-to-grow-at-a-cagr-of-9-52-from-2022-to-2027the-advancement-in-the-healthcare-and-medical-sector-is-a-major-trend-technavio-301892623.html,2023-08-04 09:30:00,The Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027|The advancement ... PR ...,AMGN,0.045569,0.139204,Neutral
"Hywin Holdings, Leonteq AG, and Arta TechFin jointly launch ""Global Mega-Trends Series"" principal-protected notes",https://www.globenewswire.com/news-release/2023/08/04/2718711/0/en/Hywin-Holdings-Leonteq-AG-and-Arta-TechFin-jointly-launch-Global-Mega-Trends-Series-principal-protected-notes.html,2023-08-04 01:00:00,"HONG KONG, Aug. 04, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) ( NASDAQ: HYW ) , a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment ...",AMGN,0.029078,0.126195,Neutral
"Hywin Holdings, Leonteq AG, and Arta TechFin jointly launch ""Global Mega-Trends Series"" principal-protected notes - Hywin Holdings  ( NASDAQ:HYW ) ",https://www.benzinga.com/pressreleases/23/08/g33564916/hywin-holdings-leonteq-ag-and-arta-techfin-jointly-launch-global-mega-trends-series-principal-prot,2023-08-04 01:00:00,"HONG KONG, Aug. 04, 2023 ( GLOBE NEWSWIRE ) -- Hywin Holdings Ltd. ( ""Hywin Wealth"" or ""Hywin"" ) HYW, a leading independent wealth management service provider in China, Leonteq Securities AG ( ""Leonteq"" ) , a Swiss fintech company with a leading marketplace for structured investment solutions, ...",AMGN,0.028355,0.125769,Neutral
Amgen  ( AMGN )  Q2 Earnings and Revenues Top Estimates,https://www.zacks.com/stock/news/2132276/amgen-amgn-q2-earnings-and-revenues-top-estimates,2023-08-03 21:35:16,"Amgen (AMGN) delivered earnings and revenue surprises of 12.61% and 5.41%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.40348,0.143722,Neutral
Amgen Raises Outlook With Horizon Still Waiting In The Wings,https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q2-2023/,2023-08-03 20:17:00,"Amgen ( AMGN ) stock rose moderately late Thursday after the biotech company reported adjusted profit of $5 per share on $6.99 billion in second-quarter sales. On average, analysts polled by FactSet expected Amgen to report $4.49 per share on $6.66 billion in sales.",AMGN,0.975103,0.531045,Bullish
"Amgen stock jumps after record earnings beat expectations, and biotech raises full-year outlook",https://www.marketwatch.com/story/amgen-stock-jumps-after-the-biotechs-record-earnings-beats-expectations-and-full-year-outlook-is-raised-e90cb53a,2023-08-03 20:13:00,"Amgen's stock jumped in after-hours trading Thursday, after the biotechnology giant reported record second-quarter earnings that rose above expectations.",AMGN,0.318897,0.035312,Neutral
AMGEN REPORTS SECOND QUARTER FINANCIAL RESULTS,https://www.prnewswire.com/news-releases/amgen-reports-second-quarter-financial-results-301893066.html,2023-08-03 20:01:00,"Positive Top-Line Results for LUMAKRAS® ( Sotorasib ) Plus Vectibix® ( Panitumumab ) in Metastatic Colorectal Cancer THOUSAND OAKS, Calif., Aug. 3, 2023 /PRNewswire/ -- Amgen ( NASDAQ:AMGN ) today announced financial results for the second quarter of 2023.",AMGN,0.014941,0.094737,Neutral
Why Is Regeneron Pharmaceuticals Moving Higher Today? - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ,https://www.benzinga.com/general/biotech/23/08/33549371/why-is-regeneron-pharmaceuticals-moving-higher-today,2023-08-03 14:35:42,"Regeneron Pharmaceuticals Inc REGN earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Street estimate. Revenues increased 11% Y/Y to $3.16 billion, beating the consensus of $3.01 billion. Dupixent global net sales ( recorded by Sanofi ) increased 33% to $2.79 billion ...",AMGN,0.27432,0.029797,Neutral
3 Dividend Stocks That Hiked Payouts by 60% in Just 5 Years,https://www.fool.com/investing/2023/08/03/3-dividend-stocks-that-hiked-payouts-by-60-in-just/,2023-08-03 12:00:00,Can these stocks keep the rate hikes coming?,AMGN,0.466963,0.37637,Bullish
"US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month - Cars.com  ( NYSE:CARS ) , DraftKings  ( NASDAQ:DKNG ) , PayPal Holdings  ( NASDAQ:PYPL ) , Cheesecake Factory  ( NASDAQ:CAKE ) , Expedia Group  ( NASDAQ:EXPE ) , Hyatt Hotels  ( NYSE:H ) , Kellogg  ( NYSE:K ) , Amgen  ( NASDAQ:AMGN ) , DoorDash  ( NYSE:DASH ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Occidental Petroleum  ( NYSE:OXY ) , Etsy  ( NASDAQ:ETSY ) , Qualcomm  ( NASDAQ:QCOM ) , Warner Bros. Discovery  ( NASDAQ:WBD ) , EVgo  ( NASDAQ:EVGO ) , Atlassian  ( NASDAQ:TEAM ) , Gilead Sciences  ( NASDAQ:GILD ) , Hasbro  ( NASDAQ:HAS ) , Bausch Health Companies  ( NYSE:BHC ) , Moderna  ( NASDAQ:MRNA ) , Qorvo  ( NASDAQ:QRVO ) , Regeneron Pharmaceuticals  ( NASDAQ:REGN ) , SPDR S&P 500  ( ARCA:SPY ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/08/33543176/us-stock-futures-dip-as-apple-amazon-earnings-loom-analyst-warns-of-perfectly-normal-5-pullback-,2023-08-03 10:53:08,"As Fitch's U.S. ratings downgrade overhang persists and earnings new flow turns negative, stock futures are pulling back yet again on Thursday. Traders may find caution a virtue as a few profile tech names, including Apple, Inc. AAPL, are scheduled to report their quarterly results.",AMGN,0.106541,0.0,Neutral
"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring, Novartis, Merck, Amgen, Ionis , BioMarin, AstraZeneca",https://www.prnewswire.com/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891245.html,2023-08-02 21:01:00,"Atherosclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Leading Companies - CSL Behring ... PR ...",AMGN,0.028868,0.037471,Neutral
"Risk-Off Mood Pervades Following Surprise Downgrade Of U.S. Treasuries By Fitch Ratings - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/markets/23/08/33523169/risk-off-mood-pervades-following-surprise-downgrade-of-u-s-treasuries-by-fitch-ratings,2023-08-02 14:24:23,"( Wednesday market open ) A defensive, ""risk-off"" mood gripped global markets early Wednesday after Fitch Ratings' surprise downgrade of its rating for U.S. Treasuries to AA+ from AAA. The move sparked a rapid retreat from riskier assets, but the bond market saw little initial reaction.",AMGN,0.039516,0.0,Neutral
"Intercept Pharmaceuticals  ( ICPT )  Reports Q2 Loss, Tops Revenue Estimates",https://www.zacks.com/stock/news/2130946/intercept-pharmaceuticals-icpt-reports-q2-loss-tops-revenue-estimates,2023-08-02 12:25:11,"Intercept (ICPT) delivered earnings and revenue surprises of 75% and 6.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.139265,0.0,Neutral
Best Dow Jones Stocks To Watch In August 2023,https://www.investors.com/research/dow-jones-stocks/,2023-08-01 19:28:00,"The Dow Jones Industrial Average remains in rally mode through the end of July, with the stock market at its 2023 highs. The best Dow Jones stocks to buy and watch in August 2023 are Apple ( AAPL ) , Boeing ( BA ) , Caterpillar ( CAT ) , Microsoft ( MSFT ) and Salesforce ( CRM ) .",AMGN,0.116067,-0.175962,Somewhat-Bearish
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/08/33502959/looking-at-amgens-recent-unusual-options-activity,2023-08-01 19:16:01,"Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.774013,0.389802,Bullish
"Mixed Brew: Pfizer, Merck Earnings Head Opposite Ways, But Uber And Caterpillar Slug Line Drives - Alaska Air Gr  ( NYSE:ALK ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/08/33501240/mixed-brew-pfizer-merck-earnings-head-opposite-ways-but-uber-and-caterpillar-slug-line-drives,2023-08-01 17:36:23,"( Tuesday market open ) The new month starts with stocks tinted red, but this week's main events are just getting underway. A rise in Treasury yields might have investors nervous early Tuesday as the 10-year yield popped back above 4% ahead of key U.S. economic data.",AMGN,0.038623,0.0,Neutral
"Earnings Extravaganza: Another One-Third of S&P 500 Companies Report this Week, Including Amazon, Apple - Apple  ( NASDAQ:AAPL ) , Advanced Micro Devices  ( NASDAQ:AMD ) ",https://www.benzinga.com/news/earnings/23/07/33474441/earnings-extravaganza-another-one-third-of-s-p-500-companies-report-this-week-including-amazon-appl,2023-07-31 16:13:15,"( Monday market open ) It's ""tech week"" on Wall Street. No, wait, it's ""pharma week."" Or is it ""employment week?"" How about all three?",AMGN,0.038592,0.0,Neutral
Amgen  ( AMGN )  to Report Q2 Earnings: Here's What to Expect,https://www.zacks.com/stock/news/2129960/amgen-amgn-to-report-q2-earnings-heres-what-to-expect,2023-07-31 15:09:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.",AMGN,0.450607,0.15337,Somewhat-Bullish
"Rising Stars, Falling Trends: July's Industry ETF Winners and Losers - Invesco Solar ETF  ( ARCA:TAN ) , Deere  ( NYSE:DE ) , SLB  ( NYSE:SLB ) , Archer-Daniels Midland  ( NYSE:ADM ) , Mueller Industries  ( NYSE:MLI ) , Amgen  ( NASDAQ:AMGN ) , Ferguson  ( NYSE:FERG ) , Vanguard Real Estate ETF  ( ARCA:VNQ ) , VanEck Gold Miners ETF  ( ARCA:GDX ) , SPDR S&P 500  ( ARCA:SPY ) , American Tower  ( NYSE:AMT ) , SMA Solar Tech  ( OTC:SMTGF ) , VanEck Oil Services ETF  ( ARCA:OIH ) , VanEck Semiconductor ETF  ( NASDAQ:SMH ) , Taiwan Semiconductor  ( NYSE:TSM ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Antero Resources  ( NYSE:AR ) , First Solar  ( NASDAQ:FSLR ) , SPDR S&P Oil & Gas Explor & Product  ( ARCA:XOP ) , Biogen  ( NASDAQ:BIIB ) , SPDR S&P Regional Banking ETF  ( ARCA:KRE ) , Enphase Energy  ( NASDAQ:ENPH ) , Broadcom  ( NASDAQ:AVGO ) , Western Alliance  ( NYSE:WAL ) , CoStar Gr  ( NASDAQ:CSGP ) , iShares Biotechnology ETF  ( NASDAQ:IBB ) , Prologis  ( NYSE:PLD ) , Waters  ( NYSE:WAT ) , Ovintiv  ( NYSE:OVV ) , Danaher  ( NYSE:DHR ) , Invesco Water Resources ETF  ( NASDAQ:PHO ) , U.S. Global Jets ETF  ( ARCA:JETS ) , Lam Research  ( NASDAQ:LRCX ) , Zoetis  ( NYSE:ZTS ) , SM Energy  ( NYSE:SM ) , SPDR Dow Jones Industrial Average ETF  ( ARCA:DIA ) , iShares Russell 2000 ETF  ( ARCA:IWM ) , NVIDIA  ( NASDAQ:NVDA ) , Zions Bancorp  ( NASDAQ:ZION ) , Apellis Pharmaceuticals  ( NASDAQ:APLS ) , Crown Castle  ( NYSE:CCI ) , Vertex Pharmaceuticals  ( NASDAQ:VRTX ) , Southwest Airlines  ( NYSE:LUV ) , VanEck Agribusiness ETF  ( ARCA:MOO ) , Pinnacle Finl Partners  ( NASDAQ:PNFP ) , Delta Air Lines  ( NYSE:DAL ) , Ecolab  ( NYSE:ECL ) , APA  ( NASDAQ:APA ) , Halliburton  ( NYSE:HAL ) , SolarEdge Technologies  ( NASDAQ:SEDG ) , Valmont Industries  ( NYSE:VMI ) , Intel  ( NASDAQ:INTC ) ",https://www.benzinga.com/markets/equities/23/07/33471902/rising-stars-falling-trends-julys-industry-etf-winners-and-losers,2023-07-31 14:59:22,"As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month. Among the largest ETFs that represent major U.S. stock indices, the SPDR S&P 500 ETF Trust SPY returned 3.1% in July, marking its fifth consecutive month of gains.",AMGN,0.110209,0.049137,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/08/33898106/looking-at-amgens-recent-unusual-options-activity,2023-08-17 16:33:02,"A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 23 strange trades. If we consider the specifics of each trade, it is accurate to state that 26% of the investors opened trades with bullish expectations and ...",AMGN,0.82082,0.036263,Neutral
Amgen  ( NASDAQ:AMGN )  Now Covered by StockNews.com,https://www.defenseworld.net/2023/08/17/amgen-nasdaqamgn-now-covered-by-stocknews-com.html,2023-08-17 07:22:42,"Equities researchers at StockNews.com assumed coverage on shares of Amgen ( NASDAQ:AMGN - Get Free Report ) in a report released on Thursday. The brokerage set a ""strong-buy"" rating on the medical research company's stock.",AMGN,0.803061,0.387953,Bullish
Amgen Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/research/amgen-stock-scores-relative-strength-rating-upgrade-hits-key-benchmark/,2023-08-16 18:25:00,Amgen Stock Scores Relative Strength Rating Upgrade. Hits Key Benchmark Investor's Business Daily ...,AMGN,0.549581,0.286188,Somewhat-Bullish
Could Amgen Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/08/16/could-amgen-stock-help-you-become-a-millionaire/,2023-08-16 14:07:53,Its pending acquisition of Horizon Therapeutics could make the company much bigger.,AMGN,0.649187,0.351304,Bullish
"U.S. retailers lose their appetite for SlimFast, owner says",https://www.reuters.com/business/retail-consumer/us-retailers-lose-their-appetite-slimfast-owner-says-2023-08-16/,2023-08-16 13:23:00,"DUBLIN, Aug 16 ( Reuters ) - Sales of SlimFast plunged further in the three months to mid-July, prompting key U.S. retailers to stock fewer of the meal replacement shakes, the brand's owner said on Wednesday as weight-loss drugs shake up the diet market.",AMGN,0.108466,0.205766,Somewhat-Bullish
Amgen Scores Relative Strength Rating Upgrade; Hits Key Benchmark,https://www.investors.com/ibd-data-stories/amgen-scores-relative-strength-rating-upgrade-hits-key-benchmark/,2023-08-16 07:00:00,Amgen Scores Relative Strength Rating Upgrade. Hits Key Benchmark Investor's Business Daily ...,AMGN,0.659096,0.310131,Somewhat-Bullish
"Biotechnology Market to Worth Around USD 3,995.22 Billion by 2032",https://www.benzinga.com/pressreleases/23/08/g33835844/biotechnology-market-to-worth-around-usd-3-995-22-billion-by-2032,2023-08-14 15:00:00,"Ottawa, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- The global biotechnology market size accounted for USD 1,224.31 billion in 2022, a study published by Towards Healthcare a sister firm of Precedence Research.",AMGN,0.013202,0.172021,Somewhat-Bullish
Is Amgen Stock Fully Valued After A 17% Rise In A Month?,https://www.forbes.com/sites/greatspeculations/2023/08/14/is-amgen-stock-fully-valued-after-a-17-rise-in-a-month/,2023-08-14 13:00:21,"Amgen stock (NASDAQ: AMGN) has seen a 17% rise in a month, outperforming the broader S&P500 index, up 1%.",AMGN,0.79415,0.271901,Somewhat-Bullish
"QUALCOMM, AIG And 2 Other Stocks Insiders Are Selling - Amgen  ( NASDAQ:AMGN ) , American Intl Gr  ( NYSE:AIG ) ",https://www.benzinga.com/news/23/08/33828098/qualcomm-aig-and-2-other-stocks-insiders-are-selling,2023-08-14 12:08:05,"The Nasdaq 100 closed lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",AMGN,0.45634,-0.176536,Somewhat-Bearish
"Take the Zacks Approach to Beat the Markets: Celsius, Adobe, Curtiss-Wright in Focus",https://www.zacks.com/stock/news/2136155/take-the-zacks-approach-to-beat-the-markets-celsius-adobe-curtiss-wright-in-focus,2023-08-14 11:57:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.09439,0.11105,Neutral
"Nasdaq Suffers Second Straight Week of Losses, Breaks Key Support Level As Tech Bears Return: Is This Time Different? - PayPal Holdings  ( NASDAQ:PYPL ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Constellation Energy  ( NASDAQ:CEG ) , Fortinet  ( NASDAQ:FTNT ) , Datadog  ( NASDAQ:DDOG ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/markets/23/08/33760613/nasdaq-suffers-second-straight-week-of-losses-breaks-key-support-level-as-tech-bears-return-is-this,2023-08-11 20:01:17,"The Nasdaq 100 Index finds itself in a rare bind as it stares down a second consecutive week of losses and hovers at the lowest level in a month. This troubling downturn, an unexpected twist in the 2023 tale, sent ripples of concern through the markets, with investors now fearing that a trend ...",AMGN,0.22595,0.200187,Somewhat-Bullish
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2135485/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-08-11 10:20:08,Sector ETF report for ...,AMGN,0.13459,0.071501,Neutral
Dow Jones Off Session Lows As Disney Jumps; Cathie Wood Loads Up On This Stock Despite 23% Plunge,https://www.investors.com/market-trend/stock-market-today/dow-jones-reverses-as-walt-disney-stock-jumps-cathie-wood-loads-up-on-this-stock-despite-23-plunge/,2023-08-10 19:20:00,Dow Jones Off Session Lows As Disney Jumps. Cathie Wood Loads Up On This Stock Despite 23% Plunge Investor's Business Daily ...,AMGN,0.080865,0.148897,Neutral
3 Dow Jones Stocks To Watch In August 2023,https://stockmarket.com/featured/3-dow-jones-stocks-to-watch-in-august-2023-2023-08-10,2023-08-10 15:26:37,"The Dow Jones Industrial Average, often just called ""the Dow,"" is a bit like the all-star team of the stock market. It's made up of 30 big, reputable American companies from various industries. Think of it as a snapshot of how the U.S. economy is doing.",AMGN,0.329992,0.296931,Somewhat-Bullish
Amgen Inc.  ( AMGN )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2134910/amgen-inc-amgn-is-attracting-investor-attention-here-is-what-you-should-know,2023-08-10 13:00:06,"Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",AMGN,0.484798,0.128536,Neutral
Want Rising Dividend Income? Buy Amgen Stock,https://www.fool.com/investing/2023/08/10/want-rising-dividend-income-buy-amgen-stock/,2023-08-10 09:59:00,The drugmaker possesses a solid medicine portfolio and pipeline.,AMGN,0.254973,0.308754,Somewhat-Bullish
"Blockchain technology in the healthcare market to grow by USD 1,939.31 million from 2022 to 2027; The growing ... - PR Newswire",https://www.prnewswire.com/news-releases/blockchain-technology-in-the-healthcare-market-to-grow-by-usd-1-939-31-million-from-2022-to-2027-the-growing-inclination-toward-data-security-to-boost-the-market---technavio-301895959.html,2023-08-09 23:30:00,"Blockchain technology in the healthcare market to grow by USD 1,939.31 million from 2022 to 2027. The growing ... PR ...",AMGN,0.04882,0.041477,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/08/33673916/looking-at-amgens-recent-unusual-options-activity,2023-08-09 17:30:42,"Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.804025,0.357288,Bullish
"Horizon  ( HZNP )  Q2 Earnings Top, Krystexxa & Uplizna Boost Sales",https://www.zacks.com/stock/news/2134466/horizon-hznp-q2-earnings-top-krystexxa-uplizna-boost-sales,2023-08-09 16:09:00,"Horizon (HZNP) reports better-than-expected second-quarter results, beating both earnings and sales estimates, with the top-line key contributors being Krystexxa and Uplizna.",AMGN,0.201944,0.038221,Neutral
65% Profit On Eli Lilly - 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug - Raising The Target - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/23/08/33670747/65-profit-on-eli-lilly-20-reduction-in-heart-attacks-and-strokes-with-weight-loss-drug-raising-the-t,2023-08-09 15:09:56,Signal Limited is a Signal ( s ) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a Signal over the short term.,AMGN,0.110209,0.117806,Neutral
Dow Jones Heavyweights - Caterpillar & Amgen Beat The Street,https://www.forbes.com/sites/johnbuckingham/2023/08/09/dow-jones-heavyweightscaterpillar--amgen-beat-the-street/,2023-08-09 13:54:00,"Unlike most market indexes, the Dow Jones Industrial Average is price-weighted, meaning that high-price stocks like Caterpillar (CAT) and Amgen (AMGN) are heavyweights...",AMGN,0.22574,0.137455,Neutral
Biotech Stocks To Watch: Track The Latest News On Pharmaceutical Stocks And Drug Companies,https://www.investors.com/news/technology/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead/,2023-08-09 12:06:00,"One minute Dow Jones industrial average component Merck ( MRK ) might be doing battle with fellow drugmaker Bristol Myers Squibb ( BMY ) over drugs that can ward off cancer. The next, biotech giants like Amgen ( AMGN ) and Sanofi ( SNY ) are tussling in court over the fate of ...",AMGN,0.366061,0.043641,Neutral
Amgen  ( NASDAQ:AMGN )  Rating Increased to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/08/09/amgen-nasdaqamgn-rating-increased-to-strong-buy-at-stocknews-com.html,2023-08-09 09:52:13,"Amgen ( NASDAQ:AMGN - Get Free Report ) was upgraded by StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a report released on Monday. A number of other research firms have also weighed in on AMGN. Jefferies Financial Group lowered their price objective on Amgen from $325.00 to ...",AMGN,0.858969,0.376762,Bullish
Horizon  ( HZNP )  Up as FTC Pauses Acquisition by Amgen Lawsuit,https://www.zacks.com/stock/news/2141403/horizon-hznp-up-as-ftc-pauses-acquisition-by-amgen-lawsuit,2023-08-28 15:11:00,"The Federal Trade Commission suspends its ongoing lawsuit to block Horizon's (HZNP) acquisition by Amgen until Sep 18, 2023. The company's stock rises 5.8% in response.",AMGN,0.594159,-0.127118,Neutral
"Top Stories: Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal - Bayer  ( OTC:BAYRY ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/08/34069633/hawaiian-electric-says-power-lines-not-responsible-for-deadly-lahaina-fire-china-targets-stock-marke,2023-08-28 14:37:08,"Walmart Inc WMT has reportedly resolved the University of California's light-bulb patent lawsuit. The university accused the retail behemoth of infringing its patents associated with ""filament"" LED light bulbs ( invented at the Santa Barbara-based school system ) .",AMGN,0.068016,0.076907,Neutral
Why Amgen  ( AMGN )  is a Top Value Stock for the Long-Term,https://www.zacks.com/stock/news/2141322/why-amgen-amgn-is-a-top-value-stock-for-the-long-term,2023-08-28 13:40:04,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.,AMGN,0.488777,0.236702,Somewhat-Bullish
Wall Street Thinks This Tiny Biotech Company Could Soar Soon,https://www.fool.com/investing/2023/08/28/wall-street-thinks-this-tiny-biotech-company-could/,2023-08-28 12:30:00,An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle.,AMGN,0.055621,0.022997,Neutral
"Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields - CVS Health  ( NYSE:CVS ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/08/34066469/wall-streets-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields,2023-08-28 12:21:53,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.104683,0.250298,Somewhat-Bullish
"Beat the Market Like Zacks: Hubbell, Adobe, Nikola in Focus",https://www.zacks.com/stock/news/2141268/beat-the-market-like-zacks-hubbell-adobe-nikola-in-focus,2023-08-28 12:02:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.097325,0.111888,Neutral
"US Stocks Seen Opening Firmer In New Week's 1st Session As Traders Look To Week's Key Data; Analyst Constructive Despite Bearish Signals - Alibaba Gr Holding  ( NYSE:BABA ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , XPeng  ( NYSE:XPEV ) , NVIDIA  ( NASDAQ:NVDA ) , Horizon Therapeutics  ( NASDAQ:HZNP ) , Baidu  ( NASDAQ:BIDU ) , Amgen  ( NASDAQ:AMGN ) , Hawaiian Electric Indus  ( NYSE:HE ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/markets/equities/23/08/34065176/us-stocks-seen-opening-firmer-in-new-weeks-1st-session-as-traders-look-to-weeks-key-data-analyst,2023-08-28 11:22:19,"Stocks appear to be on track for a cautious start on Monday as the Jack Hole Symposium is now in the rearview. The major averages had a mixed close in the week ended Aug. 25, with the Nasdaq Composite and the S&P 500 indices carving out noteworthy gains.",AMGN,0.135729,0.0,Neutral
"FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/08/34056018/ftc-takes-a-rare-step-back-pauses-legal-battle-with-amgen-over-28b-horizon-deal,2023-08-26 16:28:47,"The Federal Trade Commission ( FTC ) decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc AMGN, concerning its proposed acquisition of Horizon Therapeutics PLC HZNP valued at $27.8 billion.",AMGN,0.546745,0.25893,Somewhat-Bullish
An Update On The Amgen-Horizon Battle Just Sent The Latter Flying,https://www.investors.com/news/technology/hznp-stock-jumps-on-a-new-ftc-development-in-the-amgen-takeover-battle/,2023-08-25 21:32:00,HZNP Stock Jumps On A New FTC Development In The Amgen ... Investor's Business Daily ...,AMGN,0.364275,0.064558,Neutral
"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit - even if their drugs aren't on the list",https://www.marketwatch.com/story/as-medicare-picks-10-drugs-for-price-negotiations-50-million-people-stand-to-benefit-even-if-their-drugs-arent-on-the-list-aceec7e,2023-08-25 14:54:00,Government negotiations with drugmakers are set to launch amid a growing number of legal challenges.,AMGN,0.062843,-0.034042,Neutral
Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?,https://www.marketwatch.com/story/stock-buybacks-spur-wealth-inequality-and-stifle-innovation-but-should-they-be-banned-13e963c0,2023-08-24 21:56:00,"Stock buybacks have become a major source of wealth inequality and have stifled innovation in the U.S., according to this academic.",AMGN,0.105295,0.087187,Neutral
Can AbbVie  ( ABBV )  Protect Revenues After Humira Patent Loss?,https://www.zacks.com/stock/news/2140301/can-abbvie-abbv-protect-revenues-after-humira-patent-loss,2023-08-24 14:53:00,"AbbVie's (ABBV) newer products, Skyrizi and Rinvoq, are performing extremely well and have the potential to make up for lost Humira revenues.",AMGN,0.156461,0.075563,Neutral
Blanchard® and Amgen Win Bronze Brandon Hall Group Excellence Award for Best Unique or Innovative Learning and Development Program,https://www.prnewswire.com/news-releases/blanchard-and-amgen-win-bronze-brandon-hall-group-excellence-award-for-best-unique-or-innovative-learning-and-development-program-301908833.html,2023-08-24 14:05:00,Blanchard® and Amgen Win Bronze Brandon Hall Group Excellence Award for Best Unique or Innovative Learning ... PR ...,AMGN,0.099066,0.249748,Somewhat-Bullish
4 Surefire Stocks to Buy in the Next Bear Market,https://www.fool.com/investing/2023/08/24/4-surefire-stocks-to-buy-in-the-next-bear-market/,2023-08-24 14:00:00,Not all companies struggle when economic weakness takes hold.,AMGN,0.222838,-0.023437,Neutral
"GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus - AstraZeneca  ( NASDAQ:AZN ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/08/34022293/gri-bio-is-bringing-hope-to-patients-with-idiopathic-pulmonary-fibrosis-and-lupus,2023-08-24 12:23:59,"Inflammatory diseases are chronic conditions that involve the abnormal activation of the body's immune system, leading to chronic inflammation in various organs and tissues. Two of these diseases that are more widely known are Idiopathic Pulmonary Fibrosis ( IPF ) and Lupus.",AMGN,0.110973,0.051125,Neutral
This Is What Whales Are Betting On Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/08/34012223/this-is-what-whales-are-betting-on-amgen,2023-08-23 20:01:02,"Someone with a lot of money to spend has taken a bullish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.815635,0.261222,Somewhat-Bullish
"George Soros Bets Big On Electric Vehicles, Bitcoin, Pharmaceuticals And Consumer Internet Providers, According To Latest Filings",https://www.benzinga.com/markets/cryptocurrency/23/08/33990235/george-soros-bets-big-on-electric-vehicles-bitcoin-pharmaceuticals-and-consumer-internet-p,2023-08-22 17:09:42,"Billionaire philanthropist George Soros, while polarizing, has made some of the most successful trades in history. His fund has averaged a roughly 30% yearly return since inception. Soros made bets on Tesla Inc. as early as 2018 and ventured into cryptocurrency the same year.",AMGN,0.079656,-0.087901,Neutral
Peering Into Amgen's Recent Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/08/33968954/peering-into-amgens-recent-short-interest,2023-08-21 17:45:25,"Amgen's AMGN short percent of float has fallen 8.96% since its last report. The company recently reported that it has 6.51 million shares sold short, which is 1.22% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.27 days to cover their ...",AMGN,0.224903,0.085754,Neutral
Is Trending Stock Amgen Inc.  ( AMGN )  a Buy Now?,https://www.zacks.com/stock/news/2138583/is-trending-stock-amgen-inc-amgn-a-buy-now,2023-08-21 13:00:05,"Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",AMGN,0.487546,0.095612,Neutral
Is Amgen Stock a Top Buy and Hold?,https://www.fool.com/investing/2023/08/21/is-amgen-stock-a-top-buy-and-hold/,2023-08-21 12:15:00,The biotech checks several important boxes for long-term shareholders.,AMGN,0.764699,0.537904,Bullish
"Beat the Market the Zacks Way: Caterpillar, Amgen, Broadridge Financial Solutions in Focus",https://www.zacks.com/stock/news/2138501/beat-the-market-the-zacks-way-caterpillar-amgen-broadridge-financial-solutions-in-focus,2023-08-21 10:42:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.064276,0.060133,Neutral
"FTC Settles Suit, Potentially Averting Further Hurdles",https://www.investorideas.com/news/2023/biotech/09072FTC-Settles-Suit.asp,2023-09-07 17:38:23,"Last week, the U.S. Federal Trade Commission ( FTC ) suspended its legal challenge to Amgen Inc. ( AMGN:NASDAQ ) 's proposed acquisition of Horizon Therapeutics Plc ( HZNP:NASDAQ ) , 2022's largest deal announcement in the biopharma space.",AMGN,0.061949,0.033094,Neutral
Amgen  ( AMGN )  Stock Outperforms Industry YTD: Here's Why,https://www.zacks.com/stock/news/2145372/amgen-amgn-stock-outperforms-industry-ytd-heres-why,2023-09-06 13:40:00,"Amgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset by lower revenues from oncology biosimilars and Enbrel.",AMGN,0.608634,0.314452,Somewhat-Bullish
Jim Cramer's top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/09/06/jim-cramers-top-10-things-to-watch-in-the-stock-market-wednesday-.html,2023-09-06 13:08:22,"Equities are lower in premarket trading Wednesday, while Arm Holdings' roadshow ahead of a planned initial public offering is impressive.",AMGN,0.136113,0.0,Neutral
"Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/09/34245963/amgens-horizon-acquisition-offers-multiple-advantages-tax-breaks-shield-from-drug-pricing-negotia,2023-09-05 17:52:20,"On Friday, the U.S. Federal Trade Commission ( FTC ) gave a green light to Amgen Inc's AMGN acquisition of Horizon Therapeutics Plc HZNP, which contradicts its earlier commitment to tighter antitrust checks.",AMGN,0.582526,0.348526,Somewhat-Bullish
Should You Still Buy the Dow Jones' Best-Performing August Stocks?,https://www.fool.com/investing/2023/09/05/should-you-still-buy-the-dow-jones-best-performing/,2023-09-05 13:13:00,"They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture.",AMGN,0.319414,0.227248,Somewhat-Bullish
"Beat the Market the Zacks Way: NVIDIA, Novo Nordisk, Matson in Focus",https://www.zacks.com/stock/news/2144752/beat-the-market-the-zacks-way-nvidia-novo-nordisk-matson-in-focus,2023-09-05 12:06:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.067158,0.061268,Neutral
Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows ... - PR Newswire,https://www.prnewswire.com/news-releases/aeglea-biotherapeutics-expands-executive-leadership-team-with-appointment-of-industry-veterans-scott-burrows-and-heidy-abreu-king-jones-301917249.html,2023-09-05 11:00:00,Aeglea BioTherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows ... PR ...,AMGN,0.040622,0.064589,Neutral
GSK: 3 Pharma Stocks for Value Investors,https://stocknews.com/news/gsk-hznp-nbix-amgn-pph-3-pharma-stocks-for-value-investors/,2023-09-04 18:58:44,"The pharmaceutical industry is well-positioned to witness solid long-term growth thanks to the fast-expanding market for drugs and therapies. Moreover, given the consistent product demand, the pharma business is less susceptible to economic cycles.",AMGN,0.098524,0.176628,Somewhat-Bullish
FTC Allows Amgen  ( AMGN )  to Proceed With $28B Horizon Buyout,https://www.zacks.com/stock/news/2144523/ftc-allows-amgen-amgn-to-proceed-with-28b-horizon-buyout,2023-09-04 16:14:00,"Per the settlement terms, Amgen (AMGN) is prohibited from bundling its products with Horizon's Tepezza or Krystexxa. Amgen expects to complete the Horizon acquisition before 2023-end.",AMGN,0.704675,0.00382,Neutral
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration,https://www.prnewswire.com/news-releases/addressing-the-fragile-2023-global-osteogenesis-imperfecta-treatment-markets-growth-driven-by-research-and-collaboration-301916828.html,2023-09-04 15:45:00,Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and ... PR ...,AMGN,0.074001,0.048716,Neutral
Amgen  ( AMGN )  is a Top-Ranked Momentum Stock: Should You Buy?,https://www.zacks.com/stock/news/2144314/amgen-amgn-is-a-top-ranked-momentum-stock-should-you-buy,2023-09-04 13:50:07,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",AMGN,0.451494,0.202113,Somewhat-Bullish
"As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs",https://www.marketwatch.com/story/as-medicare-drug-price-negotiations-inch-forward-some-states-are-flexing-new-powers-to-cut-costs-for-a-broader-swath-of-drugs-a4ca7f3e,2023-09-01 15:30:00,States like Colorado are looking to set upper payment limits on certain drugs as soon as next year.,AMGN,0.063678,-0.03203,Neutral
Market Rally Gains Momentum As Yields Slide: Weekly Review,https://www.investors.com/news/stock-market-rally-gains-momentum-as-treasury-yields-slide-tesla-unveils-model-3-upgrade/,2023-09-01 14:58:00,"The stock market rally staged a follow-through day Tuesday, with the major indexes running above the 50-day line in higher volume. Tame labor and inflation data sent Treasury yields sharply lower, giving stocks a lift.",AMGN,0.044634,-0.030841,Neutral
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement,https://www.forbes.com/sites/tylerroush/2023/09/01/amgens-278-billion-purchase-of-horizon-therapeutics-on-after-ftc-settlement/,2023-09-01 14:53:09,The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.,AMGN,0.103331,-0.164441,Somewhat-Bearish
"Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal - Horizon Therapeutics  ( NASDAQ:HZNP ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/09/34172813/amgen-horizon-therapeutics-28b-acquisition-federal-trade-commission-gives-green-signal,2023-09-01 14:47:38,The U.S. Federal Trade Commission ( FTC ) has approved drug manufacturer Amgen Inc AMGN to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc HZNP. This decision reverses the FTC's earlier objections to the deal.,AMGN,0.690822,0.181075,Somewhat-Bullish
Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/anti-rheumatic-market-to-grow-exponentially-by-2029--brandessence-market-research-301915970.html,2023-09-01 14:34:00,"LONDON, Sept. 1, 2023 /PRNewswire/ -- Rheumatoid arthritis ( RA ) is a highly prevalent auto-immune ailment. This disease predominantly affects our joints, mainly that of hands and feet. It occurs when the immune system begins attacking the healthy tissues.",AMGN,0.027382,0.060193,Neutral
U.S. FTC allows Amgen to go ahead with $27.8 bln Horizon deal,https://www.reuters.com/markets/deals/us-ftc-allows-amgen-move-forward-with-278-bln-horizon-deal-cnbc-2023-09-01/,2023-09-01 13:08:00,"An Amgen sign is seen at the company's office in South San Francisco, California in this October 21, 2013. REUTERS/Robert Galbraith/Files Acquire Licensing Rights Sept 1 ( Reuters ) - The U.S.",AMGN,0.129516,-0.061926,Neutral
Here is What to Know Beyond Why Amgen Inc.  ( AMGN )  is a Trending Stock,https://www.zacks.com/stock/news/2143497/here-is-what-to-know-beyond-why-amgen-inc-amgn-is-a-trending-stock,2023-09-01 13:00:06,"Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",AMGN,0.482078,0.106902,Neutral
"Amgen  ( NASDAQ:AMGN )  Downgraded by StockNews.com to ""Buy""",https://www.defenseworld.net/2023/09/01/amgen-nasdaqamgn-downgraded-by-stocknews-com-to-buy.html,2023-09-01 09:34:49,StockNews.com downgraded shares of Amgen ( NASDAQ:AMGN - Free Report ) from a strong-buy rating to a buy rating in a research note released on Thursday. Other equities research analysts have also recently issued research reports about the stock.,AMGN,0.049732,0.075,Neutral
Is This the Green Light Biotech Stocks Have Been Waiting For?,https://www.fool.com/investing/2023/08/31/is-this-the-green-light-biotech-stocks-have-been-w/,2023-08-31 11:53:00,It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.,AMGN,0.368091,0.120528,Neutral
Medicare's First Price Negotiation List Targets Expensive Drugs  ( Revised ) ,https://www.zacks.com/stock/news/2142728/medicares-first-price-negotiation-list-targets-expensive-drugs-revised,2023-08-31 06:53:00,"The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.",AMGN,0.13459,-0.008722,Neutral
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/08/30/2734798/0/en/Alvotech-Reports-Financial-Results-for-First-Six-Months-of-2023-and-Provides-Business-Update.html,2023-08-30 20:15:00,"Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first six months of 2023 and provided a summary of recent corporate highlights.",AMGN,0.013868,0.0,Neutral
Alvotech Reports Financial Results for First Six Months of 2023 and Provides Business Update,https://www.globenewswire.com/news-release/2023/08/30/2734797/0/en/Alvotech-Reports-Financial-Results-for-First-Six-Months-of-2023-and-Provides-Business-Update.html,2023-08-30 20:15:00,"REYKJAVIK, Iceland, Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the ""Company"" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first six months of ...",AMGN,0.013819,0.0,Neutral
Medicare's First Price Negotiation List Targets Expensive Drugs,https://www.zacks.com/stock/news/2142358/medicares-first-price-negotiation-list-targets-expensive-drugs,2023-08-30 13:19:00,"The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.",AMGN,0.139669,0.006387,Neutral
Medicare's First Price Negotiation List Targets Expensive Drugs  ( Revised ) ,https://www.zacks.com/stock/news/2142728/medicares-first-price-negotiation-list-targets-expensive-drugs-revised,2023-08-30 13:19:00,"The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.",AMGN,0.13459,-0.008722,Neutral
"Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations",https://www.marketwatch.com/story/merck-amgen-abbvie-products-among-first-10-drugs-selected-for-medicare-price-negotiations-556c2484,2023-08-29 19:22:00,"Merck, Johnson & Johnson and Amgen are among the first drugmakers to have products chosen for a contentious initiative to rein in prescription-drug costs.",AMGN,0.058188,0.047971,Neutral
AMGN: 3 Best Biotech Stocks for Health and Wealth,https://stocknews.com/news/amgn-vrtx-incy-repl-sndx-3-best-biotech-stocks-for-health-and-wealth/,2023-08-29 17:56:51,"Innovative biotech companies are making remarkable progress in creating novel medications and therapies for a diverse array of conditions, such as cancer, heart disease, and rare ailments. Encouraging trial outcomes and enhanced patient well-being are spurring the demand for continuous medical ...",AMGN,0.232885,0.232763,Somewhat-Bullish
10 Drugs Selected for Medicare Price Reduction,https://www.zacks.com/stock/news/2141961/10-drugs-selected-for-medicare-price-reduction,2023-08-29 14:55:00,"We're getting Case-Shiller home price numbers ahead of the opening bell this morning, but there's not enough time to dig into it. Give us till this afternoon to speak about these. Pre-market indices are in the red currently, albeit marginally. Investors cool their heels early after back-to-back ...",AMGN,0.160633,0.041728,Neutral
Medicare Drugs Targeted Under Inflation Reduction Act,https://www.zacks.com/stock/news/2141940/medicare-drugs-targeted-under-inflation-reduction-act,2023-08-29 14:21:00,"Last year, these 10 drugs made up $50 billion, about 20%, of Medicare part D costs.",AMGN,0.15347,0.041855,Neutral
"Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle - Wants To Cut Billions In Costs. Here Are The Stocks Affected - Johnson & Johnson  ( NYSE:JNJ ) ",https://www.benzinga.com/general/biotech/23/08/34087337/biden-targets-cancer-diabetes-drugs-in-controversial-medicare-price-battle-wants-to-cut-billions-,2023-08-29 13:30:50,"The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including: Bristol Myers Squibb Co's BMS blood thinner, Eliquis Eli Lilly And Co's LLY diabetes treatment, Jardiance.",AMGN,0.227007,0.0,Neutral
"AbbVie, Merck, Lilly Highlight Biden List For Price Cuts",https://www.investors.com/news/technology/pharmaceutical-stocks-biden-administration-unveils-10-drugs-subject-to-price-cuts/,2023-08-29 13:28:00,Pharmaceutical Stocks: Biden Administration Unveils 10 Drugs ... Investor's Business Daily ...,AMGN,0.423843,0.053971,Neutral
AbbVie  ( ABBV )  Seeks Approval for Skyrizi for Ulcerative Colitis,https://www.zacks.com/stock/news/2141813/abbvie-abbv-seeks-approval-for-skyrizi-for-ulcerative-colitis,2023-08-29 13:21:00,AbbVie's (ABBV) regulatory applications filed to the FDA and the EMA seeking approval for Skyrizi for ulcerative colitis are based on data from two phase III studies.,AMGN,0.20997,0.217881,Somewhat-Bullish
Amgen Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/09/34623014/amgen-unusual-options-activity,2023-09-15 16:47:55,"Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.703874,0.164878,Somewhat-Bullish
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2149176/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-09-14 21:50:17,"In the latest trading session, Amgen (AMGN) closed at $262.30, marking a +1.97% move from the previous day.",AMGN,0.689912,0.402702,Bullish
MRNA: Moderna  ( MRNA )  Stock Analysis: Is the Biotech Stock a Buy at This Time?,https://stocknews.com/news/mrna-jazz-otsky-amgn-moderna-mrna-stock-analysis-is-the-biotech-stock-a-buy/,2023-09-14 16:50:16,MRNA: Moderna ( MRNA ) Stock Analysis: Is the Biotech Stock a Buy ... ...,AMGN,0.045874,0.171212,Somewhat-Bullish
"$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/earnings/23/09/34547484/1000-invested-in-this-stock-15-years-ago-would-be-worth-4-200-today,2023-09-13 18:30:21,"Amgen AMGN has outperformed the market over the past 15 years by 1.11% on an annualized basis producing an average annual return of 10.27%. Currently, Amgen has a market capitalization of $138.98 billion.",AMGN,0.983605,0.387251,Bullish
2 Top Dividend Stocks to Buy in September,https://www.fool.com/investing/2023/09/13/2-top-dividend-stocks-to-buy-in-september/,2023-09-13 14:30:00,These two blue-chip dividend stocks have stood the test of time.,AMGN,0.365166,0.52113,Bullish
AbbVie's  ( ABBV )  Skyrizi Crohn's Disease Study Meets Goals,https://www.zacks.com/stock/news/2148368/abbvies-abbv-skyrizi-crohns-disease-study-meets-goals,2023-09-13 14:02:00,AbbVie's (ABBV) Skyrizi met both primary endpoints of non-inferiority for clinical remission at week 24 and superiority of endoscopic remission at week 48 versus J&J's Stelara in a head-to-head study.,AMGN,0.202932,0.210757,Somewhat-Bullish
"These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts - CVS Health  ( NYSE:CVS ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/09/34530435/these-3-health-care-stocks-with-over-3-dividend-yields-are-recommended-by-wall-streets-m,2023-09-13 11:35:21,"During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.",AMGN,0.104228,0.111909,Neutral
NVS: 3 Pharma Stocks Surpassing Johnson & Johnson  ( JNJ ) ,https://stocknews.com/news/nvs-hznp-rdy-jnj-amgn-3-pharma-stocks-surpassing-johnson-johnson-jnj/,2023-09-12 16:38:07,NVS: 3 Pharma Stocks Surpassing Johnson & Johnson ...,AMGN,0.087824,0.171752,Somewhat-Bullish
Investors Heavily Search Amgen Inc.  ( AMGN ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2147660/investors-heavily-search-amgen-inc-amgn-here-is-what-you-need-to-know,2023-09-12 13:00:06,"Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",AMGN,0.488469,0.134943,Neutral
Amgen Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold,https://www.investors.com/research/amgen-stock-earns-relative-strength-rating-upgrade-hits-key-threshold/,2023-09-11 18:37:00,Amgen Stock Earns Relative Strength Rating Upgrade. Hits Key ... Investor's Business Daily ...,AMGN,0.592095,0.341341,Somewhat-Bullish
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis - Novartis  ( NYSE:NVS ) ,https://www.benzinga.com/general/biotech/23/09/34440622/another-arthritis-blockbuster-drug-faces-generic-competition-novartis-sandoz-inks-pact-with-samsu,2023-09-11 13:32:00,"Sandoz, a generic and biosimilar medicines unit of Novartis AG NVS, has entered a development and commercialization agreement with Samsung Bioepis. The agreement provides Sandoz exclusive rights to commercialize the biosimilar SB17 ustekinumab in the US, Canada, EEA, Switzerland, and the U.K.",AMGN,0.371523,-0.065606,Neutral
Which Is A Better Pick - Honeywell Stock Or Amgen?,https://www.forbes.com/sites/greatspeculations/2023/09/11/which-is-a-better-pick--honeywell-stock-or-amgen/,2023-09-11 13:00:57,We believe that Honeywell stock (NYSE: HON) and Amgen stock (NASDAQ: AMGN) will offer little returns in the next three years.,AMGN,0.665853,0.264988,Somewhat-Bullish
"Longeveron  ( NASDAQ: LGVN )  Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS  ( Compared To 80% Survival In Historical Trials )  To Market - Longeveron  ( NASDAQ:LGVN ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/23/09/34436783/longeveron-nasdaq-lgvn-reports-100-5-year-survival-in-trial-for-rare-pediatric-disease-hlhs-compa,2023-09-11 12:05:09,"Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However, some serious pediatric conditions continue to pose a threat.",AMGN,0.128822,0.0,Neutral
"Take the Zacks Approach to Beat the Market: Shopify, Novo Nordisk, Amgen in Focus",https://www.zacks.com/stock/news/2147094/take-the-zacks-approach-to-beat-the-market-shopify-novo-nordisk-amgen-in-focus,2023-09-11 12:01:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.10087,0.112974,Neutral
Amgen Reports Positive Data From Phase 1 Study Of Lumakras Combination In Non-small Cell Lung Cancer,https://markets.businessinsider.com/news/stocks/amgen-reports-positive-data-from-phase-1-study-of-lumakras-combination-in-non-small-cell-lung-cancer-1032618038,2023-09-10 15:16:35,"( RTTNews ) - Amgen ( AMGN ) announced positive data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating Lumakras ( sotorasib ) with carboplatin and pemetrexed in adult patients with KRAS G12C-mutated advanced non-small cell lung cancer or NSCLC.",AMGN,0.44622,-0.143554,Neutral
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2146847/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-09-08 21:50:17,"In the latest trading session, Amgen (AMGN) closed at $259.43, marking a +1.98% move from the previous day.",AMGN,0.666827,0.363312,Bullish
"Dow Jones Rises 100 Points, Led By Microsoft, Apple Stock; High-Flying Adobe Upgraded Ahead Of Earnings",https://www.investors.com/market-trend/stock-market-today/dow-jones-edges-higher-led-by-apple-stock-adobe-snares-upgrade-ahead-of-earnings-while-nvidia-tests-key-level/,2023-09-08 14:48:00,"Dow Jones Rises 100 Points, Led By Microsoft, Apple Stock. High ... Investor's Business Daily ...",AMGN,0.143415,-0.035362,Neutral
How Is The Market Feeling About Amgen? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/09/34363275/how-is-the-market-feeling-about-amgen,2023-09-08 14:30:23,"Amgen's AMGN short percent of float has risen 8.2% since its last report. The company recently reported that it has 7.03 million shares sold short, which is 1.32% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.43 days to cover their ...",AMGN,0.224903,0.158881,Somewhat-Bullish
"Biotech Stock Roundup: MRNA's Vaccine Update, AMGN & HZNP Clear FTC Lawsuit & More",https://www.zacks.com/stock/news/2146657/biotech-stock-roundup-mrnas-vaccine-update-amgn-hznp-clear-ftc-lawsuit-more,2023-09-08 13:58:00,Pipeline and regulatory updates from (MRNA) and Amgen (AMGN) are in focus in the biotech sector.,AMGN,0.224487,0.133694,Neutral
Futures Fall As Stock Market Rally Struggles,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stock-market-rally-struggles-cathie-wood-sells-nvidia-stock/,2023-09-08 12:11:00,"Dow Jones futures dropped Friday morning, along with S&P 500 and Nasdaq futures, as the stock market headed for a losing week. Cathie Wood's Ark Invest ETFs sold more than 13,500 shares of Nvidia stock. Ahead of Friday's opening bell, Dow Jones futures dropped 0.2%, while S&P 500 futures lost ...",AMGN,0.0864,-0.222127,Somewhat-Bearish
Amgen  ( NASDAQ:AMGN )  Rating Increased to Strong-Buy at StockNews.com,https://www.defenseworld.net/2023/09/08/amgen-nasdaqamgn-rating-increased-to-strong-buy-at-stocknews-com.html,2023-09-08 07:12:45,Amgen ( NASDAQ:AMGN ) Rating Increased to Strong-Buy at ... Defense World ...,AMGN,0.794423,0.369276,Bullish
IBD Rating Upgrades: Amgen Flashes Improved Price Strength,https://www.investors.com/ibd-data-stories/ibd-rating-upgrades-amgen-flashes-improved-price-strength-2/,2023-09-08 07:00:00,"In a welcome move, Amgen ( AMGN ) saw its Relative Strength Rating rise from 70 to 75 on Friday. X When looking for the best stocks to buy and watch, keep a close on eye on relative price strength.",AMGN,0.605266,0.375862,Bullish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2156616/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2023-09-27 22:00:20,"In the latest trading session, Amgen (AMGN) closed at $268.98, marking a -0.02% move from the previous day.",AMGN,0.613743,0.170172,Somewhat-Bullish
"September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average",https://markets.businessinsider.com/news/etf/september-s-shakeout-s-p-500-nasdaq-100-see-just-13-of-stocks-above-50-day-average-1032660395,2023-09-27 16:04:52,"In a month marked by volatility, the stock market is sending out distress signals like never before. The S&P 500 and Nasdaq 100 have both hit yearly lows in terms of the percentage of stocks trading below their 50-day moving averages.",AMGN,0.105604,0.0,Neutral
Amgen discloses more than $400 million stake in recent IPO Neumora Therapeutics,https://www.marketwatch.com/story/amgen-discloses-more-than-400-million-stake-in-recent-ipo-neumora-therapeutics-6e46f0d7,2023-09-27 12:36:00,"An Amgen disclosure of a large stake in Neumora Therapeutics indicated the value of its investment in the biotech, which recently went public, has tripled.",AMGN,0.777888,0.373627,Bullish
Futures Rise Ahead Of Key Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-economic-data-costco-stock-slides-on-earnings/,2023-09-27 12:10:00,Dow Jones Futures Rise Ahead Of Economic Data. Costco Slides ... Investor's Business Daily ...,AMGN,0.116725,0.135646,Neutral
"Protein Engineering Market size to grow by USD 2.37 billion from 2022-2027| Agilent Technologies Inc., Amgen Inc ... - PR Newswire",https://www.prnewswire.com/news-releases/protein-engineering-market-size-to-grow-by-usd-2-37-billion-from-2022-2027-agilent-technologies-inc-amgen-inc-bio-rad-laboratories-inc-are-emerging-companies-in-the-market--technavio-301939213.html,2023-09-26 23:45:00,"Protein Engineering Market size to grow by USD 2.37 billion from 2022-2027| Agilent Technologies Inc., Amgen Inc ... PR ...",AMGN,0.069697,0.06925,Neutral
Which Is A Better Pick - PepsiCo Stock Or Amgen?,https://www.forbes.com/sites/greatspeculations/2023/09/26/which-is-a-better-pick--pepsico-stock-or-amgen/,2023-09-26 10:00:38,We believe that PepsiCo stock (NYSE: PEP) is a better pick over Amgen stock (NASDAQ: AMGN).,AMGN,0.76367,0.358854,Bullish
Futures: Key Inflation Data Looms As Stocks Bounce,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-inflation-data-looms-tesla-stock-in-focus-ahead-of-deliveries/,2023-09-25 21:15:00,Dow Jones Futures: Inflation Data Looms As Yields Spike. Tesla ... Investor's Business Daily ...,AMGN,0.105604,0.044129,Neutral
Why Coherus BioSciences'  ( CHRS )  Shares Are Falling Today - Coherus BioSciences  ( NASDAQ:CHRS ) ,https://www.benzinga.com/general/biotech/23/09/34870927/fda-strikes-off-coherus-biosciences-new-injector-biosimilar-treatment-for-cancer-patients,2023-09-25 19:35:07,"The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's CHRS on-body injector ( OBI ) presentation of Udenyca ( pegfilgrastim-cbqv ) , solely due to an ongoing review of inspection findings at a third-party ...",AMGN,0.308891,0.056872,Neutral
Amgen Inc.  ( AMGN )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2154769/amgen-inc-amgn-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-09-25 13:00:07,"Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",AMGN,0.483888,0.098006,Neutral
"Beat the Market Like Zacks: Elementis, Novo Nordisk, Amgen in Focus",https://www.zacks.com/stock/news/2154739/beat-the-market-like-zacks-elementis-novo-nordisk-amgen-in-focus,2023-09-25 11:50:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.09893,0.11237,Neutral
Should You Invest in the Invesco Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2154633/should-you-invest-in-the-invesco-pharmaceuticals-etf-pjp,2023-09-25 10:20:06,Sector ETF report for ...,AMGN,0.132004,0.063692,Neutral
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... - PR Newswire,https://www.prnewswire.com/news-releases/the-thyroid-gland-disorder-treatment-market-to-grow-by-usd-868-87-million-from-2022-to-2027--abbott-laboratories-abbvie-inc-alvogen-iceland-ehf-and-more-among-key-companies--technavio-301936306.html,2023-09-25 02:15:00,The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... PR ...,AMGN,0.077845,0.027652,Neutral
Innovative Gelatin Capsules Transforming Pharmaceutical Industry: A Look into the Future,https://www.prnewswire.com/news-releases/innovative-gelatin-capsules-transforming-pharmaceutical-industry-a-look-into-the-future-301936082.html,2023-09-22 21:45:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Pharmaceutical Gelatin Market Share, Size, Trends, Industry Analysis Report, By Source, By Function, By End Use, By Regions, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's offering.",AMGN,0.060236,-0.055999,Neutral
"Global Dermatology Drugs Market Set to Skyrocket, Anticipated Valuation of $50.47 Billion by 2032",https://www.prnewswire.com/news-releases/global-dermatology-drugs-market-set-to-skyrocket-anticipated-valuation-of-50-47-billion-by-2032--301936081.html,2023-09-22 21:30:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Dermatology Drugs Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area, By Drug Class, By Route of Administration, By Distribution Channel, By Region, Segment Forecast, 2023-2032"" report has been added to ResearchAndMarkets.com's ...",AMGN,0.060541,-0.056,Neutral
"Diving Back Into A Correction: Watchlists, Nike Earnings, Coal Stocks, Housing Data",https://www.investors.com/research/investing-action-plan/diving-back-into-a-correction-watchlists-nike-earnings-coal-stocks-housing-data/,2023-09-22 21:21:00,"Diving Back Into A Correction: Watchlists, Nike Earnings, Coal ... Investor's Business Daily ...",AMGN,0.218817,-0.169165,Somewhat-Bearish
AI To Revolutionize Clinical Trials And Diagnostics - Mainz Biomed  ( NASDAQ:MYNZ ) ,https://www.benzinga.com/markets/penny-stocks/23/09/34828759/ai-to-revolutionize-clinical-trials-and-diagnostics,2023-09-22 16:51:08,"With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving diagnostics. For example, Mainz Biomed MYNZ has developled ColoAlert, an affordable test for early ...",AMGN,0.129516,0.077811,Neutral
Glioma Treatment Market worth $8.29 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34822634/glioma-treatment-market-worth-8-29-billion-by-2030-exclusive-report-by-the-insight-partners,2023-09-22 12:54:42,"Pune, India, Sept. 22, 2023 ( GLOBE NEWSWIRE ) -- Glioma is a condition that covers a broad category of brain and spinal cord tumors that concern the glial cells in the brain function and can be fatal depending on the location and severity of the tumor.",AMGN,0.023418,0.087173,Neutral
From Years to Months: How AI is Shaping the Landscape of Clinical Trials - Novartis  ( NYSE:NVS ) ,https://www.benzinga.com/general/biotech/23/09/34818722/from-years-to-months-how-ai-is-shaping-the-landscape-of-clinical-trials,2023-09-22 11:49:07,"Pharmaceutical companies are harnessing artificial intelligence ( AI ) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These human studies, crucial to drug development, can take years and accrue costs in the billions.",AMGN,0.360752,0.172304,Somewhat-Bullish
Why Shares of Neumora Therapeutics Slumped This Week,https://www.fool.com/investing/2023/09/21/why-shares-of-neumora-therapeutics-slumped-this-we/,2023-09-21 22:06:04,The clinical-stage biotech just had its IPO last week.,AMGN,0.126784,0.095482,Neutral
Amgen  ( AMGN )  Stock Moves -0.76%: What You Should Know,https://www.zacks.com/stock/news/2153920/amgen-amgn-stock-moves--076-what-you-should-know,2023-09-21 21:50:20,"In the latest trading session, Amgen (AMGN) closed at $269.41, marking a -0.76% move from the previous day.",AMGN,0.670305,0.206665,Somewhat-Bullish
2 Dividend Growth Stocks to Buy Right Now,https://www.fool.com/investing/2023/09/21/2-dividend-growth-stocks-to-buy-right-now/,2023-09-21 13:37:00,"A wise man once said, be greedy when others are fearful.",AMGN,0.54329,0.329071,Somewhat-Bullish
HP Inc. Names David Meline to Board of Directors,https://www.globenewswire.com/news-release/2023/09/21/2747292/0/en/HP-Inc-Names-David-Meline-to-Board-of-Directors.html,2023-09-21 12:35:00,"PALO ALTO, Calif., Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- HP Inc. ( NYSE: HPQ ) today announced the appointment of David Meline to its Board of Directors. Meline is the former Chief Financial Officer for Moderna Inc., a global biotechnology and pharmaceutical leader. His appointment is effective ...",AMGN,0.105604,0.0,Neutral
"Best Dividend Stocks: Amgen Hits Buy Point, Offers Solid Dividend Growth",https://www.investors.com/research/the-income-investor/dividend-stocks-amgen-outperforms-hitting-buypoint-offers-solid-dividend-growth/,2023-09-20 17:57:00,"Best Dividend Stocks: Amgen Hits Buy Point, Offers Solid Dividend ... Investor's Business Daily ...",AMGN,0.708701,0.084686,Neutral
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Amgen Inc's Directors and Officers for Breach of Fiduciary Duties - AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/pressreleases/23/09/g34769377/investigation-alert-scott-scott-attorneys-at-law-llp-investigates-amgen-incs-directors-and-officer,2023-09-20 17:16:28,"NEW YORK, Sept. 20, 2023 ( GLOBE NEWSWIRE ) -- Scott+Scott Attorneys at Law LLP ( ""Scott+Scott"" ) , an international securities and consumer rights litigation firm, is investigating whether certain directors and officers of Amgen Inc. ( ""Amgen"" ) AMGN breached their fiduciary duties to Amgen and ...",AMGN,0.950503,0.179173,Somewhat-Bullish
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/09/34768132/check-out-what-whales-are-doing-with-amgn,2023-09-20 16:16:32,"Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.729067,0.144704,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2152870/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-09-20 10:20:05,Sector ETF report for ...,AMGN,0.138066,0.072464,Neutral
JNJ: 3 Healthcare Stocks to Buy Today,https://stocknews.com/news/jnj-abbv-amgn-3-healthcare-stocks-to-buy-today/,2023-09-18 16:18:05,"Johnson & Johnson ( JNJ ) , Amgen ( AMGN ) and AbbVie ( ABBV ) are healthcare sector leaders with their company specific transformative catalysts in the fray. All three stocks are rated a strong buy by the propriety POWR Rating, ranking above the 95th percentile.",AMGN,0.328819,0.221508,Somewhat-Bullish
"Beat the Market the Zacks Way: Automatic Data Processing, Casey's, Paysafe in Focus",https://www.zacks.com/stock/news/2151789/beat-the-market-the-zacks-way-automatic-data-processing-caseys-paysafe-in-focus,2023-09-18 12:02:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.06471,0.061155,Neutral
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,2023-09-18 09:15:00,"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... PR ...",AMGN,0.08609,-0.093515,Neutral
Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... - PR Newswire,https://www.prnewswire.com/news-releases/large-molecule-injectable-drugs-market-to-grow-by-usd-191-45-billion-from-2022-2027--north-america-to-account-for-45-of-market-growth---technavio-301929312.html,2023-09-18 08:35:00,Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for ... PR ...,AMGN,0.052685,0.0,Neutral
Amgen  ( AMGN )  Increases Yet Falls Behind Market: What Investors Need to Know,https://www.zacks.com/stock/news/2161867/amgen-amgn-increases-yet-falls-behind-market-what-investors-need-to-know,2023-10-06 21:50:21,"Amgen (AMGN) closed at $267.47 in the latest trading session, marking a +0.9% move from the prior day.",AMGN,0.582526,0.31273,Somewhat-Bullish
Amgen's Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics' Lung Cancer Drug: Analysts - Mirati Therapeutics  ( NASDAQ:MRTX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35129164/amgens-adcomm-meeting-paves-way-to-launch-boost-for-mirati-therapeutics-lung-cancer,2023-10-06 16:44:32,"According to a report on Thursday, French pharma company Sanofi SA SNY is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc MRTX. The deal would potentially bolster Sanofi's drug pipeline, helping the company to reduce its reliance on the blockbuster asthma ...",AMGN,0.219809,-0.061312,Neutral
FDA AdCom Gives Thumbs Down To Late-Stage Data For Amgen's Lumakras In Advanced Form Of Lung Cancer  ( UPDATED )  - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/10/35122196/fda-adcomm-gives-thumbs-down-to-late-stage-data-amgens-lumakras,2023-10-06 16:18:00,Editor's note: The headline of this story has been updated to make clearer the FDA vote is on late-stage Lumakras data. FDA advisers concluded that the data from a late-stage trial lacks the requisite reliability to endorse the traditional approval of Amgen Inc's AMGN Lumakras for patients ...,AMGN,0.454174,0.22044,Somewhat-Bullish
Mirati  ( MRTX )  Surges 45% as Sanofi Reportedly Eyes Buyout,https://www.zacks.com/stock/news/2161744/mirati-mrtx-surges-45-as-sanofi-reportedly-eyes-buyout,2023-10-06 15:34:00,A Bloomberg article suggests that pharma giant Sanofi (SNY) is exploring a potential acquisition deal for small cancer drugmaker Mirati Therapeutics (MRTX).,AMGN,0.132004,0.075841,Neutral
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC,https://investingnews.com/amgen-completes-acquisition-of-horizon-therapeutics-plc/,2023-10-06 13:21:32,"Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines Amgen ( NASDAQ: AMGN ) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion .",AMGN,0.251464,0.153688,Somewhat-Bullish
Amgen Inc.  ( AMGN )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2161430/amgen-inc-amgn-is-attracting-investor-attention-here-is-what-you-should-know,2023-10-06 13:00:06,"Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",AMGN,0.484798,0.116051,Neutral
FDA Adcomm Gives Thumbs Down To Amgen's Lumakras For Advanced Form Of Lung Cancer - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/10/35122196/fda-adcomm-gives-thumbs-down-to-amgens-lumakras-for-advanced-form-of-lung-cancer,2023-10-06 12:59:14,FDA advisers concluded that the data from a late-stage trial lacked the requisite reliability to endorse the traditional approval of Amgen Inc's AMGN Lumakras for patients afflicted with an advanced form of lung cancer.,AMGN,0.48268,0.136274,Neutral
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against it,https://www.marketwatch.com/story/amgen-to-continue-to-seek-full-approval-of-lumakras-cancer-drug-after-fda-panel-votes-against-it-b5148d82,2023-10-06 12:36:00,Amgen will continue to seek full approval for its Lumakras cancer drug as a treatment for a form of lung cancer.,AMGN,0.116348,-0.13534,Neutral
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC,https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html,2023-10-06 12:30:00,"Advances Amgen's Mission to Serve Patients With First-in-Class Rare Disease Medicines THOUSAND OAKS, Calif., Oct. 6, 2023 /PRNewswire/ -- Amgen ( NASDAQ: AMGN ) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a ...",AMGN,0.303675,0.155416,Somewhat-Bullish
Amgen  ( NASDAQ:AMGN )  Research Coverage Started at StockNews.com,https://www.defenseworld.net/2023/10/06/amgen-nasdaqamgn-research-coverage-started-at-stocknews-com.html,2023-10-06 06:16:52,Amgen ( NASDAQ:AMGN ) Research Coverage Started at ... Defense World ...,AMGN,0.7562,0.435048,Bullish
"The Zacks Analyst Blog Highlights Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City",https://www.zacks.com/stock/news/2160567/the-zacks-analyst-blog-highlights-amgen-servicenow-rtx-automatic-data-processing-and-canadian-pacific-kansas-city,2023-10-05 11:16:00,"Amgen, ServiceNow, RTX, Automatic Data Processing and Canadian Pacific Kansas City are included in this Analyst Blog.",AMGN,0.350564,0.205907,Somewhat-Bullish
Amgen  ( AMGN )  Surpasses Market Returns: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2160368/amgen-amgn-surpasses-market-returns-some-facts-worth-knowing,2023-10-04 22:00:19,"Amgen (AMGN) reachead $265.44 at the closing of the latest trading day, reflecting a +1.7% change compared to its last close.",AMGN,0.585687,0.213652,Somewhat-Bullish
"Top Research Reports for Amgen, ServiceNow & RTX",https://www.zacks.com/research-daily/2159999/top-research-reports-for-amgen-servicenow-rtx,2023-10-04 19:55:00,"Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), ServiceNow, Inc. (NOW) and RTX Corporation (RTX).",AMGN,0.103778,0.253705,Somewhat-Bullish
Large-scale proteomics in population-based studies from UK and Iceland,https://investingnews.com/large-scale-proteomics-in-population-based-studies-from-uk-and-iceland/,2023-10-04 15:38:10,"In a paper released today, deCODE Genetics' scientists shared their findings from a plasma proteomics study performed using affinity-based methods.",AMGN,0.284696,0.070225,Neutral
Large-scale proteomics in population-based studies from UK and Iceland - Canada NewsWire,https://www.newswire.ca/news-releases/large-scale-proteomics-in-population-based-studies-from-uk-and-iceland-804037245.html,2023-10-04 15:00:00,Large-scale proteomics in population-based studies from UK and Iceland Canada ...,AMGN,0.279015,0.06909,Neutral
"Breast Cancer Therapeutics Market to Hit $63.96 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35082720/breast-cancer-therapeutics-market-to-hit-63-96-billion-globally-by-2030-exclusive-report-by-the-in,2023-10-04 09:57:03,"Pune, India, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Breast cancer is one of the most common types of cancer and has a sizable market for therapies. According to the Centers for Disease Control and Prevention, in 2020, in the US, 239,612 new cases of breast cancer were reported among women, of which ...",AMGN,0.036643,-0.119027,Neutral
Should You Still Buy the Dow Jones' Best-Performing September Stocks?,https://www.fool.com/investing/2023/10/04/should-you-buy-dow-best-performing-stocks/,2023-10-04 09:10:00,"A handful of blue-chip tickers defied the bigger bearish tide last month, but that doesn't necessarily make these stocks a buy.",AMGN,0.253426,0.143911,Neutral
Is Amgen's Lung Cancer Drug Lumakras Up to the Mark? FDA Briefing Raises Concerns - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35069802/is-amgens-lung-cancer-drug-lumakras-up-to-the-mark-fda-briefing-raises-concerns,2023-10-03 19:30:41,The FDA released briefing documents ahead of Oncologic Drugs Advisory Committee meeting scheduled for October 5 to review Amgen Inc's AMGN supplemental application for complete approval of Lumakras ( sotorasib ) for previously treated locally advanced or metastatic KRAS G12C-mutated non-small ...,AMGN,0.544495,-0.003381,Neutral
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration - Novo Nordisk  ( NYSE:NVO ) ,https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration,2023-10-03 17:35:19,"All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.",AMGN,0.262522,0.0,Neutral
AMGN: Top 3 Biotech Stocks Leading the Way This October,https://stocknews.com/news/amgn-gild-jazz-top-3-biotech-stocks-leading-the-way-this-october/,2023-10-03 16:44:08,"The biotech industry is thriving, driven by innovation and stable demand, positioning it for sustained growth. Despite macroeconomic challenges, this positive outlook is supported by an aging population and the demand for quality treatments for both rare and common diseases.",AMGN,0.308742,0.115153,Neutral
Here's Why Intuit Stock Is A Better Pick Over Amgen,https://www.forbes.com/sites/greatspeculations/2023/10/03/heres-why-intuit-stock-is-a-better-pick-over-amgen/,2023-10-03 13:00:00,"Looking at stock returns, INTU has fared better.",AMGN,0.652336,0.36686,Bullish
Futures Mixed After Government Shutdown Averted,https://www.investors.com/market-trend/stock-market-today/dow-jones-tesla-stock-q3-deliveries/,2023-10-02 12:17:00,Dow Jones Futures Fall After Shutdown Averted. Tesla Stock Awaits ... Investor's Business Daily ...,AMGN,0.120632,0.079292,Neutral
"Take the Zacks Approach to Beat the Market: Shopify, Caterpillar, Amgen in Focus",https://www.zacks.com/stock/news/2158593/take-the-zacks-approach-to-beat-the-market-shopify-caterpillar-amgen-in-focus,2023-10-02 11:44:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.065957,0.061209,Neutral
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/09/35009267/check-out-what-whales-are-doing-with-amgn,2023-09-29 18:03:33,"A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 14 strange trades. If we consider the specifics of each trade, it is accurate to state that 21% of the investors opened trades with bullish expectations and ...",AMGN,0.815149,0.199026,Somewhat-Bullish
"As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment",https://www.marketwatch.com/story/as-merck-astrazeneca-and-other-drugmakers-sign-on-medicare-price-negotiations-face-critical-moment-9d85879f,2023-09-29 14:20:00,A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve.,AMGN,0.100099,0.0,Neutral
3 Stocks to Focus on as Demand for Obesity Drugs Booms,https://www.zacks.com/stock/news/2157743/3-stocks-to-focus-on-as-demand-for-obesity-drugs-booms,2023-09-29 13:35:00,"With the obesity market gaining popularity, analysts are expecting sales to increase. Pharma companies are rushing to enter the market ...",AMGN,0.087185,0.0,Neutral
Futures Rise Ahead Of Key Inflation Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-inflation-data-nike-surges-on-earnings/,2023-09-29 12:07:00,Dow Jones Futures Rise Ahead Of Imminent Inflation Data. Nike ... Investor's Business Daily ...,AMGN,0.110124,0.076543,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2157520/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-09-29 10:20:05,Smart Beta ETF report for ...,AMGN,0.122894,0.068464,Neutral
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2157352/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-09-28 21:50:17,"In the latest trading session, Amgen (AMGN) closed at $270.82, marking a +0.68% move from the previous day.",AMGN,0.624172,0.352375,Bullish
Futures Fall Ahead Of Jobless Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobless-claims-carmax-dives-on-earnings/,2023-09-28 12:04:00,"Dow Jones futures turned higher Thursday morning, along with S&P 500 futures, while Nasdaq futures dipped, ahead of initial unemployment claims and GDP data. Meanwhile, CarMax ( KMX ) dived on weak earnings results. The Labor Department's first-time jobless claims are due out at 8:30 a.m.",AMGN,0.113597,0.082966,Neutral
Amgen Unusual Options Activity For October 17 - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/10/35296672/amgen-unusual-options-activity-for-october-17,2023-10-17 19:31:01,"A whale with a lot of money to spend has taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 16 strange trades. If we consider the specifics of each trade, it is accurate to state that 18% of the investors opened trades with bullish expectations and ...",AMGN,0.862496,0.222202,Somewhat-Bullish
PBYI vs. AMGN: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2167363/pbyi-vs-amgn-which-stock-is-the-better-value-option,2023-10-17 15:40:11,Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Puma Biotech ( PBYI Quick QuotePBYI - ) or Amgen ( AMGN Quick QuoteAMGN - ) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find ...,AMGN,0.753462,0.523296,Bullish
Investors Heavily Search Amgen Inc.  ( AMGN ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2167043/investors-heavily-search-amgen-inc-amgn-here-is-what-you-need-to-know,2023-10-17 13:00:06,"Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",AMGN,0.488469,0.104632,Neutral
USFDA gives final nod to Glenmark's psoriasis drug,https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-gives-final-nod-to-glenmarks-psoriasis-drug/3275095/lite/,2023-10-17 06:55:29,"Glenmark Pharmaceuticals Ltd. on Tuesday announced that it has received final approval from the United States Food & Drug Administration ( U.S. FDA ) for Apremilast Tablets, 10 mg, 20 mg and 30 mg. According to the company's statement, it is the generic version of Otezla Tablets, 10 mg, 20 mg ...",AMGN,0.266828,0.106946,Neutral
USFDA gives final nod to Glenmark's psoriasis drug,https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-gives-final-nod-to-glenmarks-psoriasis-drug/3275095/,2023-10-17 06:55:29,"Glenmark Pharmaceuticals Ltd. on Tuesday announced that it has received final approval from the United States Food & Drug Administration ( U.S. FDA ) for Apremilast Tablets, 10 mg, 20 mg and 30 mg. According to the company's statement, it is the generic version of Otezla Tablets, 10 mg, 20 mg ...",AMGN,0.266828,0.106946,Neutral
Will Amgen  ( AMGN )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2166638/will-amgen-amgn-beat-estimates-again-in-its-next-earnings-report,2023-10-16 16:10:10,Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,AMGN,0.409171,0.40694,Bullish
$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/10/35270975/100-invested-in-amgen-15-years-ago-would-be-worth-this-much-today,2023-10-16 16:00:26,"Amgen AMGN has outperformed the market over the past 15 years by 1.38% on an annualized basis producing an average annual return of 12.0%. Currently, Amgen has a market capitalization of $153.28 billion.",AMGN,0.983605,0.387251,Bullish
AMGN: Exploring the Upside Potential of 3 Biotech Stocks,https://stocknews.com/news/amgn-incy-alks-exploring-the-upside-potential-of-3-biotech-stocks/,2023-10-16 13:08:43,"The biotech industry is well-positioned for steady growth, owing to rapid advancements in drug developments and the growing demand to treat chronic diseases.",AMGN,0.310451,0.213649,Somewhat-Bullish
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings,https://www.zacks.com/stock/news/2166333/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings,2023-10-16 12:50:06,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,AMGN,0.268294,0.238624,Somewhat-Bullish
"Beat the Market the Zacks Way: Novo Nordisk, MakeMyTrip, Fastenal in Focus",https://www.zacks.com/stock/news/2166368/beat-the-market-the-zacks-way-novo-nordisk-makemytrip-fastenal-in-focus,2023-10-16 12:08:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.065238,0.10113,Neutral
PacBio Announces Appointment of David Meline to Board of Directors,https://www.prnewswire.com/news-releases/pacbio-announces-appointment-of-david-meline-to-board-of-directors-301957110.html,2023-10-16 12:05:00,"Former CFO of Moderna, Amgen, and 3M Brings Decades of Relevant Experience to the PacBio Board MENLO PARK, Calif., Oct. 16, 2023 /PRNewswire/ -- PacBio ( NASDAQ: PACB ) , a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Meline to ...",AMGN,0.081552,0.058019,Neutral
Which Is A Better Pick - Abbott Stock Or Amgen?,https://www.forbes.com/sites/greatspeculations/2023/10/16/which-is-a-better-pick--abbott-stock-or-amgen/,2023-10-16 12:00:06,"There is more to the comparison, and in the sections below, we discuss why we believe ABT will offer better returns than AMGN in the next three years.",AMGN,0.704675,0.299984,Somewhat-Bullish
In-Depth Analysis: Amgen Versus Competitors In Biotechnology Industry - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/10/35244136/in-depth-analysis-amgen-versus-competitors-in-biotechnology-industry,2023-10-13 16:00:22,"In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Amgen AMGN and its primary competitors in the Biotechnology ...",AMGN,0.464844,0.079048,Neutral
Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics,https://www.prnewswire.com/news-releases/growing-geriatric-population-fuels-ankylosing-spondylitis-market-management-of-pain-and-mobility-gains-importance-in-aging-demographics-301956060.html,2023-10-13 15:45:00,Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance ... PR ...,AMGN,0.036643,0.067285,Neutral
Sanofi reaps rewards of immunology investment with eczema results,https://www.marketwatch.com/story/sanofi-reaps-rewards-of-immunology-investment-with-eczema-results-9ce642b0,2023-10-13 14:00:00,Pharmaceutical giant set to take on Amgen with atopic dermatitis treatment.,AMGN,0.221819,0.151207,Somewhat-Bullish
Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?,https://www.fool.com/investing/2023/10/13/is-this-dividend-stock-screaming-buy-after-latest/,2023-10-13 12:30:00,The biotech is ending the year with a bang.,AMGN,0.554365,0.282728,Somewhat-Bullish
Is Amgen Stock a Buy Now?,https://www.fool.com/investing/2023/10/13/is-amgen-stock-a-buy-now/,2023-10-13 09:25:00,The company recently closed its acquisition of Horizon Therapeutics.,AMGN,0.602879,0.226083,Somewhat-Bullish
 ( AMGN )  Rises As Market Takes a Dip: Key Facts,https://www.zacks.com/stock/news/2165200/amgn-rises-as-market-takes-a-dip-key-facts,2023-10-12 21:50:20,"In the closing of the recent trading day, Amgen (AMGN) stood at $285.04, denoting a +0.51% change from the preceding trading day.",AMGN,0.517534,0.113451,Neutral
GILD: How to Enhance Your Own Strategies with POWR Ratings,https://stocknews.com/news/gild-amgn-uthr-biib-regn-how-to-enhance-your-own-strategies-with-powr-ratings/,2023-10-12 16:29:47,"One thing Wall Street is never short of is ideas. Technical strategies, fundamental strategies, seasonal investing, and the list goes on and on and on.",AMGN,0.173832,0.036379,Neutral
Check Out What Whales Are Doing With AMGN - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/10/35224311/check-out-what-whales-are-doing-with-amgn,2023-10-12 16:01:48,"Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.76367,0.19683,Somewhat-Bullish
Amgen's  ( AMGN )  Stock Rallies Almost 5% on Broker Upgrade,https://www.zacks.com/stock/news/2165040/amgens-amgn-stock-rallies-almost-5-on-broker-upgrade,2023-10-12 15:55:00,A Leerink Partner analyst expects accelerating pipeline news flow for Amgen (AMGN).,AMGN,0.613172,0.289195,Somewhat-Bullish
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations - Cardiol Therapeutics  ( NASDAQ:CRDL ) ,https://www.benzinga.com/general/biotech/23/10/35220787/cardiol-therapeutics-fights-heart-inflammation-with-novel-formulations,2023-10-12 13:53:19,"697,000 people die from heart disease every year in the United States - that is one in every five deaths. In fact, cardiovascular disease is the number one killer for most Americans per the CDC. Everyday life choices play an essential role in heart health, and sometimes unfortunate accidents can ...",AMGN,0.033328,-0.01534,Neutral
Global CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032,https://investingnews.com/global-car-t-cell-therapy-market-projected-to-reach-83-billion-by-2032/,2023-10-12 13:39:21,"FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines.",AMGN,0.105883,0.065147,Neutral
Dow Jones Rises After Fed Minutes As House Vote On New Speaker Looms; Meta Breaks Out,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-after-fed-minutes-as-house-vote-on-new-speaker-looms-meta-breaks-out/,2023-10-11 19:52:00,Dow Jones Rises After Fed Minutes As House Vote On New ... Investor's Business Daily ...,AMGN,0.199037,0.209207,Somewhat-Bullish
"Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected Upgrade",https://www.investors.com/news/technology/amgen-stock-surges-to-10-month-high-after-snagging-an-unexpected-upgrade/,2023-10-11 19:49:00,"Amgen Stock Surges To 10-Month High, Up 4% On An Unexpected ... Investor's Business Daily ...",AMGN,0.653008,-0.007515,Neutral
"Amgen's cancer-drug pipeline looks promising despite FDA setback, analysts say",https://www.marketwatch.com/story/amgens-cancer-drug-pipeline-looks-promising-despite-fda-setback-analysts-say-70339525,2023-10-11 12:47:00,"Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade ...",AMGN,0.866386,0.249245,Somewhat-Bullish
Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,https://www.zacks.com/stock/news/2164069/should-you-invest-in-the-vaneck-biotech-etf-bbh,2023-10-11 10:20:06,Sector ETF report for ...,AMGN,0.134968,0.071604,Neutral
Should You Still Buy the Nasdaq's Best-Performing September Stocks?,https://www.fool.com/investing/2023/10/10/should-you-still-buy-the-nasdaqs-best-performing-o/,2023-10-10 10:53:00,"Tech stocks sold off last month, but these three were gainers.",AMGN,0.213048,0.112066,Neutral
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October,https://www.fool.com/investing/2023/10/09/2-magnificent-dividend-stocks-to-buy-hand-over-fis/,2023-10-09 14:15:00,These two healthcare stocks are reliable passive income vehicles.,AMGN,0.374714,0.58081,Bullish
Mirati  ( MRTX )  Gets Buyout Offer From Bristol Myers for $4.8B,https://www.zacks.com/stock/news/2162730/mirati-mrtx-gets-buyout-offer-from-bristol-myers-for-48b,2023-10-09 14:01:00,"Sanofi (SNY) is set to acquire Mirati (MRTX) for $58 per share in cash along with a contingent value right of $12 per share, tied to a regulatory milestone.",AMGN,0.116631,0.053482,Neutral
Here's Why Mirati Stock Tumbled On A $5.8 Billion Takeover Bid,https://www.investors.com/news/technology/mrtx-stock-takes-a-hit-after-receiving-a-lowball-takeover-bid/,2023-10-09 13:52:00,MRTX Stock Takes A Hit After Receiving A Lowball Takeover Bid Investor's Business Daily ...,AMGN,0.235823,-0.105897,Neutral
Coherus  ( CHRS )  Stock Rises on BLA Re-Filing for Udenyca Onbody,https://www.zacks.com/stock/news/2162656/coherus-chrs-stock-rises-on-bla-re-filing-for-udenyca-onbody,2023-10-09 13:49:00,"Coherus (CHRS) resubmits biologics license application for Udenyca Onbody, an on-body injector presentation of Udenyca to the FDA. Stock rises.",AMGN,0.139669,0.0,Neutral
"Beat the Market the Zacks Way: UnitedHealth, Novo Nordisk, Check Point Software in Focus",https://www.zacks.com/stock/news/2162451/beat-the-market-the-zacks-way-unitedhealth-novo-nordisk-check-point-software-in-focus,2023-10-09 11:20:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.059268,0.094033,Neutral
"Apple, Fed Meeting, Caterpillar, Jobs Report; Investing Action Plan",https://www.investors.com/research/investing-action-plan/apple-fed-meeting-caterpillar-jobs-report-investing-action-plan/,2023-10-27 21:53:00,"Apple, Fed Meeting, Caterpillar, Jobs Report. Investing Action Plan Investor's Business Daily ...",AMGN,0.104759,0.056462,Neutral
"Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets - CVS Health  ( NYSE:CVS ) , Enphase Energy  ( NASDAQ:ENPH ) , Alphabet  ( NASDAQ:GOOGL ) , Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/earnings/23/10/35474151/bears-roam-wall-street-as-middle-east-conflict-earnings-outlook-raise-concerns-despite-strong-q3-us,2023-10-27 20:33:57,"It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S. corporations.",AMGN,0.09347,0.0,Neutral
"Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen Also Set To Report",https://www.investors.com/research/earnings-preview/apple-headlines-earnings-calendar-with-chip-titan-amd-health-giant-amgen/,2023-10-27 18:52:00,"Apple Headlines Earnings Calendar With Chip Titan AMD, Amgen ... Investor's Business Daily ...",AMGN,0.319817,0.020985,Neutral
Performance Comparison: Amgen And Competitors In Biotechnology Industry - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/10/35467984/performance-comparison-amgen-and-competitors-in-biotechnology-industry,2023-10-27 16:00:18,"In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Amgen AMGN in relation to its major competitors in the ...",AMGN,0.441424,0.141169,Neutral
"AbbVie  ( ABBV )  Q3 Earnings Beat, Shares Down Despite Raised View",https://www.zacks.com/stock/news/2173886/abbvie-abbv-q3-earnings-beat-shares-down-despite-raised-view,2023-10-27 14:51:00,"AbbVie's (ABBV) third-quarter 2023 earnings and sales beat estimates. Though the company raised its EPS outlook for both 2023 and 2024, share price dives as some key drugs misses out on estimates.",AMGN,0.148045,-0.029829,Neutral
Weight-Loss Beating Continues For Devices Makers; Why It's Overdone,https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/,2023-10-27 13:00:00,Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...,AMGN,0.034907,0.0,Neutral
A large international study of migraine reveals new biological pathways for treatment,https://www.newswire.ca/news-releases/a-large-international-study-of-migraine-reveals-new-biological-pathways-for-treatment-816056881.html,2023-10-26 15:00:00,"REYKJAVIK, Iceland , Oct. 26, 2023 /CNW/ -- A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of novel ...",AMGN,0.07031,0.071295,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2172536/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-10-26 13:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.203215,0.11418,Neutral
3 Pharma Stocks That Are Screaming Buys in October,https://www.fool.com/investing/2023/10/26/3-pharma-stocks-that-are-screaming-buys-in-october/,2023-10-26 11:30:00,Each company delivers an above-average dividend and revenue growth.,AMGN,0.151539,0.035847,Neutral
Wearable Injectors Market Share Worth $13.88 Billion by 2027 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35435683/wearable-injectors-market-share-worth-13-88-billion-by-2027-exclusive-report-by-the-insight-partne,2023-10-26 11:18:47,"Pune, India, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Wearable injectors are drug delivery devices that adhere to the body to deliver larger volumes of drugs subcutaneously. Several pharmaceutical and medical device companies have developed wearable injectors.",AMGN,0.0378,0.069057,Neutral
UniQure  ( QURE )  Expected to Beat Earnings Estimates: Should You Buy?,https://www.zacks.com/stock/news/2171738/uniqure-qure-expected-to-beat-earnings-estimates-should-you-buy,2023-10-25 14:02:19,UniQure (QURE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMGN,0.176502,-0.002866,Neutral
Moderna  ( MRNA )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2171770/moderna-mrna-to-report-q3-earnings-whats-in-the-cards,2023-10-25 13:10:00,"Investors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports third-quarter earnings.",AMGN,0.201523,0.055846,Neutral
Amgen  ( AMGN )  to Report Q3 Earnings: Will It Beat Estimates?,https://www.zacks.com/stock/news/2171289/amgen-amgn-to-report-q3-earnings-will-it-beat-estimates,2023-10-25 11:26:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.",AMGN,0.219312,0.215777,Somewhat-Bullish
USA Compression and Disney have been highlighted as Zacks Bull and Bear of the Day,https://www.zacks.com/stock/news/2171221/usa-compression-and-disney-have-been-highlighted-as-zacks-bull-and-bear-of-the-day,2023-10-25 08:49:00,"Chicago, IL - October 25, 2023 - Zacks Equity Research shares USA Compression Partners ( USAC Quick QuoteUSAC - ) as the Bull of the Day and Disney ( DIS Quick QuoteDIS - ) as the Bear of the Day.",AMGN,0.193575,0.174337,Somewhat-Bullish
Amgen  ( AMGN )  Outperforms Broader Market: What You Need to Know,https://www.zacks.com/stock/news/2171081/amgen-amgn-outperforms-broader-market-what-you-need-to-know,2023-10-24 21:50:18,"In the latest trading session, Amgen (AMGN) closed at $276.12, marking a +1.12% move from the previous day.",AMGN,0.608634,0.225467,Somewhat-Bullish
Amgen  ( AMGN )  Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release,https://www.zacks.com/stock/news/2170849/amgen-amgn-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release,2023-10-24 14:00:52,Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMGN,0.262522,0.16165,Somewhat-Bullish
3 Biotech Stocks With Decent Dividend for a Steady Return,https://www.zacks.com/stock/news/2170733/3-biotech-stocks-with-decent-dividend-for-a-steady-return,2023-10-24 13:15:00,"Here we pick three medical device stocks, AbbVie (ABBV), Amgen (AMGN) and Gilead Sciences (GILD), which have a solid five-year dividend growth history.",AMGN,0.406197,0.344854,Somewhat-Bullish
GSK Gears Up for Q3 Earnings: Will It Surpass Estimates?,https://www.zacks.com/stock/news/2170671/gsk-gears-up-for-q3-earnings-will-it-surpass-estimates,2023-10-24 11:25:00,"We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive third-quarter sales performance.",AMGN,0.231773,0.060659,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/10/35383209/looking-at-amgens-recent-unusual-options-activity,2023-10-23 20:30:50,"Someone with a lot of money to spend has taken a bearish stance on Amgen AMGN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",AMGN,0.802099,0.286965,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk",https://www.zacks.com/stock/news/2170092/the-zacks-analyst-blog-highlights-apple-amgen-becton-dickinson-unitedhealth-and-verisk,2023-10-23 10:32:00,"Apple, Amgen, Becton, Dickinson, UnitedHealth and Verisk are included in this Analyst Blog.",AMGN,0.348592,0.215181,Somewhat-Bullish
"Take the Zacks Approach to Beat the Market: Novo Nordisk, Amgen, Fabrinet in Focus",https://www.zacks.com/stock/news/2170088/take-the-zacks-approach-to-beat-the-market-novo-nordisk-amgen-fabrinet-in-focus,2023-10-23 09:23:00,"Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.",AMGN,0.066139,0.061217,Neutral
"Asthma Biologics Market Predicted to Reach USD 19.2 billion by 2031, Growing at a 12.5% CAGR | Exclusive Report by Transparency Market Research",https://www.prnewswire.com/news-releases/asthma-biologics-market-predicted-to-reach-usd-19-2-billion-by-2031--growing-at-a-12-5-cagr--exclusive-report-by-transparency-market-research-301964281.html,2023-10-23 09:14:00,"Asthma Biologics Market Predicted to Reach USD 19.2 billion by 2031, Growing at a 12.5% CAGR | Exclusive Report ... PR ...",AMGN,0.046273,0.278548,Somewhat-Bullish
AbbVie  ( ABBV )  to Report Q3 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2170056/abbvie-abbv-to-report-q3-earnings-whats-in-the-cards,2023-10-23 08:32:00,AbbVie's (ABBV) Q3 performance will likely reflect its newer immunotherapy drugs trying to compensate for declining Humira sales following the loss of U.S. exclusivity.,AMGN,0.2138,0.05686,Neutral
"Top Stock Reports for Apple, Amgen & Becton, Dickinson",https://www.zacks.com/research-daily/2169481/top-stock-reports-for-apple-amgen-becton-dickinson,2023-10-20 18:41:00,"Today's Research Daily features new research reports on 12 major stocks, including Apple Inc. (AAPL), Amgen Inc. (AMGN) and Becton, Dickinson and Company (BDX).",AMGN,0.195814,0.239195,Somewhat-Bullish
Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem,https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/,2023-10-19 14:47:00,Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...,AMGN,0.1172,-0.089813,Neutral
Is Invesco Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2168544/is-invesco-pharmaceuticals-etf-pjp-a-strong-etf-right-now,2023-10-19 10:20:05,Smart Beta ETF report for ...,AMGN,0.115509,0.055568,Neutral
Amgen  ( AMGN )  Stock Moves -0.3%: What You Should Know,https://www.zacks.com/stock/news/2168393/amgen-amgn-stock-moves--03-what-you-should-know,2023-10-18 21:50:17,"Amgen (AMGN) closed the most recent trading day at $283.58, moving -0.3% from the previous trading session.",AMGN,0.531019,0.111033,Neutral
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates,https://www.zacks.com/stock/news/2168288/5-biotech-stocks-set-to-outpace-q3-earnings-estimates,2023-10-18 15:20:00,"Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.",AMGN,0.353418,0.073833,Neutral
Dow Jones Up As Yields Spike; Berkshire Slumps As Warren Buffett Snaps Up These Assets,https://www.investors.com/market-trend/stock-market-today/dow-jones-up-as-yields-spike-berkshire-slumps-as-warren-buffett-snaps-up-these-assets/,2023-11-06 20:33:00,Dow Jones Up As Yields Spike. Berkshire Slumps As Warren Buffett ... Investor's Business Daily ...,AMGN,0.076236,0.076805,Neutral
"The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman - and Martin Shkreli",https://www.marketwatch.com/story/the-doctor-lowering-drug-prices-for-1-million-patients-with-help-from-mark-cuban-sam-altman-and-martin-shkreli-5e72d77a,2023-11-06 20:32:00,Kristopher Koeller relies on two daily medications to keep his blood pressure under control. They're both generics that have been on the market for decades-the kind of drugs that should be cheap.,AMGN,0.027941,0.007658,Neutral
AMGN: November Buy Alert: 3 Biotech Stocks Making Gains,https://stocknews.com/news/amgn-inva-orgo-november-buy-alert-3-biotech-stocks-making-gains/,2023-11-06 18:41:15,"The biotech industry is well-positioned for steady growth, owing to rapid advancements in drug developments and the growing impact of chronic diseases.",AMGN,0.278618,0.29423,Somewhat-Bullish
Amgen Inc.  ( AMGN )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2179089/amgen-inc-amgn-is-a-trending-stock-facts-to-know-before-betting-on-it,2023-11-06 14:00:06,"Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",AMGN,0.482982,0.113008,Neutral
"Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market ... - PR Newswire",https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-to-account-for-39-of-market-growth--technavio-301976707.html,2023-11-03 22:35:00,"Gene Therapy Market size to grow by USD 4.61 billion from 2022 to 2027, North America to account for 39% of market ... PR ...",AMGN,0.074692,0.0,Neutral
Market Rally Back In Force As Yields Plunge: Weekly Review,https://www.investors.com/news/stock-market-rally-back-in-force-as-treasury-yields-plunge-arista-palantir-are-winners/,2023-11-03 16:55:59,"The stock market rally took off this past week as Treasury yields plunged on generally weak economic data and soothing words from Fed Chief Jerome Powell Nasdaq staged a follow-through day to confirm the market rally on Wednesday, with the S&P 500 and Dow Jones following through on Thursday.",AMGN,0.035476,0.043443,Neutral
"Amgen Wins Big With FDA, Analyst Sees Soaring Potential - Johnson & Johnson  ( NYSE:JNJ ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/11/35571081/amgen-wins-big-with-fda-analyst-sees-soaring-potential,2023-11-02 19:01:03,"The FDA approval of Amgen, Inc's AMGN biosimilar version of Johnson & Johnson's JNJ psoriasis treatment, Stelara, for multiple inflammatory diseases sent shares climbing in early trading on Thursday. Amgen has exhibited the ability ""to grow mid-cycle assets, despite underwhelming initial ...",AMGN,0.94121,0.514615,Bullish
SpringWorks Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights,https://www.globenewswire.com/news-release/2023/11/02/2772053/0/en/SpringWorks-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Business-Highlights.html,2023-11-02 10:30:00,- PDUFA target action date for nirogacestat NDA in adults with desmoid tumors remains set for November ...,AMGN,0.017862,0.044986,Neutral
These Analysts Revise Their Forecasts On Amgen After Q3 Results - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/earnings/23/11/35545825/these-analysts-revise-their-forecasts-on-amgen-after-q3-results,2023-11-01 18:18:32,"Amgen Inc AMGN reported mixed third-quarter financial results. Amgen reported quarterly sales of $6.90 billion, slightly missing the consensus of $6.94 billion. Adjusted EPS increased 6% to $4.96, driven by increased revenues, beating the consensus of $4.66.",AMGN,0.970877,0.232021,Somewhat-Bullish
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2176198/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-11-01 13:10:03,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.220809,0.12016,Neutral
"Company News for Nov 01, 2023",https://www.zacks.com/stock/news/2176192/company-news-for-nov-01-2023,2023-11-01 12:05:00,"Companies In The Article Are: AMGN, NVDA, RGEN, COCO ...",AMGN,0.582526,-0.31296,Somewhat-Bearish
Should SPDR Portfolio S&P 500 High Dividend ETF  ( SPYD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2176036/should-spdr-portfolio-sp-500-high-dividend-etf-spyd-be-on-your-investing-radar,2023-11-01 10:20:06,Style Box ETF report for ...,AMGN,0.122894,0.068464,Neutral
USFDA approves Amgen's biosimilar for multiple inflammatory diseases,https://www.financialexpress.com/healthcare/pharma-healthcare/usfda-approves-amgens-biosimilar-for-multiple-inflammatory-diseases/3293732/,2023-11-01 07:53:43,"The U.S. Food and Drug Administration ( USFDA ) on Wednesday approved Wezlana ( ustekinumab-auub ) as a biosimilar to and interchangeable with Stelara ( ustekinumab ) for multiple inflammatory diseases. The FDA granted the approval of Wezlana to Amgen, Inc.",AMGN,0.087503,0.133526,Neutral
"Fear & Greed Index Remains In 'Fear' Zone Ahead Of Fed's Decision - Caterpillar  ( NYSE:CAT ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/earnings/23/11/35529691/fear-greed-index-remains-in-fear-zone-ahead-of-feds-decision,2023-11-01 06:11:30,"The CNN Money Fear and Greed index remained in the ""Fear"" zone on Tuesday. U.S. stocks closed higher on Tuesday, ahead of the Federal Reserve's monetary policy decision. The central bank is widely projected to keep interest rates unchanged on Wednesday. Data on jobs report for October will be ...",AMGN,0.232439,0.01923,Neutral
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana,https://www.marketwatch.com/story/amgen-gets-fda-approval-for-inflammatory-diseases-treatment-d4d01c80,2023-10-31 22:22:00,"Amgen has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases.",AMGN,0.659096,0.019039,Neutral
Amgen's stock hit by expectations its obesity pipeline is facing a longer wait,https://www.marketwatch.com/story/amgens-stock-jumps-premarket-after-earnings-beat-and-company-again-raises-guidance-d4015936,2023-10-31 15:59:00,Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.,AMGN,0.288044,-0.031612,Neutral
"Amgen  ( AMGN )  Beats on Q3 Earnings Beat, Lags Sales, Ups View",https://www.zacks.com/stock/news/2175771/amgen-amgn-beats-on-q3-earnings-beat-lags-sales-ups-view,2023-10-31 15:30:00,"Amgen (AMGN) beats Q3 estimates for earnings but misses on sales. Following the acquisition of Horizon Therapeutics, it raises earnings and sales guidance for 2023.",AMGN,0.334529,0.181836,Somewhat-Bullish
Why Amgen  ( AMGN )  Shares Are Trading Lower Today - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/10/35514314/amgen-lifts-annual-outlook-after-q3-performance-but-stock-still-falls-heres-why,2023-10-31 13:55:36,"Amgen Inc AMGN reported Q3 FY23 sales of $6.90 billion, slightly missing the consensus of $6.94 billion. Total revenues increased 4% Y/Y, resulting from a 5% increase in product sales.",AMGN,0.561184,0.27822,Somewhat-Bullish
"Amgen Boosts Guidance, But Sales Of Its Biggest Blockbuster Lag",https://www.investors.com/news/technology/amgen-stock-amgen-earnings-q3-2023/,2023-10-31 13:05:28,Amgen Stock Dips As Blockbuster Enbrel Lags. Boosts Outlook ... Investor's Business Daily ...,AMGN,0.904419,0.354858,Bullish
Amgen  ( AMGN )  Q3 Earnings Top Estimates,https://www.zacks.com/stock/news/2175197/amgen-amgn-q3-earnings-top-estimates,2023-10-31 12:25:06,"Amgen (AMGN) delivered earnings and revenue surprises of 6.67% and 0.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",AMGN,0.399204,0.145279,Neutral
Futures Rise Ahead Of Key Housing Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-key-housing-data-tesla-stock-continues-to-slide/,2023-10-31 12:22:57,"Dow Jones futures rose Tuesday morning, as Wall Street braces for the start of the Federal Reserve's two-day meeting. Meanwhile, Tesla stock continued to fall Tuesday, with solid losses, after Monday's dive below the 200 price level.",AMGN,0.101154,0.002219,Neutral
"U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive - Meritage Homes  ( NYSE:MTH ) , Arista Networks  ( NYSE:ANET ) , JetBlue Airways  ( NASDAQ:JBLU ) , Chesapeake Energy  ( NASDAQ:CHK ) ",https://www.benzinga.com/news/earnings/23/10/35510696/u-s-stocks-poised-to-extend-gains-as-fed-meeting-gets-underway-why-this-analyst-expects-young-bull-,2023-10-31 11:44:44,"Early indications suggest U.S. stock could strive to retain the winning momentum intact, although key catalysts scheduled for the next couple of sessions could leave investors cautious. Some of the Smid-cap earnings have come in better than expected, triggering a strong upward move in the ...",AMGN,0.084423,0.0,Neutral
Is Invesco Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2175072/is-invesco-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2023-10-31 10:20:05,Smart Beta ETF report for ...,AMGN,0.117486,0.060435,Neutral
"Charlie Munger says not much 'low-hanging fruit left' as he discusses Apple, Costco vs. Walmart and EVs.",https://www.marketwatch.com/story/charlie-munger-says-not-much-low-hanging-fruit-left-as-he-discusses-apple-costco-vs-walmart-and-evs-105a3ff0,2023-10-31 10:04:00,"Our call of the day comes from a podcast interview with the legendary Charlie Munger, who discusses a range of investing topics.",AMGN,0.059268,-0.040454,Neutral
S&P 500 futures steady as lower Treasury yields support sentiment,https://www.marketwatch.com/story/s-p-500-futures-steady-as-lower-treasury-yields-support-sentiment-7e463e27,2023-10-31 07:49:00,"U.S. stock futures were mildly mixed early Tuesday, holding most of the previous day's rally as Treasury yields moved lower.",AMGN,0.195814,0.0,Neutral
"Cram Session: Week Ahead Packed with Earnings, Fed Meeting, Jobs Data as Markets Attempt Rebound - Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/markets/23/10/35497918/cram-session-week-ahead-packed-with-earnings-fed-meeting-jobs-data-as-markets-attempt-rebound,2023-10-30 18:25:25,"( Monday market open ) This week offers something for everyone as Wall Street licks its wounds after Friday's plunge to fresh five-month lows. Major indexes bounced in premarket trading early Monday, helped by technical buying and a drop in crude oil prices, but remain squarely in correction mode ...",AMGN,0.089378,0.024916,Neutral
"Drug, Biotech Stocks' Q3 Earnings Due on Oct 31: AMGN, PFE, INCY",https://www.zacks.com/stock/news/2174650/drug-biotech-stocks-q3-earnings-due-on-oct-31-amgn-pfe-incy,2023-10-30 15:37:00,"Let's take a look at three biotech/drug companies, AMGN, PFE and INCY, slated to release quarterly results on Oct 31.",AMGN,0.297061,0.089505,Neutral
AMGN: Amgen  ( AMGN )  Earnings Watch: Buy or Sell?,https://stocknews.com/news/amgn-gild-jazz-alks-amgen-amgn-earnings-watch-buy-or-sell/,2023-10-30 15:34:04,"Pharmaceutical major Amgen Inc. ( AMGN ) is scheduled to report its third-quarter earnings on October 31. In this piece, I have discussed why it could be wise to buy the stock now. Wall Street expects a year-over-year decline in earnings on higher revenues when AMGN reports results for the ...",AMGN,0.558244,0.259511,Somewhat-Bullish
Dow Jones Rises As Apple Climbs Ahead Of Earnings; GM Reportedly Settles With UAW,https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-apple-climbs-ahead-of-earnings-gm-settles-with-uaw/,2023-10-30 15:08:05,Dow Jones Rises As Apple Climbs Ahead Of Earnings. GM ... Investor's Business Daily ...,AMGN,0.158868,-0.073442,Neutral
"Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient",https://www.fool.com/investing/2023/10/30/gene-therapy-could-be-on-the-cusp-of-major-breakth/,2023-10-30 12:30:00,This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.,AMGN,0.051999,0.081572,Neutral
Futures Rise Ahead Of Fed Meeting; Apple Earnings Loom,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-fed-meeting-apple-earnings-jobs-report-loom/,2023-10-30 12:11:51,Futures Rise Ahead Of Fed Meeting. Apple Earnings Loom Investor's Business Daily ...,AMGN,0.070207,0.0,Neutral
"Beat the Market the Zacks Way: Novo Nordisk, Lifeway Foods, Casey's in Focus",https://www.zacks.com/stock/news/2174326/beat-the-market-the-zacks-way-novo-nordisk-lifeway-foods-caseys-in-focus,2023-10-30 11:52:00,Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.,AMGN,0.068112,0.060308,Neutral
2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now,https://www.fool.com/investing/2023/10/29/2-dow-jones-dividend-stocks-to-buy-hand-over-fist/,2023-10-29 10:30:00,These two defensive dividend stocks sport compelling valuations and attractive yields.,AMGN,0.38588,0.549143,Bullish
Five Dow Stocks Near Buy Points,https://www.investors.com/news/microsoft-leads-5-dow-jones-stocks-near-buy-points/,2023-10-28 15:43:00,Microsoft Leads These 5 Dow Jones Stocks Near Buy Points Investor's Business Daily ...,AMGN,0.258694,0.068822,Neutral
AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical  ( BMRN ) ,https://stocknews.com/news/amgn-vrtx-jazz-bmrn-3-biotech-stocks-beating-biomarin-pharmaceutical-bmrn/,2023-11-16 13:47:24,AMGN: 3 Biotech Stocks Beating BioMarin Pharmaceutical ...,AMGN,0.244245,0.246887,Somewhat-Bullish
The Difficult-To-Express Proteins Market Is Expected To Grow At A Rate Of More Than 11% Through 2023-2027 As Per The Business Research Company's Difficult-To-Express Proteins Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35755379/the-difficult-to-express-proteins-market-is-expected-to-grow-at-a-rate-of-more-than-11-through-202,2023-11-13 16:30:00,"LONDON, Nov. 13, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Difficult-To-Express Proteins Global Market Report 2023, the global difficult-to-express proteins market is set to experience significant growth, with a projected increase from $3.65 billion in 2022 to $4.11 ...",AMGN,0.065685,0.166065,Somewhat-Bullish
3 Top Dividend Stocks to Maximize Your Retirement Income,https://www.zacks.com/stock/news/2183228/3-top-dividend-stocks-to-maximize-your-retirement-income,2023-11-13 14:10:04,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.217346,0.118668,Neutral
IO Biotech Announces 2023 Third Quarter Results - IO Biotech  ( NASDAQ:IOBT ) ,https://www.benzinga.com/pressreleases/23/11/g35747830/io-biotech-announces-2023-third-quarter-results,2023-11-13 13:12:16,"Completed enrollment of 380 patients in pivotal Phase 3 trial of lead therapeutic cancer vaccine, IO102-IO103 in combination with KEYTRUDA® ( pembrolizumab ) , in patients with advanced melanoma",AMGN,0.025873,-0.00548,Neutral
IO Biotech Announces 2023 Third Quarter Results,https://www.globenewswire.com/news-release/2023/11/13/2779042/0/en/IO-Biotech-Announces-2023-Third-Quarter-Results.html,2023-11-13 13:12:00,"• Completed enrollment of 380 patients in pivotal Phase 3 trial of lead therapeutic cancer vaccine, IO102-IO103 in combination with KEYTRUDA® ( pembrolizumab ) , in patients with advanced melanoma • Presented encouraging preliminary data from Phase 2 basket trial of IO102-IO103 at the IASLC 2023 ...",AMGN,0.026299,0.042,Neutral
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/11/35728436/investigating-amgens-standing-in-biotechnology-industry-compared-to-competitors,2023-11-10 16:00:14,"In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating Amgen AMGN against its key competitors in the Biotechnology ...",AMGN,0.500995,0.238117,Somewhat-Bullish
2 Top Biotech Stocks to Buy Right Now,https://www.fool.com/investing/2023/11/10/2-top-biotech-stocks-to-buy-right-now/,2023-11-10 15:15:00,Don't give up on these stocks too fast.,AMGN,0.521812,0.388976,Bullish
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research,https://www.prnewswire.com/news-releases/oncology-drugs-market-worth-520-billion-by-2033---exclusive-report-by-we-market-research-301984776.html,2023-11-10 15:01:00,"CHICAGO, Nov. 10, 2023 /PRNewswire/ -- According to the latest findings from We Market Research, the oncology drug market is on track to achieve a value of USD 205 billion by the year 2023.",AMGN,0.040622,0.059987,Neutral
Is SPDR Portfolio S&P 500 High Dividend ETF  ( SPYD )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2182112/is-spdr-portfolio-sp-500-high-dividend-etf-spyd-a-strong-etf-right-now,2023-11-10 11:20:06,Smart Beta ETF report for ...,AMGN,0.115232,0.06109,Neutral
Dow Jones Dives As Powell Gives This Inflation Warning; Tesla Stock Gets Hammered,https://www.investors.com/market-trend/stock-market-today/dow-jones-dives-as-fed-chair-jerome-powell-gives-this-inflation-warning-tesla-stock-gets-hammered-apple-stock-microsoft-stock/,2023-11-09 20:23:00,Dow Jones Dives As Powell Gives This Inflation Warning. Tesla ... Investor's Business Daily ...,AMGN,0.12546,-0.241261,Somewhat-Bearish
Should First Trust Dow 30 Equal Weight ETF  ( EDOW )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2181404/should-first-trust-dow-30-equal-weight-etf-edow-be-on-your-investing-radar,2023-11-09 11:20:06,Style Box ETF report for ...,AMGN,0.130217,0.070327,Neutral
Amgen's Rare Autoimmune Disease Candidate Shows Improvement In Disease Burden In Treating Sjögren's Syndrome - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/11/35667804/amgens-rare-autoimmune-disease-candidate-shows-improvement-in-disease-burden-in-treating-sj-grens,2023-11-08 16:43:15,"Amgen Inc AMGN released new data from its Phase 2 study of dazodalibep for Sjögren's, a chronic ( long-lasting ) autoimmune disorder that happens when the immune system attacks the glands that make moisture in the eyes, mouth, and other parts of the body.",AMGN,0.2872,-0.149925,Neutral
Should You Invest in the Invesco Biotechnology & Genome ETF  ( PBE ) ?,https://www.zacks.com/stock/news/2180608/should-you-invest-in-the-invesco-biotechnology-genome-etf-pbe,2023-11-08 11:20:04,Sector ETF report for ...,AMGN,0.129168,0.070052,Neutral
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio,https://www.zacks.com/stock/news/2180122/why-this-1-momentum-stock-could-be-a-great-addition-to-your-portfolio,2023-11-07 14:50:08,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",AMGN,0.428632,0.195348,Somewhat-Bullish
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2179993/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-11-07 14:10:03,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.206245,0.113906,Neutral
Amgen  ( NASDAQ:AMGN )  Rating Lowered to Buy at StockNews.com,https://www.defenseworld.net/2023/11/25/amgen-nasdaqamgn-rating-lowered-to-buy-at-stocknews-com.html,2023-11-25 07:10:48,"Amgen ( NASDAQ:AMGN - Get Free Report ) was downgraded by stock analysts at StockNews.com from a ""strong-buy"" rating to a ""buy"" rating in a research note issued on Thursday.",AMGN,0.759392,0.383184,Bullish
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/11/35941406/investigating-amgens-standing-in-biotechnology-industry-compared-to-competitors,2023-11-24 16:00:16,"In today's rapidly changing and highly competitive business world, it is imperative for investors and industry observers to carefully assess companies before making investment choices. In this article, we will undertake a comprehensive industry comparison, evaluating Amgen AMGN vis-à-vis its key ...",AMGN,0.571381,0.327785,Somewhat-Bullish
Should Schwab U.S. Dividend Equity ETF  ( SCHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2188831/should-schwab-us-dividend-equity-etf-schd-be-on-your-investing-radar,2023-11-24 11:20:07,Style Box ETF report for ...,AMGN,0.120733,0.067941,Neutral
P/E Ratio Insights for Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/11/35919857/pe-ratio-insights-for-amgen,2023-11-22 16:15:12,"In the current session, Amgen Inc. AMGN is trading at $262.34, after a 0.18% drop. Over the past month, the stock decreased by 3.61%, and in the past year, by 7.54%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio.",AMGN,0.364275,-0.125831,Neutral
New ETF invested in Ozempic maker and exposed to other obesity drugs falls in first day of trade,https://www.marketwatch.com/story/new-etf-invested-in-ozempic-maker-and-exposed-to-other-obesity-drugs-falls-in-first-day-of-trade-a489a9b0,2023-11-22 13:01:00,The new Tema Cardiovascular and Metabolic ETF fell in its first day of trade. It is exposed to weight-loss drugs including Ozempic.,AMGN,0.690822,0.056772,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2186558/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-11-20 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.215415,0.119475,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2186419/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2023-11-20 11:20:07,Sector ETF report for ...,AMGN,0.135729,0.071814,Neutral
Amgen Inc.  ( AMGN )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2185899/amgen-inc-amgn-is-attracting-investor-attention-here-is-what-you-should-know,2023-11-17 14:00:05,"Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",AMGN,0.488469,0.083439,Neutral
The War In Alzheimer's Treatment Is Just Beginning,https://www.investors.com/news/technology/biotech-stocks-the-war-in-alzheimers-treatment-is-just-beginning-why-there-is-still-hope/,2023-11-17 13:15:00,Biotech Stocks: The Race For An Alzheimer's Cure Takes Off Investor's Business Daily ...,AMGN,0.05093,-0.09242,Neutral
Is First Trust Dow 30 Equal Weight ETF  ( EDOW )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2185775/is-first-trust-dow-30-equal-weight-etf-edow-a-strong-etf-right-now,2023-11-17 11:20:06,Smart Beta ETF report for ...,AMGN,0.11894,0.060738,Neutral
Amgen  ( AMGN )  Registers a Bigger Fall Than the Market: Important Facts to Note,https://www.zacks.com/stock/news/2194481/amgen-amgn-registers-a-bigger-fall-than-the-market-important-facts-to-note,2023-12-06 22:50:15,"In the latest trading session, Amgen (AMGN) closed at $269.35, marking a -0.56% move from the previous day.",AMGN,0.523451,0.107323,Neutral
P/E Ratio Insights for Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/12/36113823/pe-ratio-insights-for-amgen,2023-12-06 14:46:02,"In the current market session, Amgen Inc. AMGN price is at $271.31, after a 0.16% increase. However, over the past month, the stock decreased by 0.58%, and in the past year, by 4.86%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing ...",AMGN,0.433523,-0.005784,Neutral
"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... - PR Newswire",https://www.prnewswire.com/news-releases/fallopian-tube-cancer-therapeutics-market-size-to-grow-by-usd-832-01-million-from-2023-2028-abbvie-inc-amgen-inc-arrien-pharmaceuticals-llc-and-more-among-the-key-companies-in-the-market---technavio-302006567.html,2023-12-05 22:15:00,"Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen ... PR ...",AMGN,0.057628,-0.003,Neutral
3 Top Dividend Stocks to Maximize Your Retirement Income,https://www.zacks.com/stock/news/2192894/3-top-dividend-stocks-to-maximize-your-retirement-income,2023-12-04 14:10:04,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.21258,0.118241,Neutral
Pfizer  ( PFE )  Stock Down 5% as Obesity Drug Fails in Phase II,https://www.zacks.com/stock/news/2192689/pfizer-pfe-stock-down-5-as-obesity-drug-fails-in-phase-ii,2023-12-04 10:32:00,The failure of the phase IIb study on danuglipron is a significant blow to Pfizer's (PFE) efforts to take a share of the growing market of GLP-1 drugs for treating obesity.,AMGN,0.170475,0.109247,Neutral
This Diversified Portfolio Is Geared for Market-Beating Gains Over the Next 20 Years,https://www.fool.com/investing/2023/12/03/this-diversified-portfolio-is-geared-for-market-be/,2023-12-03 15:30:00,Modern portfolio theory is a helpful guide to choosing winning investments.,AMGN,0.096477,0.190224,Somewhat-Bullish
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd ... - PR Newswire,https://www.prnewswire.com/news-releases/laryngeal-cancer-therapeutics-market-size-to-grow-by-usd-575-25-million-from-2022-2027-accord-healthcare-ltd-amgen-inc-astrazeneca-plc-athenex-inc-and-more-among-the-major-companies-in-the-market--technavio-302002789.html,2023-12-01 22:35:00,Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd ... PR ...,AMGN,0.132368,-0.053456,Neutral
Why Is BioMarin  ( BMRN )  Up 14.3% Since Last Earnings Report?,https://www.zacks.com/stock/news/2192385/why-is-biomarin-bmrn-up-143-since-last-earnings-report,2023-12-01 16:31:56,BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AMGN,0.190417,0.053491,Neutral
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2191965/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2023-12-01 11:20:06,Smart Beta ETF report for ...,AMGN,0.122269,0.068311,Neutral
"Amgen Clears Technical Benchmark, Hitting 80-Plus RS Rating",https://www.investors.com/ibd-data-stories/amgen-clears-technical-benchmark-hitting-80-plus-rs-rating/,2023-12-01 08:00:00,"On Friday, Amgen ( AMGN ) earned a positive adjustment to its Relative Strength ( RS ) Rating, from 79 to 82. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",AMGN,0.762438,0.579129,Bullish
"Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for ... - PR Newswire",https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-613-9-million-from-2022-to-2027--growing-research-in-gene-therapy-for-cvds-and-orphan-diseases-is-the-major-market-trend--technavio-302002646.html,2023-12-01 07:35:00,"Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for ... PR ...",AMGN,0.048523,0.017903,Neutral
Looking Into Amgen's Recent Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/11/36028089/looking-into-amgens-recent-short-interest,2023-11-30 17:00:20,"Amgen's AMGN short percent of float has risen 5.83% since its last report. The company recently reported that it has 6.77 million shares sold short, which is 1.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.97 days to cover their ...",AMGN,0.224903,0.158881,Somewhat-Bullish
Amgen  ( AMGN )  Up 2.2% Since Last Earnings Report: Can It Continue?,https://www.zacks.com/stock/news/2191630/amgen-amgn-up-22-since-last-earnings-report-can-it-continue,2023-11-30 16:30:55,Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,AMGN,0.31482,0.253954,Somewhat-Bullish
"The Zacks Analyst Blog Highlights McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software",https://www.zacks.com/stock/news/2191553/the-zacks-analyst-blog-highlights-mcdonalds-amgen-nextera-energy-general-mills-and-take-two-interactive-software,2023-11-30 15:16:00,"McDonald's, Amgen, NextEra Energy, General Mills and Take-Two Interactive Software are included in this Analyst Blog.",AMGN,0.364987,0.227421,Somewhat-Bullish
"Amazon  ( AMZN )  Teams Up With Amgen, Expands Customer Base",https://www.zacks.com/stock/news/2191357/amazon-amzn-teams-up-with-amgen-expands-customer-base,2023-11-30 13:44:00,Amazon's (AMZN) AWS gets selected by Amgen. This highlights the efficiency and reliability of AWS' innovative cloud products and services.,AMGN,0.296582,0.214205,Somewhat-Bullish
"Top Stock Reports for McDonald's, Amgen & NextEra Energy",https://www.zacks.com/research-daily/2190730/top-stock-reports-for-mcdonalds-amgen-nextera-energy,2023-11-29 19:52:00,"Today's Research Daily features new research reports on 16 major stocks, including McDonald's Corporation (MCD), Amgen Inc. (AMGN) and NextEra Energy, Inc. (NEE).",AMGN,0.213048,0.25453,Somewhat-Bullish
Is Trending Stock Amgen Inc.  ( AMGN )  a Buy Now?,https://www.zacks.com/stock/news/2190248/is-trending-stock-amgen-inc-amgn-a-buy-now,2023-11-28 14:00:05,"Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",AMGN,0.488469,0.123059,Neutral
1 Spectacular Dividend Stock Every Investor Should Consider,https://www.fool.com/investing/2023/11/28/1-spectacular-dividend-stock-every-investor-should/,2023-11-28 14:00:00,This biotech pioneer has been an exceptional growth and income stock.,AMGN,0.405651,0.406091,Bullish
"This Stock Hasn't Split Since 1999 - $1,000 Invested Then Would Be Worth A Boatload Today",https://www.benzinga.com/general/23/11/35977573/this-stock-hasnt-split-since-1999-1-000-invested-then-would-be-worth-a-boatload-today,2023-11-28 13:36:17,"When investing in the stock market, a history of strong returns should be high on your priority list. Combine this with a positive outlook on the future, and you may have a winner to add to your portfolio. Amgen Inc., an American multinational biopharmaceutical company, fits this mold.",AMGN,0.112008,0.068225,Neutral
Should You Invest in the Invesco Pharmaceuticals ETF  ( PJP ) ?,https://www.zacks.com/stock/news/2190100/should-you-invest-in-the-invesco-pharmaceuticals-etf-pjp,2023-11-28 11:20:06,Sector ETF report for ...,AMGN,0.129866,0.063182,Neutral
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2189650/improve-your-retirement-income-with-these-3-top-ranked-dividend-stocks,2023-11-27 14:10:03,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.216376,0.119894,Neutral
Market Whales and Their Recent Bets on AMGN Options - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/12/36241553/market-whales-and-their-recent-bets-on-amgn-options,2023-12-14 16:46:01,"Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen AMGN revealed 13 unusual trades. Delving into the details, we found 15% of traders were bullish, while 84% showed bearish tendencies.",AMGN,0.712214,-0.077029,Neutral
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2197926/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-12-14 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.211191,0.117636,Neutral
Amgen's  ( AMGN )  Tarlatamab BLA Gets FDA Priority Tag for SCLC,https://www.zacks.com/stock/news/2197836/amgens-amgn-tarlatamab-bla-gets-fda-priority-tag-for-sclc,2023-12-14 13:24:00,"Amgen's (AMGN) BLA for tarlatamab to treat advanced small cell lung cancer gets FDA's priority review. A decision is expected on Jun 12, 2024.",AMGN,0.324495,0.088958,Neutral
Vertex  ( VRTX )  Soars 13.2%: Is Further Upside Left in the Stock?,https://www.zacks.com/stock/news/2197712/vertex-vrtx-soars-132-is-further-upside-left-in-the-stock,2023-12-14 11:12:00,Vertex (VRTX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.,AMGN,0.358152,0.0,Neutral
1 Biotech Stock That Could Be the Next Amgen,https://www.fool.com/investing/2023/12/13/1-biotech-stock-that-could-be-the-next-amgen/,2023-12-13 15:15:00,The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.,AMGN,0.358669,0.261825,Somewhat-Bullish
Amgen  ( NASDAQ:AMGN )  Upgraded to Strong-Buy by StockNews.com,https://www.defenseworld.net/2023/12/13/amgen-nasdaqamgn-upgraded-to-strong-buy-by-stocknews-com.html,2023-12-13 07:42:51,StockNews.com upgraded shares of Amgen ( NASDAQ:AMGN - Free Report ) from a buy rating to a strong-buy rating in a report released on Tuesday morning. Several other equities analysts have also commented on the company. Barclays increased their target price on Amgen from $210.00 to $230.00 in a ...,AMGN,0.126119,0.12312,Neutral
Amgen  ( AMGN )  Outpaces Stock Market Gains: What You Should Know,https://www.zacks.com/stock/news/2197055/amgen-amgn-outpaces-stock-market-gains-what-you-should-know,2023-12-12 22:50:14,"Amgen (AMGN) reachead $273.99 at the closing of the latest trading day, reflecting a +0.68% change compared to its last close.",AMGN,0.472338,0.339581,Somewhat-Bullish
Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics?,https://www.fool.com/investing/2023/12/12/better-growth-stock-viking-therapeutics-or-iovance/,2023-12-12 13:45:00,Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.,AMGN,0.060388,0.17028,Somewhat-Bullish
"PVH To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday - Airbnb  ( NASDAQ:ABNB ) , Achieve Life Sciences  ( NASDAQ:ACHV ) ",https://www.benzinga.com/news/23/12/36194642/pvh-to-rally-around-11-here-are-10-top-analyst-forecasts-for-tuesday,2023-12-12 13:00:33,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised Velocity Financial, Inc. VEL price target from $14 to $17. BTIG analyst Sarah Barcomb ...",AMGN,0.247838,0.462995,Bullish
Sanofi drops rare disease drug purchase after FTC files suit,https://www.financialexpress.com/healthcare/pharma-healthcare/sanofi-drops-rare-disease-drug-purchase-after-ftc-files-suit/3336644/,2023-12-12 11:17:33,"Sanofi SA said Monday it was canceling plans to license Maze Therapeutics Inc.'s treatment for a rare genetic disorder after the Federal Trade Commission sued to block the deal. The French drugmaker said it was disappointed with the FTC's actions, which it said would hold up bringing Maze's drug ...",AMGN,0.112008,-0.103951,Neutral
Insights Into Amgen's Performance Versus Peers In Biotechnology Sector - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/12/36179137/insights-into-amgens-performance-versus-peers-in-biotechnology-sector,2023-12-11 16:00:37,"In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Amgen AMGN in comparison to its major competitors within the Biotechnology ...",AMGN,0.480056,0.093233,Neutral
Here's Why Amgen  ( AMGN )  is a Strong Value Stock,https://www.zacks.com/stock/news/2196159/heres-why-amgen-amgn-is-a-strong-value-stock,2023-12-11 14:40:06,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",AMGN,0.400265,0.236939,Somewhat-Bullish
Here is What to Know Beyond Why Amgen Inc.  ( AMGN )  is a Trending Stock,https://www.zacks.com/stock/news/2196075/here-is-what-to-know-beyond-why-amgen-inc-amgn-is-a-trending-stock,2023-12-11 14:00:07,"Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",AMGN,0.48028,0.145514,Neutral
"Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights",https://www.prnewswire.com/news-releases/red-biotechnology-market-to-reach-1-513-22-billion-globally-by-2030-at-10-7-cagr-coherent-market-insights-302009313.html,2023-12-08 07:14:00,"BURLINGAME, Calif., Dec. 8, 2023 /PRNewswire/ -- According to Coherent Market Insights, The global red biotechnology market was valued at US$ 742.80 Billion in 2023 and is forecast to reach a value of US$ 1,513.22 Billion by 2030 at a CAGR of 10.7% between 2023 and 2030.",AMGN,0.028833,0.001897,Neutral
"Santa Claus Rally In Gear For Dow, Other Indexes; Tesla Eyes New Record To Wrap Up The Year",https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-after-economic-data-tesla-eyes-new-record/,2023-12-26 16:06:00,Dow Jones Gains After Economic Data. Tesla Eyes New Record Investor's Business Daily ...,AMGN,0.112269,0.124747,Neutral
Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/23/12/36385381/full-approval-for-amgens-flagship-cancer-drug-lumakras-pushed-for-around-four-years,2023-12-26 15:45:56,"Amgen Inc AMGN announced that the FDA has reviewed the company's supplemental New Drug Application, seeking full approval of the KRAS-blocking drug Lumakras ( sotorasib ) . In October, the FDA advisers voted 10-2, expressing doubts about relying on the primary goal of the late-stage ...",AMGN,0.524949,0.07983,Neutral
How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks,https://www.zacks.com/stock/news/2202153/how-to-maximize-your-retirement-portfolio-with-these-top-ranked-dividend-stocks,2023-12-26 14:10:03,"The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?",AMGN,0.214937,0.119267,Neutral
Futures Rise Ahead Of Key Economic Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-ahead-of-economic-data-google-stock-leads-eight-stocks-to-buy-and-watch/,2023-12-26 13:23:00,Dow Jones Futures Rise Ahead Of Economic Data. Google Leads 8 Stocks To Buy And Watch Investor's Business Daily ...,AMGN,0.154951,0.103117,Neutral
Analyzing Amgen In Comparison To Competitors In Biotechnology Industry - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/23/12/36379308/analyzing-amgen-in-comparison-to-competitors-in-biotechnology-industry,2023-12-25 16:00:35,"In the fast-paced and cutthroat world of business, conducting thorough company analysis is essential for investors and industry experts. In this article, we will undertake a comprehensive industry comparison, evaluating Amgen AMGN in comparison to its major competitors within the Biotechnology ...",AMGN,0.492659,0.123018,Neutral
"Biotech stocks set for a rebound in 2024, analysts say",https://www.marketwatch.com/story/biotech-stocks-set-for-a-rebound-in-2024-analysts-say-24df6236,2023-12-22 16:06:00,"A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting up biotech for a brighter 2024, analysts say.",AMGN,0.17715,0.070894,Neutral
Dow Jones Rallies 100 Points Despite Nike Carnage; Warren Buffett News Lifts This Oil Giant,https://www.investors.com/market-trend/stock-market-today/dow-jones-holds-up-well-despite-nike-carnage-occidental-petroleum-jumps-warren-buffett-news/,2023-12-22 15:52:00,Dow Jones Rallies 100 Points Despite Nike Carnage. Warren Buffett News Lifts This Oil Giant Investor's Business Daily ...,AMGN,0.168884,0.070989,Neutral
Investors Heavily Search Amgen Inc.  ( AMGN ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2201494/investors-heavily-search-amgen-inc-amgn-here-is-what-you-need-to-know,2023-12-22 14:00:06,"Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",AMGN,0.483888,0.119284,Neutral
Spotlight on Amgen: Analyzing the Surge in Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/12/36350619/spotlight-on-amgen-analyzing-the-surge-in-options-activity,2023-12-21 19:31:37,"Investors with a lot of money to spend have taken a bullish stance on Amgen AMGN. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",AMGN,0.653008,0.186475,Somewhat-Bullish
Is Invesco Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2200881/is-invesco-pharmaceuticals-etf-pjp-a-strong-etf-right-now,2023-12-21 11:20:06,Smart Beta ETF report for ...,AMGN,0.116631,0.055779,Neutral
Looking Into Amgen's Recent Short Interest - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/23/12/36331858/looking-into-amgens-recent-short-interest,2023-12-20 19:00:23,"Amgen's AMGN short percent of float has risen 19.69% since its last report. The company recently reported that it has 8.10 million shares sold short, which is 1.52% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.96 days to cover their ...",AMGN,0.224903,0.158881,Somewhat-Bullish
Five obesity-drug trends to watch in 2024: Who can compete with Eli Lilly and Novo Nordisk?,https://www.marketwatch.com/story/five-obesity-drug-trends-to-watch-in-2024-who-can-compete-with-eli-lilly-and-novo-nordisk-1dc62a7d,2023-12-20 16:17:00,"The obesity drugs that powered huge investor gains in 2023 are poised to inspire more corporate dealmaking, scientific breakthroughs and better patient access in the year ahead, analysts say.",AMGN,0.043778,0.200504,Somewhat-Bullish
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income,https://www.zacks.com/stock/news/2200487/3-top-ranked-dividend-stocks-a-smarter-way-to-boost-your-retirement-income,2023-12-20 14:10:02,"The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.",AMGN,0.207571,0.116065,Neutral
Can Dogs of the Dow ETFs Snap Losing Trend in 2024?,https://www.zacks.com/stock/news/2200407/can-dogs-of-the-dow-etfs-snap-losing-trend-in-2024,2023-12-20 12:27:00,"The Dogs of the Dow underperformed the broader market in 2023. However, with the Fed likely to cut rates in 2024, can these dividend dogs roar next year?",AMGN,0.147818,0.0,Neutral
"Amgen Provides Exposure To Obesity Drug At A Reasonable Price, Says Bullish Analyst - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36310979/amgen-provides-exposure-to-obesity-drug-at-a-reasonable-price-says-bullish-analyst,2023-12-19 19:42:29,"Amgen, Inc. AMGN shares have been in focus amid developments in the AI-powered healthcare space. The company's oral and injectable metabolic pipeline gives investors exposure to the obesity metabolic space at a much lower premium than peers, according to BMO Capital Markets.",AMGN,0.928849,0.338288,Somewhat-Bullish
"Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday - Cara Therapeutics  ( NASDAQ:CARA ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/news/23/12/36300674/uber-to-rally-over-13-here-are-10-top-analyst-forecasts-for-tuesday,2023-12-19 12:30:23,"Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler boosted Itron, Inc. ITRI price target from $72 to $91.",AMGN,0.236588,0.354882,Bullish
Amgen  ( AMGN )  Advances But Underperforms Market: Key Facts,https://www.zacks.com/stock/news/2199629/amgen-amgn-advances-but-underperforms-market-key-facts,2023-12-18 22:50:20,"Amgen (AMGN) reachead $275.48 at the closing of the latest trading day, reflecting a +0.01% change compared to its last close.",AMGN,0.587962,0.31776,Somewhat-Bullish
Is Amgen Stock a Buy Now?,https://www.fool.com/investing/2023/12/17/is-amgen-stock-a-buy-now/,2023-12-17 14:00:00,"Boring businesses can be successful, too.",AMGN,0.539641,0.261984,Somewhat-Bullish
Amgen  ( AMGN )  Stock Sinks As Market Gains: What You Should Know,https://www.zacks.com/stock/news/2206572/amgen-amgn-stock-sinks-as-market-gains-what-you-should-know,2024-01-05 22:50:19,"In the closing of the recent trading day, Amgen (AMGN) stood at $303, denoting a -0.06% change from the preceding trading day.",AMGN,0.700945,0.383645,Bullish
"JPMorgan Healthcare, CES Show, Bank Earnings, Inflation Data",https://www.investors.com/research/investing-action-plan/jpmorgan-healthcare-ces-show-bank-earnings-inflation-data-investing-action-plan/,2024-01-05 22:29:00,"The big benchmarks launched the New Year by posting their first weekly slip since October. The Dow trimmed less than 1% while the Nasdaq lopped off 3%. Chips faltered, but solar stocks and auto retailers were the hardest hit industries. Big Pharma names had a good week, as Merck ( MRK ) led the ...",AMGN,0.082535,0.133922,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/24/01/36516275/looking-at-amgens-recent-unusual-options-activity,2024-01-05 19:46:09,"Whales with a lot of money to spend have taken a noticeably bearish stance on Amgen. Looking at options history for Amgen AMGN we detected 20 trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% with ...",AMGN,0.738815,0.089758,Neutral
IBD Stock Of The Day: The Buying Opportunity In Weight Loss,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-lingers-in-a-buy-zone-after-snagging-two-obesity-deals/,2024-01-05 18:01:00,Novo Nordisk Stock Lingers In Buy Zone After Snagging Two Obesity Deals Investor's Business Daily ...,AMGN,0.120431,0.032569,Neutral
It's Been An Abysmal Two Years. But Biotech Is Looking Up.,https://www.investors.com/news/technology/biotech-stocks-pharma-heat-up-in-2024-as-buyouts-obesity-ai-drive-excitement/,2024-01-05 14:00:00,"Biotech Stocks, Pharma Heat Up In 2024 As Buyouts, Obesity And AI Drive Excitement Investor's Business Daily ...",AMGN,0.02379,0.0,Neutral
Futures Fall Ahead Of Imminent Jobs Report,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobs-report-ai-leader-palantir-dives-on-downgrade/,2024-01-05 13:15:00,"Stocks jeopardized their weekly winning streak Friday as Dow Jones futures and other major indexes fell Friday morning ahead of the Labor Department's pivotal December jobs report. Meanwhile, artificial intelligence leader Palantir Technologies ( AI ) tumbled on a PLTR stock analyst's downgrade.",AMGN,0.135538,0.182724,Somewhat-Bullish
Why the Market Dipped But Amgen  ( AMGN )  Gained Today,https://www.zacks.com/stock/news/2205955/why-the-market-dipped-but-amgen-amgn-gained-today,2024-01-04 23:00:18,"Amgen (AMGN) reachead $303.17 at the closing of the latest trading day, reflecting a +0.82% change compared to its last close.",AMGN,0.571903,0.276725,Somewhat-Bullish
Here's How Much a $1000 Investment in Amgen Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2205532/heres-how-much-a-1000-investment-in-amgen-made-10-years-ago-would-be-worth-today,2024-01-04 13:30:05,Holding on to popular or trending stocks for the long-term can make your portfolio a winner.,AMGN,0.668028,0.318064,Somewhat-Bullish
Antibody Therapeutics Market is Expected to Reach $479.0 Billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/24/01/g36487416/antibody-therapeutics-market-is-expected-to-reach-479-0-billion-marketsandmarkets,2024-01-04 12:30:00,"Chicago, Jan. 04, 2024 ( GLOBE NEWSWIRE ) -- Antibody Therapeutics market in terms of revenue was estimated to be worth $247.3 Billion in 2023 and is poised to reach $479.0 billion by 2028, growing at a CAGR of 14.1% from 2023 to 2028 according to a latest report published by MarketsandMarkets™.",AMGN,0.079392,0.0,Neutral
Amgen Inc.  ( AMGN )  Is a Trending Stock: Facts to Know Before Betting on It,https://www.zacks.com/stock/news/2204932/amgen-inc-amgn-is-a-trending-stock-facts-to-know-before-betting-on-it,2024-01-03 14:00:06,"Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",AMGN,0.487546,0.14691,Neutral
Futures Fall Ahead Of Fed Minutes,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-fed-minutes-coindesk-nvidia-tesla-slide/,2024-01-03 13:11:00,"Dow Jones futures dropped Wednesday morning ahead of minutes from the Federal Reserve's latest policy meeting. Meanwhile, market leaders Coindesk ( COIN ) and Nvidia ( NVDA ) , along with Tesla stock, fell sharply in early morning trading.",AMGN,0.172404,0.127417,Neutral
Is Invesco Biotechnology & Genome ETF  ( PBE )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2204768/is-invesco-biotechnology-genome-etf-pbe-a-strong-etf-right-now,2024-01-03 11:20:07,Smart Beta ETF report for ...,AMGN,0.116631,0.066983,Neutral
Should SPDR Portfolio S&P 500 High Dividend ETF  ( SPYD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2204769/should-spdr-portfolio-sp-500-high-dividend-etf-spyd-be-on-your-investing-radar,2024-01-03 11:20:06,Style Box ETF report for ...,AMGN,0.122894,0.068464,Neutral
Futures Fall As Apple Slides On Downgrade,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-apple-stock-slides-on-downgrade-tesla-deliveries/,2024-01-02 13:21:00,Dow Jones Futures Fall 200 Points As Apple Slides On Downgrade. Tesla Deliveries Imminent Investor's Business Daily ...,AMGN,0.154703,0.07912,Neutral
"3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar",https://www.fool.com/investing/2024/01/01/3-top-etfs-im-planning-to-buy-hand-over-fist-in-20/,2024-01-01 11:17:00,I'm adding some ETFs to my retirement portfolio in 2024. here are the three I'm starting with.,AMGN,0.114682,0.006707,Neutral
Amgen  ( AMGN )  Stock Moves -0.15%: What You Should Know,https://www.zacks.com/stock/news/2203905/amgen-amgn-stock-moves--015-what-you-should-know,2023-12-29 22:50:20,"The latest trading day saw Amgen (AMGN) settling at $288.02, representing a -0.15% change from its previous close.",AMGN,0.588876,0.182616,Somewhat-Bullish
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024,https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/,2023-12-29 15:00:00,"There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.",AMGN,0.144853,0.05482,Neutral
Futures Dip Ahead Of Final Session Of 2023,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-final-trading-session-of-2023-nvidia-rises-on-new-chip-for-china/,2023-12-29 13:18:00,Dow Jones futures took a dip along with other major indexes Friday morning as investors headed into the final trading session of 2023. But Nvidia battled the market tide and climbed after launching a gaming chip for China that will comply with U.S. export restrictions.,AMGN,0.182851,0.068266,Neutral
Amgen Sees Relative Strength Rating Improve To 74,https://www.investors.com/ibd-data-stories/amgen-sees-relative-strength-rating-improve-to-74/,2023-12-29 08:00:00,"Amgen ( AMGN ) saw a positive improvement to its Relative Strength ( RS ) Rating on Friday, with an upgrade from 69 to 74. X When you're researching the best stocks to buy and watch, keep a close on eye on relative price strength.",AMGN,0.654522,0.026115,Neutral
S&P 500 Near Record High As These 3 Dow Stocks Test Buy Points,https://www.investors.com/market-trend/stock-market-today/stock-market-sp-500-near-record-high-as-these-3-dow-components-test-buy-points/,2023-12-28 20:08:00,"The S&P 500 climbed within inches of a record high Thursday afternoon, as the stock market rose moderately but small caps broke a trend of outperformance. The S&P 500 climbed 0.2% to 4,791, leaving the index within 27 points of its prior record high 4,818, reached nearly two years ago.",AMGN,0.126119,-0.123681,Neutral
Amgen's Options: A Look at What the Big Money is Thinking - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/23/12/36415244/amgens-options-a-look-at-what-the-big-money-is-thinking,2023-12-28 17:46:15,"Investors with a lot of money to spend have taken a bullish stance on Amgen AMGN. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",AMGN,0.666827,0.188316,Somewhat-Bullish
Stock Market Rally Continues; Dow Jones Hits Another Record High,https://www.investors.com/market-trend/stock-market-today/stock-market-keeps-continues-dow-jones-hits-another-record-high/,2023-12-28 15:49:00,Stock Market Rally Continues. Dow Jones Hits Another Record High Investor's Business Daily ...,AMGN,0.142565,-0.144126,Neutral
"Biotech Stock Roundup: BMY's KRTX and RYZB Acquisition, CYTK Surges on Study Data",https://www.zacks.com/stock/news/2203052/biotech-stock-roundup-bmys-krtx-and-ryzb-acquisition-cytk-surges-on-study-data,2023-12-28 13:39:00,"Bristol Myers (BMY) and Cytokinetics (CYTK) are in the news on acquisition announcements and study updates, respectively.",AMGN,0.169676,0.100268,Neutral
Futures Mixed Ahead Of Jobless Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fall-ahead-of-jobless-claims-cathie-wood-shakes-up-bitcoin-positions/,2023-12-28 13:16:00,Dow Jones Futures Fall Ahead Of Jobless Claims. Cathie Wood Shakes Up Bitcoin Positions Investor's Business Daily ...,AMGN,0.168197,0.140152,Neutral
Amgen  ( AMGN )  Surpasses Market Returns: Some Facts Worth Knowing,https://www.zacks.com/stock/news/2202891/amgen-amgn-surpasses-market-returns-some-facts-worth-knowing,2023-12-27 23:00:19,"In the latest trading session, Amgen (AMGN) closed at $286.53, marking a +0.93% move from the previous day.",AMGN,0.531019,0.320673,Somewhat-Bullish
FDA Rejects Amgen's  ( AMGN )  NDA Seeking Full Nod for Lumakras,https://www.zacks.com/stock/news/2202718/fda-rejects-amgens-amgn-nda-seeking-full-nod-for-lumakras,2023-12-27 16:09:00,"Per the FDA, Amgen (AMGN) will need to complete an additional confirmatory study on Lumakras in certain lung cancer patients before February 2028 to secure full approval.",AMGN,0.389889,0.09105,Neutral
"Futures Dip After Nasdaq, S&P 500 Hit New Highs",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fed-manufacturing-data-tesla-stock-retakes-buy-point/,2023-12-27 13:11:00,Dow Jones Futures Dip Ahead Of Fed Data. Tesla Stock Retakes Buy Point Investor's Business Daily ...,AMGN,0.17879,0.118582,Neutral
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,https://www.zacks.com/stock/news/2210202/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick,2024-01-15 14:50:07,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",AMGN,0.556576,0.257667,Somewhat-Bullish
Amgen Inc.  ( AMGN )  is Attracting Investor Attention: Here is What You Should Know,https://www.zacks.com/stock/news/2210094/amgen-inc-amgn-is-attracting-investor-attention-here-is-what-you-should-know,2024-01-15 14:00:06,"Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",AMGN,0.486627,0.143592,Neutral
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond,https://www.fool.com/investing/2024/01/15/5-biotech-stocks-that-could-be-big-winners-in-2024/,2024-01-15 11:30:00,These five biotech companies could have a lot of room to run.,AMGN,0.143415,0.169678,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca",https://www.zacks.com/stock/news/2209905/the-zacks-analyst-blog-highlights-eli-lilly-novo-nordisk-amgen-and-astrazeneca,2024-01-15 10:50:00,"Eli Lilly, Novo Nordisk, Amgen and AstraZeneca are included in this Analyst Blog.",AMGN,0.261117,0.040358,Neutral
Why Vera Therapeutics Stock Soared by 22% This Week,https://www.fool.com/investing/2024/01/12/why-vera-therapeutics-stock-soared-by-22-this-week/,2024-01-12 23:44:15,Executive changes and a bullish analyst take combined to boost sentiment on the company.,AMGN,0.146916,-0.059967,Neutral
Futures Lower Ahead Of Key Inflation Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-inflation-data-tesla-stock-dives-despite-cathie-wood-buys/,2024-01-12 13:17:00,Dow Jones Futures Drop Ahead Of Inflation Data. Tesla Stock Dives Despite Cathie Wood Buys Investor's Business Daily ...,AMGN,0.180056,0.125872,Neutral
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts,https://www.zacks.com/stock/news/2209351/fda-finds-no-link-between-obesity-drugs-and-suicidal-thoughts,2024-01-12 12:47:00,The GLP-1 segment is an important class of drugs for multiple cardiometabolic diseases and is gaining significant popularity.,AMGN,0.227007,0.056869,Neutral
"Ozempic not linked to suicidal thoughts, FDA report finds",https://www.financialexpress.com/healthcare/pharma-healthcare/ozempic-not-linked-to-suicidal-thoughts-fda-report-finds/3363168/,2024-01-12 11:12:49,"US regulators found no link between weight-loss drugs like Novo Nordisk A/S's Ozempic and suicidal thoughts, a positive sign for the popular medications as similar reviews in Europe remain ongoing.",AMGN,0.121037,0.025567,Neutral
Amgen  ( AMGN )  Suffers a Larger Drop Than the General Market: Key Insights,https://www.zacks.com/stock/news/2209160/amgen-amgn-suffers-a-larger-drop-than-the-general-market-key-insights,2024-01-11 22:50:22,"Amgen (AMGN) reachead $303.10 at the closing of the latest trading day, reflecting a -0.48% change compared to its last close.",AMGN,0.699089,0.363878,Bullish
Al Gore is officially too old to serve on Apple's board | Business,https://www.cnn.com/2024/01/11/tech/al-gore-is-officially-too-old-for-apple/index.html,2024-01-11 22:33:00,Al Gore is officially too old to serve on Apple's board ...,AMGN,0.151539,0.059806,Neutral
"Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance - Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/general/biotech/24/01/36594746/large-drugmakers-show-enthusiasm-to-embrace-100b-obesity-market-despite-novo-and-lillys-dominance,2024-01-11 16:40:37,"Pharmaceutical companies, including Amgen Inc AMGN and Pfizer Inc PFE, are strategically positioning themselves to tap into the burgeoning obesity market. The pursuit involves developing innovative drugs or engaging in strategic acquisitions to compete with established players such as Novo ...",AMGN,0.531326,0.077283,Neutral
Xeris  ( XERS )  Up on Licensing Deal With Amgen to Develop Tepezza,https://www.zacks.com/stock/news/2208740/xeris-xers-up-on-licensing-deal-with-amgen-to-develop-tepezza,2024-01-11 13:30:00,"Xeris (XERS) gains 16% after signing a licensing deal with Amgen, which allows the latter to utilize the XeriJect technology to develop a subcutaneous formulation of teprotumumab in Thyroid Eye Disease.",AMGN,0.377142,0.350647,Bullish
Futures Rise Ahead Of Imminent CPI Inflation Report,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-cpi-inflation-report-nvidia-stock-set-to-hit-record-high/,2024-01-11 13:22:00,"Dow Jones futures were slightly higher in premarket trades Thursday, as Wall Street braced for a critical inflation report from the Labor Department. Among individual stocks, Nvidia stock rallied and set to hit another record high, while crypto stock Coinbase ( COIN ) jumped on SEC approval for ...",AMGN,0.206509,0.139379,Neutral
How Is The Market Feeling About Amgen? - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/short-sellers/24/01/36582492/how-is-the-market-feeling-about-amgen,2024-01-10 19:30:22,"Amgen's AMGN short percent of float has risen 11.84% since its last report. The company recently reported that it has 9.06 million shares sold short, which is 1.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.11 days to cover their ...",AMGN,0.224903,0.158881,Somewhat-Bullish
Futures Mixed As CPI Inflation Data Looms,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-goldman-sachs-downgraded-bitcoin-stock-coinbase-slides/,2024-01-10 13:14:00,Dow Jones Futures Fall As Goldman Sachs Downgraded. Bitcoin Stock Coinbase Slides Investor's Business Daily ...,AMGN,0.172342,0.120675,Neutral
"Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference - Amgen  ( NASDAQ:AMGN ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/news/24/01/36572344/is-ai-more-valuable-in-advertising-than-healthcare-jim-cramer-questions-wall-streets-preference,2024-01-10 11:02:56,"In a recent revelation, CNBC's Mad Money host Jim Cramer disclosed that the financial market values artificial intelligence ( AI ) technology more for advertising than for healthcare. What Happened: Cramer shared his insights while attending JPMorgan's healthcare conference, reported CNBC on ...",AMGN,0.213048,0.175148,Somewhat-Bullish
"Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030 - Ambrx Biopharma  ( NASDAQ:AMAM ) , Amgen  ( NASDAQ:AMGN ) ",https://www.benzinga.com/pressreleases/24/01/g36558906/global-oncology-cancer-drugs-market-revenue-projected-to-surpass-289-billion-by-2030,2024-01-09 15:25:00,"PALM BEACH, Fla., Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- FN Media Group News Commentary - According to the report titled ""Aging in the United States,"" published by the Population Reference Bureau, ""the number of Americans aged 65 and older is projected to increase more than double over 95 million ...",AMGN,0.097141,-0.069713,Neutral
Looking At Amgen's Recent Unusual Options Activity - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/24/01/36558676/looking-at-amgens-recent-unusual-options-activity,2024-01-09 15:16:23,"Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen AMGN revealed 35 unusual trades. Delving into the details, we found 37% of traders were bullish, while 62% showed bearish tendencies.",AMGN,0.742397,0.078821,Neutral
Futures Lower As Netflix Slides On Downgrade,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-netflix-slides-on-downgrade-nvidia-set-to-hit-more-record-highs/,2024-01-09 13:12:00,Dow Jones Futures Fall As Netflix Slides On Downgrade. Nvidia To Hit More Record Highs Investor's Business Daily ...,AMGN,0.17741,0.125977,Neutral
Futures: Magnificent Seven Stocks Lead Market Rally,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-magnificent-seven-stocks-rally-nvidia-breaks-out-past-buy-point/,2024-01-08 21:55:00,Dow Jones Futures: Magnificent Seven Stocks Rally. Nvidia Breaks Out Past Buy Point Investor's Business Daily ...,AMGN,0.153226,0.123387,Neutral
"Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships",https://www.marketwatch.com/story/nvidia-dives-deeper-into-ai-drug-development-with-amgen-recursion-partnerships-de481c8b,2024-01-08 18:00:00,"Nvidia is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships with Amgen and Recursion Pharmaceuticals.",AMGN,0.26042,0.185456,Somewhat-Bullish
Investigating Amgen's Standing In Biotechnology Industry Compared To Competitors - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/news/24/01/36537225/investigating-amgens-standing-in-biotechnology-industry-compared-to-competitors,2024-01-08 16:00:38,"Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct comprehensive company evaluations. In this article, we will delve into an extensive industry comparison, evaluating Amgen AMGN in comparison to its major ...",AMGN,0.480056,0.175875,Somewhat-Bullish
Futures Mixed As Boeing Dives On Groundings,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-boeing-dives-on-groundings-coinbase-rallies-on-price-target-hike/,2024-01-08 13:09:00,Dow Jones Futures Fall As Boeing Dives On Groundings. Coinbase Rallies On Price Hike Investor's Business Daily ...,AMGN,0.141935,0.054607,Neutral
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference - SpringWorks Therapeutics  ( NASDAQ:SWTX ) ,https://www.benzinga.com/pressreleases/24/01/g36529625/springworks-therapeutics-highlights-2023-accomplishments-and-anticipated-milestones-for-2024-at-th,2024-01-08 11:30:44,"STAMFORD, Conn., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- SpringWorks Therapeutics, Inc. SWTX, a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, will present today at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT ( 10:30 a.m.",AMGN,0.017394,0.003569,Neutral
SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference,https://www.globenewswire.com/news-release/2024/01/08/2805220/0/en/SpringWorks-Therapeutics-Highlights-2023-Accomplishments-and-Anticipated-Milestones-for-2024-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html,2024-01-08 11:30:00,"STAMFORD, Conn., Jan. 08, 2024 ( GLOBE NEWSWIRE ) -- SpringWorks Therapeutics, Inc. ( Nasdaq: SWTX ) , a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, will present today at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30 a.m. PT ( 10:30 a.m.",AMGN,0.017769,0.053152,Neutral
Dogs Of The Dow 2024: 10 Blue-Chip Dividend Payers,https://www.forbes.com/sites/brettowens/2024/01/07/dogs-of-the-dow-2024-10-blue-chip-dividend-payers/,2024-01-07 12:15:00,"The 2024 Dogs of the Dow are particularly homely hounds-which means we're talking big dividends. This year's Dogs yield more than three-times the broader market's paltry payout. So, should we hold our noses and buy? Let's grab some peanut butter treats and investigate.",AMGN,0.096361,0.107227,Neutral
Amgen  ( AMGN )  Outperforms Broader Market: What You Need to Know,https://www.zacks.com/stock/news/2216157/amgen-amgn-outperforms-broader-market-what-you-need-to-know,2024-01-25 22:50:16,"In the latest trading session, Amgen (AMGN) closed at $310.26, marking a +1.56% move from the previous day.",AMGN,0.631282,0.353207,Bullish
"Amgen Inc.  ( AMGN )  Soars to 52-Week High, Time to Cash Out?",https://www.zacks.com/stock/news/2215717/amgen-inc-amgn-soars-to-52-week-high-time-to-cash-out,2024-01-25 14:15:04,"Amgen (AMGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",AMGN,0.739411,0.437982,Bullish
"Futures Higher Ahead Of GDP, Jobless Claims; Tesla Dives",https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-gdp-jobless-claims-tesla-dives-on-earnings-musk-warning/,2024-01-25 13:22:08,"Dow Jones Futures Fall Ahead of GDP, Jobless Claims. Tesla Dives On Earnings, Musk Warning Investor's Business Daily ...",AMGN,0.149889,0.088261,Neutral
Should Schwab U.S. Dividend Equity ETF  ( SCHD )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2215497/should-schwab-us-dividend-equity-etf-schd-be-on-your-investing-radar,2024-01-25 11:20:06,Style Box ETF report for ...,AMGN,0.12013,0.067797,Neutral
Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,https://www.zacks.com/stock/news/2215507/should-you-invest-in-the-ishares-biotechnology-etf-ibb,2024-01-25 11:20:04,Sector ETF report for ...,AMGN,0.138066,0.072464,Neutral
"The Zacks Analyst Blog Highlights Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson",https://www.zacks.com/stock/news/2215470/the-zacks-analyst-blog-highlights-novartis-amgen-palo-alto-brown-brown-and-ericsson,2024-01-25 09:58:00,"Novartis, Amgen, Palo Alto, Brown & Brown and Ericsson are included in this Analyst Blog.",AMGN,0.404563,0.181316,Somewhat-Bullish
"Top Research Reports for Novartis, Amgen & Palo Alto Networks",https://www.zacks.com/research-daily/2214881/top-research-reports-for-novartis-amgen-palo-alto-networks,2024-01-24 19:15:00,"Today's Research Daily features new research reports on 16 major stocks, including Novartis AG (NVS), Amgen Inc. (AMGN) and Palo Alto Networks, Inc. (PANW).",AMGN,0.285526,0.224801,Somewhat-Bullish
"These Stocks Led Dow's Run to 38,000. It's Not Who You Expect.",https://www.investors.com/research/dow-jones-cleared-38000-thanks-to-these-stocks-aapl-lagged-msft-underperformed/,2024-01-24 17:58:00,"Dow Jones cleared 38,000 thanks to these stocks. AAPL, MSFT did not help as much Separator Investor's Business Daily ...",AMGN,0.244109,0.0,Neutral
Tech Futures Rally As Netflix Surges,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-as-netflix-surges-on-earnings-tesla-earnings-next/,2024-01-24 13:15:00,Dow Jones Futures Rise As Netflix Surges On Earnings. Tesla Earnings Next Investor's Business Daily ...,AMGN,0.172713,0.111839,Neutral
What's Going On Johnson & Johnson Stock Today? - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/general/biotech/24/01/36755938/whats-going-on-johnson-johnson-stock-today,2024-01-24 12:54:16,"Tuesday, Johnson & Johnson JNJ released better-than-expected earnings for its fourth quarter of 2023. It reported quarterly adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 ...",AMGN,0.219809,0.065799,Neutral
This 1 Bullish Move by Merck Could Drive Growth for Years to Come,https://www.fool.com/investing/2024/01/23/this-1-bullish-move-by-merck-could-drive-growth-fo/,2024-01-23 13:45:00,It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.,AMGN,0.043658,-0.002968,Neutral
Futures Mixed After Earnings Reports,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-big-earnings-reports-magnificent-seven-stock-netflix-to-report-next/,2024-01-23 13:12:00,Dow Jones Futures Fall On Big Earnings Reports. Magnificent Seven Stock Netflix To Report Next Investor's Business Daily ...,AMGN,0.170576,0.096618,Neutral
5 Magnificent Dividend Growth Stocks to Buy and Hold Forever,https://www.fool.com/investing/2024/01/23/5-magnificent-dividend-growth-stocks-to-buy-and-ho/,2024-01-23 11:45:00,These dividend growers ought to shine in 2024 and beyond.,AMGN,0.171688,0.380978,Bullish
Wearable Injectors Market Surges Towards US$ 19.4 Billion by 2033 with 10.2% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36711531/wearable-injectors-market-surges-towards-us-19-4-billion-by-2033-with-10-2-cagr-persistence-market,2024-01-22 09:00:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Wearable Injectors Market has witnessed remarkable growth in recent years, driven by a combination of technological advancements and the growing demand for convenient and patient-centric drug delivery solutions.",AMGN,0.014693,0.047485,Neutral
"USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and ... - PR Newswire",https://www.prnewswire.com/news-releases/usd-10-40-billion-growth-in-vascular-endothelial-market-between-2022-and-2027--the-strategic-alliances-and-collaborations-are-notably-driving-market-growth-17-000-technavio-research-reports-302039609.html,2024-01-22 04:35:00,"USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and ... PR ...",AMGN,0.049939,0.083583,Neutral
Top Wall Street analysts pick these stocks for solid returns,https://www.cnbc.com/2024/01/21/top-wall-street-analysts-pick-these-stocks-for-solid-returns.html,2024-01-21 12:02:43,"TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Amazon and Nvidia.",AMGN,0.092748,0.145361,Neutral
Here's Why Amgen  ( AMGN )  Gained But Lagged the Market Today,https://www.zacks.com/stock/news/2213088/heres-why-amgen-amgn-gained-but-lagged-the-market-today,2024-01-19 22:50:17,"Amgen (AMGN) reachead $307.81 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close.",AMGN,0.549988,0.213311,Somewhat-Bullish
Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/liquid-biopsy-in-cancer-diagnostics-global-market-is-likely-to-increase-at-a-massive-growth-rate-of-17-by-2028--delveinsight-302039144.html,2024-01-19 22:01:00,Liquid Biopsy in Cancer Diagnostics Global Market is Likely to Increase at a Massive Growth Rate of ~17% by 2028 ... PR ...,AMGN,0.021143,-0.132382,Neutral
Amgen's Blockbuster Osteoporosis Drug Prolia Flagged With FDA Strictest Warning - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/general/biotech/24/01/36699737/amgens-blockbuster-osteoporosis-drug-prolia-flagged-with-fda-strictest-warning,2024-01-19 18:29:11,"The FDA has added a serious warning to the prescribing information for Amgen Inc's AMGN drug Prolia ( denosumab ) , emphasizing an increased risk of severely low calcium levels in specific patient groups.",AMGN,0.414559,-0.179888,Somewhat-Bearish
Futures Higher Ahead Of Inflation Reading,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-inflation-survey-nvidia-stock-jumps-to-record-highs/,2024-01-19 13:20:00,Dow Jones Futures Rise Ahead Of Key Inflation Survey. Nvidia Stock Jumps To Record High Investor's Business Daily ...,AMGN,0.168785,0.139559,Neutral
"GeminiBio Appoints Steven Sandoval, Sr. to its Board of Directors",https://www.prnewswire.com/news-releases/geminibio-appoints-steven-sandoval-sr-to-its-board-of-directors-302037950.html,2024-01-18 14:00:00,* Senior biopharma and cell therapy engineering/operations executive with 30+ years of experience to help drive growth,AMGN,0.073546,0.107281,Neutral
Tech Futures Rally Ahead Of Jobless Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobless-claims-nvidia-stock-set-to-hit-more-record-highs/,2024-01-18 13:20:00,Dow Jones Futures Fall Ahead Of Jobless Claims. Nvidia Set To Hit More Record Highs Investor's Business Daily ...,AMGN,0.16171,0.135664,Neutral
Amgen  ( AMGN )  Ascends While Market Falls: Some Facts to Note,https://www.zacks.com/stock/news/2211768/amgen-amgn-ascends-while-market-falls-some-facts-to-note,2024-01-17 23:00:17,"Amgen (AMGN) closed the most recent trading day at $304.08, moving +0.2% from the previous trading session.",AMGN,0.553265,0.17929,Somewhat-Bullish
Amgen Options Trading: A Deep Dive into Market Sentiment - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/options/24/01/36666528/amgen-options-trading-a-deep-dive-into-market-sentiment,2024-01-17 19:30:57,"Financial giants have made a conspicuous bearish move on Amgen. Our analysis of options history for Amgen AMGN revealed 18 unusual trades. Delving into the details, we found 27% of traders were bullish, while 72% showed bearish tendencies.",AMGN,0.708432,0.023286,Neutral
Futures Drop Ahead Of Retail Sales,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-retail-sales-tesla-stock-slides-on-more-price-cuts/,2024-01-17 13:17:00,"Dow Jones futures sank along with other major indexes early Wednesday, as markets continued to slide after failing to gain their footing on Tuesday. Meanwhile, Tesla stock struggled below critical benchmarks after the company lowered prices on its Model Y electric vehicles in Germany.",AMGN,0.17179,0.144019,Neutral
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/markets/equities/24/01/36653786/cathie-woods-ark-invest-liquidates-15-8m-worth-of-proshares-bitcoin-strategy-etf-units,2024-01-17 03:39:39,"On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF BITO units. This trade comes amidst a dynamic period in the cryptocurrency market, reflecting Ark Invest's strategic adjustments in response to evolving market ...",AMGN,0.224903,0.301824,Somewhat-Bullish
Osteoporosis Drugs Market is Projected to Develop at a CAGR of 3.5% from 2023 to 2033 | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36635069/osteoporosis-drugs-market-is-projected-to-develop-at-a-cagr-of-3-5-from-2023-to-2033-persistence-m,2024-01-16 08:00:00,"New York, Jan. 16, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Osteoporosis Drugs Market is a rapidly evolving sector within the pharmaceutical industry, primarily driven by the growing aging population and the increasing prevalence of osteoporosis worldwide.",AMGN,0.021797,0.044643,Neutral
"Disney, Caterpillar, McDonald's, Ford: Investing Action Plan",https://www.investors.com/research/investing-action-plan/disney-stock-caterpillar-mcdonalds-ford-investing-action-plan/,2024-02-02 23:00:00,"Disney Stock, Caterpillar, McDonald's, Ford: Investing Action Plan Investor's Business Daily ...",AMGN,0.053931,0.030931,Neutral
"AbbVie  ( ABBV )  Q4 Earnings Beat, Raises Sales View for Key Drugs",https://www.zacks.com/stock/news/2220511/abbvie-abbv-q4-earnings-beat-raises-sales-view-for-key-drugs,2024-02-02 18:04:00,AbbVie???s (ABBV) fourth-quarter earnings and sales beat estimates. Management hikes the 2027 forecast for new immunology drugs to more than $27 billion.,AMGN,0.146916,0.01294,Neutral
Why you can count on the Dow making changes in February,https://www.marketwatch.com/story/why-you-can-count-on-the-dow-making-changes-in-february-6334fda9,2024-02-01 16:49:00,"Investors can count on the Dow Jones Industrial Average changing its members next month, for the first time in nearly four years, for several reasons. The question is, who's out and who's in?",AMGN,0.075995,0.0,Neutral
Futures Rebound Ahead Of Jobless Claims,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-jobless-claims-amazon-apple-to-report/,2024-02-01 14:33:00,"Dow Jones Rises On Surprise Jobless Claims. Amazon, Apple To Report Investor's Business Daily ...",AMGN,0.175539,0.136375,Neutral
Unlocking Q4 Potential of Amgen  ( AMGN ) : Exploring Wall Street Estimates for Key Metrics,https://www.zacks.com/stock/news/2219395/unlocking-q4-potential-of-amgen-amgn-exploring-wall-street-estimates-for-key-metrics,2024-02-01 14:15:21,Get a deeper insight into the potential performance of Amgen (AMGN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.,AMGN,0.349575,0.19197,Somewhat-Bullish
Is Amgen Stock a Buy Now?,https://www.fool.com/investing/2024/02/01/is-amgen-stock-a-buy-now/,2024-02-01 12:15:00,"The biotech has an excellent track record, but that isn't enough to make its shares attractive.",AMGN,0.70166,0.260005,Somewhat-Bullish
Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2219196/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,2024-02-01 11:20:06,Smart Beta ETF report for ...,AMGN,0.122894,0.06159,Neutral
Amgen  ( AMGN )  Stock Moves -0.11%: What You Should Know,https://www.zacks.com/stock/news/2219074/amgen-amgn-stock-moves--011-what-you-should-know,2024-01-31 22:50:18,"Amgen (AMGN) reachead $314.26 at the closing of the latest trading day, reflecting a -0.11% change compared to its last close.",AMGN,0.575407,0.179308,Somewhat-Bullish
Eli Lilly  ( LLY )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2218932/eli-lilly-lly-to-report-q4-earnings-whats-in-the-cards,2024-01-31 16:48:00,"On Eli Lilly's (LLY) fourth-quarter conference call, investor focus is likely to be on the sales performance of its tirzepatide medicines, Mounjaro and Zepbound.",AMGN,0.207216,0.058657,Neutral
Regeneron  ( REGN )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2218887/regeneron-regn-to-report-q4-earnings-whats-in-the-cards,2024-01-31 16:20:00,Investors' focus is likely to be on the performance of Dupixent and the uptake of Eylea HD when Regeneron (REGN) reports its fourth-quarter 2023 results.,AMGN,0.17618,0.122537,Neutral
"Futures Mixed Ahead Of Fed Decision, Powell",https://www.investors.com/market-trend/stock-market-today/tech-falls-dow-jones-futures-rise-ahead-of-fed-decision-amd-google-microsoft-tesla-slide/,2024-01-31 13:21:00,"Dow Jones Futures Rise Ahead Of Today's Fed Decision, Powell. Google, Microsoft, Tesla Slide Investor's Business Daily ...",AMGN,0.173958,0.12846,Neutral
Amgen Options Trading: A Deep Dive into Market Sentiment - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/insights/options/24/01/36853303/amgen-options-trading-a-deep-dive-into-market-sentiment,2024-01-30 20:00:44,"Deep-pocketed investors have adopted a bullish approach towards Amgen AMGN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.",AMGN,0.814341,0.219763,Somewhat-Bullish
Will Amazon's  ( AMZN )  Q4 Earnings Benefit From AWS Momentum?,https://www.zacks.com/stock/news/2218033/will-amazons-amzn-q4-earnings-benefit-from-aws-momentum,2024-01-30 15:14:00,"Amazon's (AMZN) fourth-quarter results are likely to reflect benefits from AWS' expanding customer base, driven by the strong services portfolio and rising number of cloud regions.",AMGN,0.197413,0.289785,Somewhat-Bullish
Amgen  ( AMGN )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,https://www.zacks.com/stock/news/2218010/amgen-amgn-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,2024-01-30 15:00:49,Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,AMGN,0.258808,0.216361,Somewhat-Bullish
Futures Fall Ahead Of Key Economic Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-key-economic-data-alphabet-amd-microsoft-to-report-earnings/,2024-01-30 13:23:00,"Dow Jones futures fell slightly Tuesday morning, as Wall Street prepared for key economic data, with the early release of two housing reports, consumer confidence numbers and job openings.",AMGN,0.142989,0.05936,Neutral
"Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc ... - PR Newswire",https://www.prnewswire.com/news-releases/renal-anemia-therapeutics-market-to-record-growth-of-usd-2-08-billion-from-2023-to-2028--akebia-therapeutics-inc-and-amgen-inc-to-emerge-as-some-of-the-key-companies---technavio-302045440.html,2024-01-29 23:30:00,"Renal Anemia Therapeutics Market to Record Growth of USD 2.08 billion from 2023 to 2028, Akebia Therapeutics Inc ... PR ...",AMGN,0.100941,0.114068,Neutral
Futures: Fed Meeting On Deck; AI Leader Surges Late,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-fed-meeting-on-deck-ai-stock-supermicro-surges-on-earnings-beat/,2024-01-29 21:54:00,Dow Jones Futures: Fed Meeting On Deck. AI Stock Supermicro Surges On Earnings Beat Investor's Business Daily ...,AMGN,0.114318,0.072028,Neutral
Will Amgen  ( AMGN )  Beat Estimates Again in Its Next Earnings Report?,https://www.zacks.com/stock/news/2217364/will-amgen-amgn-beat-estimates-again-in-its-next-earnings-report,2024-01-29 17:10:11,Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,AMGN,0.407844,0.460842,Bullish
Investors Heavily Search Amgen Inc.  ( AMGN ) : Here is What You Need to Know,https://www.zacks.com/stock/news/2216980/investors-heavily-search-amgen-inc-amgn-here-is-what-you-need-to-know,2024-01-29 14:00:06,"Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.",AMGN,0.490323,0.104893,Neutral
Is Amgen a Good Dividend Stock to Buy Right Now?,https://www.fool.com/investing/2024/01/29/is-amgen-a-good-dividend-stock-to-buy-right-now/,2024-01-29 13:30:00,Its diverse product mix and strong fundamentals make a decent case.,AMGN,0.43494,0.265827,Somewhat-Bullish
Can Amgen  ( AMGN )  Keep the Beat Streak Alive in Q4 Earnings?,https://www.zacks.com/stock/news/2216908/can-amgen-amgn-keep-the-beat-streak-alive-in-q4-earnings,2024-01-29 13:18:00,"Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.",AMGN,0.360752,0.33925,Somewhat-Bullish
Futures Mixed Ahead Of Busy Week,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-ahead-of-busy-week-sofi-stock-surges-on-first-ever-profit/,2024-01-29 13:06:00,Dow Jones Futures Fall Ahead Of Busy Week. SoFi Stock Surges On First Ever Profit Investor's Business Daily ...,AMGN,0.143415,0.073996,Neutral
deCODE genetics: A sequence variant that increases risk of pregnancy loss,https://investingnews.com/decode-genetics-a-sequence-variant-that-increases-risk-of-pregnancy-loss/,2024-01-29 11:05:00,"Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland Denmark, and the USA published a study today in Nature Structural & Molecular Biology titled ""Variant in the synaptonemal complex protein SYCE2 associates with pregnancy loss through effects on ...",AMGN,0.306963,-0.154352,Somewhat-Bearish
deCODE genetics: A sequence variant that increases risk of pregnancy loss - Canada NewsWire,https://www.newswire.ca/news-releases/decode-genetics-a-sequence-variant-that-increases-risk-of-pregnancy-loss-804766724.html,2024-01-29 10:00:00,deCODE genetics: A sequence variant that increases risk of pregnancy loss Canada ...,AMGN,0.303175,-0.142151,Neutral
deCODE genetics: A sequence variant that increases risk of pregnancy loss - PR Newswire,https://www.prnewswire.com/news-releases/decode-genetics-a-sequence-variant-that-increases-risk-of-pregnancy-loss-302043584.html,2024-01-29 10:00:00,deCODE genetics: A sequence variant that increases risk of pregnancy loss PR ...,AMGN,0.263942,-0.127168,Neutral
"deCODE genetics: Eine Sequenzvariante, die das Risiko eines Schwangerschaftsverlusts erhöht USA - Deutsch - USA - PR Newswire",https://www.prnewswire.com/news-releases/decode-genetics-eine-sequenzvariante-die-das-risiko-eines-schwangerschaftsverlusts-erhoht-302044475.html,2024-01-29 10:00:00,"deCODE genetics: Eine Sequenzvariante, die das Risiko eines Schwangerschaftsverlusts erhöht USA - Deutsch - USA PR ...",AMGN,0.231332,-0.100448,Neutral
deCODE genetics: Una variante de secuencia que aumenta el riesgo de pérdida del embarazo - PR Newswire,https://www.prnewswire.com/news-releases/decode-genetics-una-variante-de-secuencia-que-aumenta-el-riesgo-de-perdida-del-embarazo-302043800.html,2024-01-29 10:00:00,deCODE genetics: Una variante de secuencia que aumenta el riesgo de pérdida del embarazo PR ...,AMGN,0.199447,-0.018663,Neutral
deCODE genetics : Un variant de séquence qui augmente le risque de fausse couche - PR Newswire,https://www.prnewswire.com/news-releases/decode-genetics--un-variant-de-sequence-qui-augmente-le-risque-de-fausse-couche-302044593.html,2024-01-29 10:00:00,deCODE genetics : Un variant de séquence qui augmente le risque de fausse couche PR ...,AMGN,0.163909,0.02134,Neutral
"Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®",https://www.globenewswire.com/news-release/2024/01/29/2818530/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT03-a-Proposed-Biosimilar-for-Prolia-and-Xgeva.html,2024-01-29 09:00:00,"Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic ( PK ) study for AVT03, a biosimilar candidate to Prolia® and Xgeva®, which both ...",AMGN,0.025219,0.0,Neutral
"Alvotech Announces Positive Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®",https://www.globenewswire.com/news-release/2024/01/29/2818535/0/en/Alvotech-Announces-Positive-Top-Line-Results-from-a-Pharmacokinetic-Study-for-AVT03-a-Proposed-Biosimilar-for-Prolia-and-Xgeva.html,2024-01-29 09:00:00,"REYKJAVIK, Iceland, Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today positive top-line results from a pharmacokinetic ( PK ) study for AVT03, a ...",AMGN,0.02506,0.0,Neutral
Amgen's Planning to Take a Bite Out of Cancer. Here's What It Means for the Stock.,https://www.fool.com/investing/2024/01/27/amgens-planning-to-take-a-bite-out-of-cancer-heres/,2024-01-27 14:00:00,Its new approach to treating cancer is more than just a nibble around the edges.,AMGN,0.425541,0.270512,Somewhat-Bullish
Should You Buy the Dogs of the Dow in 2024?,https://www.fool.com/investing/2024/01/27/should-you-buy-the-dogs-of-the-dow-in-2024/,2024-01-27 11:59:00,The popular dividend-investing strategy has been around for years. Is it right for you?,AMGN,0.064797,0.134527,Neutral
Amgen  ( NASDAQ:AMGN )  Upgraded to Strong-Buy at StockNews.com,https://www.defenseworld.net/2024/01/27/amgen-nasdaqamgn-upgraded-to-strong-buy-at-stocknews-com.html,2024-01-27 10:30:43,"Amgen ( NASDAQ:AMGN - Get Free Report ) was upgraded by equities researchers at StockNews.com from a ""buy"" rating to a ""strong-buy"" rating in a research note issued to investors on Saturday. Other equities research analysts also recently issued reports about the company.",AMGN,0.040553,0.083332,Neutral
"Apple, Boeing, Microsoft, Alphabet And A Fed Meeting, For Starters: Investing Action Plan",https://www.investors.com/research/investing-action-plan/apple-boeing-microsoft-alphabet-and-a-fed-meeting-for-starters-investing-action-plan/,2024-01-26 22:32:00,"As the stock market pushes its rally toward the end of a third straight month, some of its biggest names line up for earnings releases in the coming week. Apple ( AAPL ) , Alphabet ( GOOGL ) , Microsoft ( MSFT ) and Meta Platforms ( META ) are part of the picture.",AMGN,0.071677,-0.053265,Neutral
P/E Ratio Insights for Amgen - Amgen  ( NASDAQ:AMGN ) ,https://www.benzinga.com/insights/news/24/01/36808927/pe-ratio-insights-for-amgen,2024-01-26 20:45:14,"In the current session, the stock is trading at $310.50, after a 0.08% spike. Over the past month, Amgen Inc. AMGN stock increased by 8.17%, and in the past year, by 23.83%.",AMGN,0.43852,0.061083,Neutral
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.,https://www.prnewswire.com/news-releases/regenerative-medicine-market-worth-49-0-billion--marketsandmarkets-302044495.html,2024-01-26 15:30:00,"CHICAGO, Jan. 26, 2024 /PRNewswire/ -- Regenerative Medicine Market in terms of revenue was estimated to be worth $16.0 billion in 2023 and is poised to reach $49.0 billion by 2028, growing at a CAGR of 25.1% from 2023 to 2028 according to a new report by MarketsandMarkets™.",AMGN,0.073773,0.107998,Neutral
Key Takeaways From JNJ's  ( JNJ )  Q4 Earnings Presentation,https://www.zacks.com/stock/news/2216453/key-takeaways-from-jnjs-jnj-q4-earnings-presentation,2024-01-26 14:30:00,J&J's (JNJ) Innovative Medicines as well as MedTech units outperform expectations in the fourth quarter. Here we discuss some highlights of its performance in the fourth quarter.,AMGN,0.114137,0.145984,Neutral
Futures Lower Ahead Of Key Inflation Data,https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-intel-plunges-on-earnings-cathie-wood-loads-up-as-tesla-dives/,2024-01-26 13:18:00,Dow Jones Futures Fall As Intel Plunges On Earnings. Cathie Wood Loads Up As Tesla Dives Investor's Business Daily ...,AMGN,0.180124,0.148327,Neutral
